<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Chinese herbal medicine for atopic eczema - Gu, S - 2013 | Cochrane Library</title> <meta content="Chinese herbal medicine for atopic eczema - Gu, S - 2013 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008642.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Chinese herbal medicine for atopic eczema - Gu, S - 2013 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008642.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD008642.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Chinese herbal medicine for atopic eczema" name="citation_title"/> <meta content="Sherman Gu" name="citation_author"/> <meta content="RMIT University" name="citation_author_institution"/> <meta content="sherman.gu@rmit.edu.au" name="citation_author_email"/> <meta content="Angela WH Yang" name="citation_author"/> <meta content="RMIT University" name="citation_author_institution"/> <meta content="Charlie CL Xue" name="citation_author"/> <meta content="RMIT University" name="citation_author_institution"/> <meta content="Chun G Li" name="citation_author"/> <meta content="University of Western Sydney" name="citation_author_institution"/> <meta content="Carmen Pang" name="citation_author"/> <meta content="c/o Cochrane Skin Group, The University of Nottingham" name="citation_author_institution"/> <meta content="Weiya Zhang" name="citation_author"/> <meta content="The University of Nottingham" name="citation_author_institution"/> <meta content="Hywel C Williams" name="citation_author"/> <meta content="The University of Nottingham" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="9" name="citation_issue"/> <meta content="10.1002/14651858.CD008642.pub2" name="citation_doi"/> <meta content="2013" name="citation_date"/> <meta content="2013/09/10" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008642.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008642.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008642.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Administration, Oral; Administration, Topical; Dermatitis, Atopic [*drug therapy]; Dermatologic Agents [*therapeutic use]; Drugs, Chinese Herbal [*administration &amp; dosage, adverse effects]; Randomized Controlled Trials as Topic" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008642.pub2&amp;doi=10.1002/14651858.CD008642.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008642.pub2&amp;doi=10.1002/14651858.CD008642.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008642.pub2&amp;doi=10.1002/14651858.CD008642.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008642.pub2&amp;doi=10.1002/14651858.CD008642.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008642.pub2&amp;doi=10.1002/14651858.CD008642.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008642.pub2&amp;doi=10.1002/14651858.CD008642.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008642.pub2&amp;doi=10.1002/14651858.CD008642.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008642.pub2&amp;doi=10.1002/14651858.CD008642.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008642.pub2&amp;doi=10.1002/14651858.CD008642.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008642.pub2&amp;doi=10.1002/14651858.CD008642.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008642.pub2&amp;doi=10.1002/14651858.CD008642.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008642.pub2&amp;doi=10.1002/14651858.CD008642.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008642.pub2&amp;doi=10.1002/14651858.CD008642.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008642.pub2&amp;doi=10.1002/14651858.CD008642.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008642.pub2&amp;doi=10.1002/14651858.CD008642.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008642.pub2&amp;doi=10.1002/14651858.CD008642.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008642.pub2&amp;doi=10.1002/14651858.CD008642.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008642.pub2&amp;doi=10.1002/14651858.CD008642.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008642.pub2&amp;doi=10.1002/14651858.CD008642.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008642.pub2&amp;doi=10.1002/14651858.CD008642.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008642.pub2&amp;doi=10.1002/14651858.CD008642.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008642.pub2&amp;doi=10.1002/14651858.CD008642.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008642.pub2&amp;doi=10.1002/14651858.CD008642.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="Qh5938oe";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD008642\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD008642\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008642\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD008642\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","ko","ms","ja","hr","fr","fa","zh_HANS"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD008642.pub2",title:"Chinese herbal medicine for atopic eczema",firstPublishedDate:"Sep 10, 2013 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Skin Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=Qh5938oe&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD008642.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD008642.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD008642.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD008642.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD008642.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD008642.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;アブストラクト&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;초록&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;쉬운 말 요약&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD008642.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD008642.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD008642.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD008642.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>7799 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD008642.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008642.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008642.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008642.pub2/full#CD008642-abs-0005"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008642.pub2/full#CD008642-sec-0141"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008642.pub2/full#CD008642-sec-0043"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008642.pub2/full#CD008642-sec-0044"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008642.pub2/full#CD008642-sec-0049"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008642.pub2/full#CD008642-sec-0050"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008642.pub2/full#CD008642-sec-0079"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008642.pub2/full#CD008642-sec-0135"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008642.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008642.pub2/appendices#CD008642-sec-0146"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008642.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008642.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/table_n/CD008642StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/table_n/CD008642StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008642.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008642.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008642.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD008642.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD008642.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD008642.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2015 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Chinese herbal medicine for atopic eczema</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD008642.pub2/information#CD008642-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Sherman Gu</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD008642.pub2/information#CD008642-cr-0003">Angela WH Yang</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD008642.pub2/information#CD008642-cr-0004">Charlie CL Xue</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD008642.pub2/information#CD008642-cr-0005">Chun G Li</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD008642.pub2/information#CD008642-cr-0006">Carmen Pang</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD008642.pub2/information#CD008642-cr-0007">Weiya Zhang</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD008642.pub2/information#CD008642-cr-0008">Hywel C Williams</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/information/en#CD008642-sec-0160">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 10 September 2013 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD008642.pub2">https://doi.org/10.1002/14651858.CD008642.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD008642-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD008642-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD008642-abs-0011">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD008642-abs-0013">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD008642-abs-0004">Français</a> </li> <li class="section-language"> <a class="" href="full/ja#CD008642-abs-0003">日本語</a> </li> <li class="section-language"> <a class="" href="full/ko#CD008642-abs-0002">한국어</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD008642-abs-0015">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD008642-abs-0001" lang="en"> <section id="CD008642-sec-0001"> <h3 class="title" id="CD008642-sec-0001">Background</h3> <p>Chinese herbal medicine (CHM) has been increasingly used for atopic eczema. A previous version of this Cochrane review published in 2004 found some evidence of a possible benefit for oral ingestion of CHM for eczema, but the results were inconclusive and the evidence needs to be updated. We have expanded the scope of this review to include an assessment of the topical and oral effects of CHM for eczema. </p> </section> <section id="CD008642-sec-0002"> <h3 class="title" id="CD008642-sec-0002">Objectives</h3> <p>To assess the effects of oral ingestion and topical applications of CHM for the management of eczema in children and adults. </p> </section> <section id="CD008642-sec-0003"> <h3 class="title" id="CD008642-sec-0003">Search methods</h3> <p>We searched the following databases up to September 2012: the Cochrane Skin Group Specialised Register, CENTRAL in <i>The Cochrane Library</i> (2012, Issue 8), MEDLINE (from 1946), EMBASE (from 1974), AMED (from 1985), LILACS (from 1982), and CINAHL (from 1981). We searched the following from inception: SCOPUS, HERBMED, ProQuest, CQVIP, CNKI, and Wanfang Data. We also searched trials registers, handsearched conference proceedings, checked the reference lists of all included and excluded studies and review articles for further references to relevant trials, and contacted experts in Chinese medicine for unpublished studies. </p> </section> <section id="CD008642-sec-0004"> <h3 class="title" id="CD008642-sec-0004">Selection criteria</h3> <p>All randomised controlled trials (RCTs) in children and adults with eczema comparing CHM to placebo; no intervention; active controls, including acupuncture; or conventional medicines. </p> </section> <section id="CD008642-sec-0005"> <h3 class="title" id="CD008642-sec-0005">Data collection and analysis</h3> <p>Two authors selected the RCTs, extracted data, and assessed quality independently. We contacted study authors for missing data. We collected adverse events from the included studies. </p> </section> <section id="CD008642-sec-0006"> <h3 class="title" id="CD008642-sec-0006">Main results</h3> <p>We included 28 studies, with a total of 2306 participants. We assessed most of the studies at high 'risk of bias', particularly in blinding of participants and personnel, and there was substantial inconsistency between studies, so any positive effect of CHM must be treated with caution. We did not include the four studies from the previous version in this review, because they investigated a CHM product that has been withdrawn from the market since 2004. </p> <p>Four studies (three oral and one topical) compared CHM to placebo. Pooled data from 2 studies showed the total effectiveness rate in the CHM group was higher (by risk ratio (RR) 2.09, 95% confidence interval (CI) 1.32 to 3.32; 2 studies; n = 85), and the itching visual analogue score (VAS) in the CHM group was 1.53 lower (by standardised mean difference (SMD), 95% CI 2.64 to 0.41; 2 Studies; n = 94) than the placebo group, where a lower VAS score indicates reduced itch. One study of 85 participants with moderate to severe eczema who received an oral CHM formula for 12 weeks reported a quality of life (QoL) score 2.5 lower in the CHM group (by difference in means (MD), 95% CI 4.77 to 0.23; 1 study; n = 85) than the placebo group, where a lower score indicates better QoL.   </p> <p>Twenty‐two studies and 1 arm from a study with a 4‐arm parallel controlled design compared CHM (5 oral, 6 topical, and 12 mixed oral and topical) to conventional medicines. The total effectiveness rate in the CHM groups was superior (RR 1.43, 95% CI 1.27 to 1.61; 21 studies; n = 1868; very low quality evidence), and the itching VAS in the CHM groups was 0.83 lower (SMD, 95% CI 1.43 to 0.22; 7 studies; n = 465) than the comparators. </p> <p>Two studies compared combined oral and topical CHM to the same oral CHM formula alone. The total effectiveness rate in 1 study was not statistically significant (RR 1.13, 95% CI 0.78 to 1.63; 1 study; n = 20). In the other study, the itching VAS in the CHM group was 1.05 lower (MD, 95% CI 1.75 to 0.35; 1 study; n = 23) than the control group. </p> <p>With regard to side‐effects, four studies did not give any report of adverse events. The other 24 studies reported minor adverse events, which were reversed soon after stopping CHM. One participant withdrew from one trial because of exacerbation of their condition after using the CHM intervention. </p> <p>Eight studies received government funding.</p> </section> <section id="CD008642-sec-0007"> <h3 class="title" id="CD008642-sec-0007">Authors' conclusions</h3> <p>We could not find conclusive evidence that CHM taken by mouth or applied topically to the skin could reduce the severity of eczema in children or adults. </p> <p>Well‐designed, adequately powered RCTs are needed to evaluate the efficacy and safety of CHM for managing eczema. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD008642-abs-0005" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD008642-abs-0005">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD008642-abs-0012">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD008642-abs-0014">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD008642-abs-0010">Français</a> </li> <li class="section-language"> <a class="" href="full/hr#CD008642-abs-0009">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/ja#CD008642-abs-0008">日本語</a> </li> <li class="section-language"> <a class="" href="full/ko#CD008642-abs-0006">한국어</a> </li> <li class="section-language"> <a class="" href="full/ms#CD008642-abs-0007">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD008642-abs-0016">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD008642-abs-0005" lang="en"> <h3>Chinese herbal medicine taken by mouth or applied to the skin for atopic eczema in children and adults </h3> <p>Atopic eczema (eczema in short) is a common skin condition, where skin changes occur and cause redness, scaling, swelling, and skin thickening due to chronic scratching. It is associated with loss of sleep, self‐esteem, and quality of life. The frequency of eczema has increased over the past 10 years. </p> <p>A former Cochrane review published in 2004 found some evidence of a possible benefit of using oral Chinese herbal medicine (CHM) for eczema; however, the results from only 4 included studies were inconclusive and need to be updated (those four studies have not been included in this update as they investigated a product that has been withdrawn from the market since 2004). As well as updating that review, we have also widened the scope of the review to assess the effects of topical CHM for eczema. We wrote a new protocol to expand the scope of this review. </p> <p>This review included 28 randomised controlled trials (RCTs), with 2306 children and adults, of which 4 compared CHM to placebo, 22 to conventional medications, and 2 to CHM taken by mouth. </p> <p>Most of the included studies reported a higher number of participants who had recovered and significantly improved, with less itching in the CHM groups than the control groups. Where CHM was compared to conventional drugs, although the total effectiveness rate outcome was superior with CHM, it was based on very low quality evidence. One study reported that the quality of life (QoL) score in the CHM group was better than in the placebo group after using a CHM formula taken by mouth for 12 weeks. We assessed most of the studies as at high 'risk of bias' and therefore not of good quality, and there was substantial inconsistency between the studies, so any positive effect in CHM must be treated with caution. </p> <p>One study reported one severe adverse event. Minor adverse events were observed in 24 studies, including temporary elevation of enzymes in 3 cases, which was reversed soon after stopping CHM. </p> <p>Eight included studies received government funding.</p> <p>We could not find conclusive evidence that CHM taken by mouth or applied to the skin was of benefit to children or adults with eczema. </p> <p>Well‐designed, adequately powered RCTs are needed to evaluate the efficacy and safety of CHM for eczema. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD008642-sec-0141" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD008642-sec-0141"></div> <h3 class="title" id="CD008642-sec-0142">Implications for practice</h3> <section id="CD008642-sec-0142"> <p>We could not find conclusive evidence that oral ingestion of other Chinese herbs or Chinese herbal formulae used in the included studies could improve the condition. Furthermore, we could not find convincing evidence that topical application of CHM, whether used alone or in conjunction with oral ingestion of Chinese herbal formulae, could reduce the severity of eczema in children or adults. Even though in the included studies there were statistically significant differences in the outcome measures where CHM treatment groups were compared to those in the control groups, because of a low strength of evidence and high risk of bias, these claims cannot be regarded as reliable.  </p> </section> <h3 class="title" id="CD008642-sec-0143">Implications for research</h3> <section id="CD008642-sec-0143"> <p>There is evidence that CHM has been increasingly used for the management of eczema since the publication of the first Cochrane systematic review in this area, and many included studies were government‐funded research projects (almost one third of the included studies received funding). The following are our suggestions for conducting a randomised controlled trial of CHM for eczema in the future. </p> <p> <ul id="CD008642-list-0008"> <li> <p>Recruitment of participants with similar ages or severity of their condition is needed to minimise heterogeneous outcomes within the study. Stratified randomisation is recommended if the study recruits both children and adults. </p> </li> <li> <p>Sample size in the intervention group and control group should be balanced. Characteristics of participants in the two groups should be comparable. Methods for randomisation must be clearly described on the published paper. </p> </li> <li> <p>Blinding should always be used, because in most cases, outcome measures for eczema are subjective. An open‐label design study could lead to risk of bias for outcome assessment. </p> </li> <li> <p>Application of the intervention should be used alone, i.e. oral ingestion or topical application with appropriate comparator unless efficacy of the oral ingestion or topical application of the intervention has been confirmed respectively. Quality control, including appropriate toxicology studies and quality assurance of Chinese herbs to be investigated, should be performed prior to the conduct of clinical trials as contamination of any non‐CHM components detracts from the high standards and tradition of Chinese medicine. </p> </li> <li> <p>Assessment of effectiveness of the intervention should rely on data from both objective and subjective outcome measures assessed at baseline and at the end point of the trial. Using published and validated scoring systems, such as EASI, SASSAD, or SCORAD as a primary outcome measure may help to achieve this, and continuous data should always be reported or provided upon request. </p> </li> <li> <p>Adverse events should be adequately reported. Liver and renal function tests should be used as one of the safety parameters in a randomised controlled trial. </p> </li> </ul> </p> <p>In summary, well‐designed, adequately powered, randomised placebo‐controlled clinical trials are required to evaluate the efficacy and safety of CHM for managing eczema. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD008642-sec-0043" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD008642-sec-0043"></div> <div class="table" id="CD008642-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">CHM compared to placebo</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>CHM compared to placebo for atopic eczema</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> Participants with atopic eczema<br/> <b>Settings:</b> Hospital outpatients<br/> <b>Intervention:</b> CHM<br/> <b>Comparison:</b> Placebo </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risk* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Number of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Placebo</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> CHM</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Total effectiveness rate</b> (<a href="./references#CD008642-fig-0007" title="">Analysis 1.1</a>)<br/> Clinician's rating<br/> Follow up: 2 to 4 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Low¹</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 2.09</b> <br/> (1.32 to 3.32) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>85<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low²,³</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>2 additional studies did not report this outcome. A higher total effectiveness rate indicates improvement of the condition </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>1 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>2 per 100</b> <br/> (1 to 3) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>High¹</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>40 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>84 per 100</b> <br/> (53 to 100) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Itching VAS</b> (<a href="./references#CD008642-fig-0008" title="">Analysis 1.2</a>)<br/> Participant's rating. Scale from 1 to 10<br/> Follow up: 4 to 12 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean itching VAS ranged across control groups from<br/> <b>0.2 to 7.8 scores</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean itching in VAS in the intervention groups was <b>1.53 standard deviations lower</b> (2.64 to 0.41 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>94<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low³,⁴</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lower score indicates improvement of the condition. 2 additional studies did not report this outcome </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Overall severity score</b> (<a href="./references#CD008642-fig-0009" title="">Analysis 1.3</a>) <br/> Clinician's rating. Scale from 1 to 80<br/> Follow up: 2 to 16 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean overall severity score ranged across control groups from<br/> <b>5.7 to 46.9 scores</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean overall severity score in the intervention groups was <b>0.88 standard deviations lower</b> (1.67 to 0.09 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>239<br/> (4 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low²,³,⁴</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lower score indicates improvement of the condition</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>QoL</b> (<a href="./references#CD008642-fig-0011" title="">Analysis 1.5</a>)<br/> Participant's rating. Scale from 0 to 30<br/> Follow up: 4 to 16 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean QoL in the control groups was<br/> <b>10.1 scores</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean QoL in the intervention groups was <b>2.5 lower</b> (4.77 to 0.23 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>85<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate³</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lower score indicates better quality of life. 3 additional studies did not report this outcome </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Adverse events</b> (<a href="./references#CD008642-fig-0013" title="">Analysis 1.7</a>)<br/> Participant's report<br/> Follow up: 2 to 12 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Low¹</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 0.71</b> <br/> (0.06 to 8.67) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>129<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low²,³</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>1 additional study reported numbers of adverse events that were greater than the total participants. Data were treated as adverse event 'count data' rather than participant level data, which could not be pooled with these 2 studies </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>1 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>1 per 100</b> <br/> (0 to 9) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>High¹</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>6 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>4 per 100</b> <br/> (0 to 52) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in the footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI)<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate<br/> <b>Very low quality:</b> We are very uncertain about the estimate </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p>¹The low and high assumed risk values are the two extreme numbers of the events taken from the control groups in the included studies.<br/> ²Unclear risk of bias in allocation concealment and high risk of bias in blinding of participants and personnel.<br/> ³Total number of events was less than 300.<br/> ⁴Unexplained heterogeneity. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD008642-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">CHM compared to drugs</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>CHM compared to drugs for atopic eczema</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> Participants with atopic eczema<br/> <b>Settings:</b> Hospital outpatients<br/> <b>Intervention:</b> CHM<br/> <b>Comparison:</b> Drugs </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risk* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Number of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Drugs</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> CHM</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Total effectiveness rate</b> (<a href="./references#CD008642-fig-0015" title="">Analysis 2.1</a>)<br/> Clinician's rating<br/> Follow up: 2 to 52 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Low¹</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 1.43</b> <br/> (1.27 to 1.61) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>1868<br/> (21 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low²,³,⁴,⁵</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>A higher total effectiveness rate indicates improvement of the condition</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>20 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>29 per 100</b> <br/> (25 to 32) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>High¹</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>90 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>100 per 100</b> <br/> (100 to 100) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Total effectiveness rate with subgroup analysis ‐ individualised treatment</b> <br/> Clinician's rating<br/> Follow up: 4 to 8 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Low¹</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 1.50</b> <br/> (1.30 to 1.74) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>567<br/> (7 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low²,³,⁴</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>20 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>30 per 100</b> <br/> (26 to 35) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>High¹</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>70 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>100 per 100</b> <br/> (91 to 100) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Total effectiveness rate with subgroup analysis ‐ non‐individualised treatment</b> <br/> Clinician's rating<br/> Follow up: 2 to 52 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Low¹</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 1.37</b> <br/> (1.17 to 1.60) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>1301<br/> (14 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low²,³,⁴,⁵</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>20 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>27 per 100</b> <br/> (23 to 32) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>High¹</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>90 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>100 per 100</b> <br/> (100 to 100) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Itching VAS</b> (<a href="./references#CD008642-fig-0017" title="">Analysis 2.3</a>)<br/> Participant's rating. Scale from 0 to 10<br/> Follow up: 2 to 12 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean itching VAS ranged across control groups from<br/> <b>0.3 to 5.75 scores</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean itching VAS in the intervention groups was <b>0.83 standard deviations lower</b> (1.43 to 0.22 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>465<br/> (7 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low²,³,⁵</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lower score indicates improvement of the condition. 16 additional studies did not report this outcome </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Overall severity score</b> (<a href="./references#CD008642-fig-0018" title="">Analysis 2.4</a>)<br/> Clinician's rating. Scale from 0 to 103<br/> Follow up: 2 to 12 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean overall severity score ranged across control groups from<br/> <b>0.3 to 70.82 scores</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean overall severity score in the intervention groups was <b>0.97 standard deviations lower</b> (1.23 to 0.71 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1062<br/> (15 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low²,³,⁵</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lower score indicates improvement of the condition. 8 additional studies did not report this outcome </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Adverse events</b> (<a href="./references#CD008642-fig-0020" title="">Analysis 2.6</a>)<br/> Participant's reports<br/> Follow up: 2 to 52 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Low¹</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 0.44</b> <br/> (0.32 to 0.61) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>1396<br/> (15 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low²,³,⁴</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>4 additional studies did not report this outcome</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>1 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>0 per 100</b> <br/> (0 to 1) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>High¹</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>60 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>26 per 100</b> <br/> (19 to 37) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in the footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI)<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate<br/> <b>Very low quality:</b> We are very uncertain about the estimate </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p>¹The low and high assumed risk values are the two extreme numbers of the events taken from the control groups in the included studies.<br/> ²Unclear risk of bias in allocation concealment and high risk of bias in blinding participants and personnel.<br/> ³High risk of bias in blinding of outcome assessment.<br/> ⁴High risk of bias in other potential sources of bias.<br/> ⁵Unexplained heterogeneity. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD008642-tbl-0003"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Combination of oral and topical CHM compared to same oral CHM</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Combination of oral and topical CHM compared to same oral CHM for atopic eczema</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> Participants with atopic eczema<br/> <b>Settings:</b> Hospital outpatients<br/> <b>Intervention:</b> Combination of oral and topical CHM<br/> <b>Comparison:</b> Same oral CHM </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risk* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Number of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>CHM (oral)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> CHM (combination of oral and topical)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Total effectiveness rate</b> (<a href="./references#CD008642-fig-0022" title="">Analysis 3.1</a>)<br/> Clinician's rating<br/> Follow up: 4 to 24 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.13</b> <br/> (0.78 to 1.63) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>20<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low¹,</b>² </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1 additional study did not report this outcome. A higher total effectiveness rate indicates improvement of the condition </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>80 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>90 per 100</b> <br/> (62 to 100) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Overall severity score</b> (<a href="./references#CD008642-fig-0026" title="">Analysis 3.5</a>)<br/> Clinician's rating. Scale from 0 to 103<br/> Follow up: 4 to 24 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean overall severity score in the control groups was<br/> <b>21.02 scores</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean overall severity score in the intervention groups was <b>3.43 lower</b> (7.01 lower to 0.15 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low¹,</b>² </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lower score indicates improvement of the condition. 1 additional study was a within‐patient design; data were analysed separately </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>QoL</b> (<a href="./references#CD008642-fig-0027" title="">Analysis 3.6</a>)<br/> Participant's rating. Scale from 0 to 30<br/> Follow up: 4 to 24 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean QoL in the control groups was<br/> <b>5.8 scores</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean QoL in the intervention groups was <b>0.9 higher</b> (2.89 lower to 4.69 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low¹,</b>² </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lower score indicates better quality of life. 1 additional study did not report this outcome </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Adverse events</b> (<a href="./references#CD008642-fig-0028" title="">Analysis 3.7</a>)<br/> Participant's report<br/> Follow up: 4 to 12 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1</b> <br/> (0.07 to 13.87) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>20<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low¹,</b>² </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1 additional study was a within‐patient study, and data on adverse events were analysed separately in this review </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>10 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>10 per 100</b> <br/> (1 to 100) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Itching VAS</b> (<a href="./references#CD008642-fig-0024" title="">Analysis 3.3</a>)<br/> Participant's rating. Scale from 0 to 10<br/> Follow up: 1 to 2 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean itching VAS in the control groups was<br/> <b>5.76 scores</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean itching VAS in the intervention groups was <b>1.05 lower</b> (1.75 to 0.35 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low¹,²,³</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lower score indicates improvement of the condition. This was a within‐patient study</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Skin lesion score</b> (<a href="./references#CD008642-fig-0025" title="">Analysis 3.4</a>)<br/> Clinician's rating. Scale from 0 to 24<br/> Follow up: 1 to 2 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean skin lesion score in the control groups was<br/> <b>9.05 scores</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean skin lesion score in the intervention groups was <b>1.59 lower</b> (2.92 to 0.26 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low¹,</b> ²<b>,³</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lower score indicates improvement of the condition. This was a within‐patient study</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI)<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate<br/> <b>Very low quality:</b> We are very uncertain about the estimate </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p>¹Unclear risk of bias in allocation concealment and high risk of bias in blinding of participants and personnel.<br/> ²Total number of events was less than 300.<br/> ³High risk of bias in incomplete outcome data. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD008642-sec-0044" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD008642-sec-0044"></div> <section id="CD008642-sec-0045"> <h3 class="title" id="CD008642-sec-0045">Description of the condition</h3> <p>Atopic eczema is a common skin condition, which affects around one in five children in developed countries. In 2009, the International Study of Asthma and Allergies in Childhood (ISAAC) published data on symptoms of eczema (<a href="./references#CD008642-bbs2-0066" title="OdhiamboJA , WilliamsHC , ClaytonTO , RobertsonCF , AsherMI , ISAAC Phase Three Study Group. Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three. Journal of Allergy &amp; Clinical Immunology2009;124(6):1251‐8 e23. [MEDLINE: 20004783] ">Odhiambo 2009</a>). In this study, the authors found in 6 to 7 year‐old children from 143 centres in 60 countries, disease prevalence ranged from 0.9% in India to 22.5% in Ecuador. Amongst 13 to 14 year‐olds from 230 centres in 96 countries, disease prevalence was found to range from 0.2% in China to 24.6% in Colombia. Industrialised countries have previously been reported to have higher disease prevalence (<a href="./references#CD008642-bbs2-0062" title="KerdelF , Jimenez‐AcostaF . Dermatology: Just the facts. New York: McGraw‐Hill Medical, 2003. ">Kerdel 2003</a>; <a href="./references#CD008642-bbs2-0071" title="Schultz‐LarsenF , HanifinJM . Epidemiology of atopic dermatitis. Immunology &amp; Allergy Clinics of North America2002;22(1):1‐24. ">Schultz‐Larsen 2002</a>), although data from this most recent ISAAC study (<a href="./references#CD008642-bbs2-0066" title="OdhiamboJA , WilliamsHC , ClaytonTO , RobertsonCF , AsherMI , ISAAC Phase Three Study Group. Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three. Journal of Allergy &amp; Clinical Immunology2009;124(6):1251‐8 e23. [MEDLINE: 20004783] ">Odhiambo 2009</a>) suggest that eczema is a disease in developing countries as well, especially in Latin America and some countries in Africa. The prevalence of atopic eczema has increased over the last 10 years in both developed and developing countries, especially in those aged 6 to 7 years (<a href="./references#CD008642-bbs2-0077" title="WilliamsH , StewartA , vonMutiusE , CooksonW , AndersonHR , International Study of Asthma and Allergies in Childhood (ISAAC) Phase One and Three Study Groups. Is eczema really on the increase worldwide?. Journal of Allergy &amp; Clinical Immunology2008;121(4):947‐54 e15. [MEDLINE: 18155278] ">Williams 2008</a>), for reasons that are unclear. The causes of atopic eczema are still not fully understood, but probably involve an interaction between genetic factors that determine the integrity of the skin barrier and immune responses, and environmental factors, such as early‐life gut bacteria; humidity; irritation from soaps; microbes, such as <i>Staphylococcus aureus</i>; and allergens, such as house dust mites. Most children with atopic eczema improve with time, but around 40% persist with the condition into adulthood (<a href="./references#CD008642-bbs2-0076" title="WilliamsHC , WüthrichB . The natural history of atopic dermatitis. In: WilliamsHC editor(s). Atopic Dermatitis: The epidemiology, causes and prevention of atopic eczema. Cambridge: Cambridge University Press, 2000:41‐59. ">Williams 2000</a>). </p> <p>There was no such terminology as 'atopic eczema' in the classical literature of ancient Chinese medicine. The definition of 'Si Wan Feng' (wind of the four fossae) in Chinese medicine however correlates to atopic eczema in conventional medicine based on the comparison of Chinese medical literature records and the descriptions of clinical features in conventional medicine. 'Si Wan Feng' in Chinese medicine was officially defined as atopic eczema in the <i>Criteria of Diagnosis and Therapeutic Effect of Disease and Syndromes in Traditional Chinese Medicine</i> published by the State Administration of Traditional Chinese Medicine, China (<a href="./references#CD008642-bbs2-0068" title="State Administration of Traditional Chinese Medicine of the People's Republic ofChina . Criteria of diagnosis and therapeutic effect of diseases and syndromes in traditional Chinese medicine. Chinese Medicine Profession Standards of the People's Republic of China1994; Vol. ZY/T001.8, issue 94:147. ">SATCM 1994</a>). Although the term 'atopic' eczema is frequently used, not all people with typical atopic eczema are truly atopic; that is, they do not demonstrate specific immunoglobulin E (IgE) antibodies to common environmental allergens, such as house dust mite, pollens, grass, and foods (<a href="./references#CD008642-bbs2-0054" title="FlohrC , WeilandSK , WeinmayrG , BjörksténB , BråbäckL , BrunekreefB , et al. The role of atopic sensitization in flexural eczema: Findings from the international study of asthma and allergies in childhood phase two. Journal of Allergy &amp; Clinical Immunology2008;121(1):141‐7 e4. [MEDLINE: 17980410] ">Flohr 2008</a>). In accordance with the World Allergy Organisation recommendations on nomenclature (<a href="./references#CD008642-bbs2-0060" title="JohanssonSG , BieberT , DahlR , FriedmannPS , LanierBQ , LockeyRF , et al. Revised nomenclature for allergy for global use: Report of the nomenclature review committee of the world allergy organization, October 2003. Journal of Allergy &amp; Clinical Immunology2004;113(5):832‐6. [MEDLINE: 15131563] ">Johansson 2004</a>), we used the term 'eczema' throughout this review. </p> <p>Eczema is characterised by poorly demarcated redness of the skin and associated surface changes, such as scaling, swelling (oedema), accentuation of the hair follicles, and skin thickening (lichenification) as a result of chronic scratching. Eczema is an itchy skin condition, which can result in sleep loss for the child and family members. The stigma of a visible skin disease can affect a person's self‐esteem, and severe disease is associated with a poor quality of life (QoL) (<a href="./references#CD008642-bbs2-0069" title="Schmid‐OttG , BurchardR , NiederauerHH , LamprechtF , KünsebeckHW . Stigmatization and quality of life of patients with psoriasis and atopic dermatitis [Stigmatisierungsgefühl und Lebensqualität bei Patienten mit Psoriasis und Neurodermitis]. Hautarzt2003;54(9):852‐7. [MEDLINE: 12955263] ">Schmid‐Ott 2003</a>). </p> </section> <section id="CD008642-sec-0046"> <h3 class="title" id="CD008642-sec-0046">Description of the intervention</h3> <p>Current treatment for eczema has limitations. Topical administration of corticosteroids, as one of the standard first‐line therapies for the management of inflammatory episodes of eczema, can be associated with certain adverse events, such as skin thinning, if used for too long or in a too‐strong concentration for sensitive sites, such as the face where the skin is naturally thinner. Long‐term application of steroids has been a great concern to those using them and to healthcare professionals (<a href="./references#CD008642-bbs2-0057" title="HanifinJM , CooperKD , HoVC , KangS , KrafchikBR , MargolisDJ , et al. Guidelines of care for atopic dermatitis. Journal of the American Academy of Dermatology2004;50(3):391‐404. [EMBASE: 2004116938] ">Hanifin 2004</a>). A study showed up to 72.5% of people who were using steroids (or their guardians) were concerned about the application of corticosteroids for the treatment of eczema (<a href="./references#CD008642-bbs2-0047" title="CharmanCR , MorrisAD , WilliamsHC . Topical corticosteroid phobia in patients with atopic eczema. British Journal of Dermatology2000;142(5):931‐6. [MEDLINE: 10809850] ">Charman 2000</a>). New drugs for the treatment of eczema, such as tacrolimus and pimecrolimus (these two drugs are categorised as topical immunomodulators (TIMs) or calcineurin inhibitors), have been developed as second‐line therapies. However, issues regarding the long‐term safety of these new drugs, particularly the potential link between TIMs and cancer, have been raised (<a href="./references#CD008642-bbs2-0046" title="Centre for Drug Evaluation and Research. Alert for healthcare professionals: pimecrolimus (marketed as Elidel) / tacrolimus (marketed as Protopic). Food &amp; Drug Administration2005. ">CDER 2005</a>). Therefore, many eczema sufferers have chosen to use complementary and alternative medicine, including Chinese herbal medicine (CHM), for the management of eczema (<a href="./references#CD008642-bbs2-0059" title="HonKL , MaKC , WongY , LeungTF , FokTF . A survey of traditional Chinese medicine use in children with atopic dermatitis attending a paediatric dermatology clinic. Journal of Dermatological Treatment2005;16(3):154‐7. [EMBASE: 2005434025] ">Hon 2005</a>). </p> </section> <section id="CD008642-sec-0047"> <h3 class="title" id="CD008642-sec-0047">How the intervention might work</h3> <p>In Chinese medicine, those with eczema are recognised as having a specific constitution that leads to internal dampness‐heat accumulated because of the reduced function of the spleen. Exposure to wind, dampness, and heat pathogens can trigger symptoms (<a href="./references#CD008642-bbs2-0078" title="ZhaoBN , ZhangZL . Concise Chinese Medicine Dermatology. Beijing: China Prospects Publisher, 1983. ">Zhao 1983</a>). Clinically, eczema is classified into the following patterns from a Chinese medicine viewpoint: accumulation of internal dampness, excess of dampness with spleen deficiency, or Yin deficiency with dryness of blood (<a href="./references#CD008642-bbs2-0048" title="ChenGT , YangSS . Practical diagnostics and therapeutics of integrated traditional Chinese and western medicine. Beijing: Medical and Pharmaceutical Science and Technology Press, 1991. ">Chen 1991</a>). Chinese herbal medicine is one of the important components in Chinese medicine for prevention and treatment of diseases. Botanical resources, such as barks, seeds, flowers, roots, or animal or mineral substances, are prescribed and administered in the form of decoctions (liquids from extraction of herbs by boiling), pills, washing lotions, or ointments for conditions diagnosed by practitioners qualified to practice Chinese medicine or Oriental medicine. Chinese herbal medicines may be neither Chinese nor herbal; the term CHM in this review is used loosely to refer to any medicinal substances used within the paradigm of Chinese medicine practice. Chinese herbal medicines have been employed for the treatment of eczema for many years. They may be administered orally or topically or by a combination of oral ingestion and topical application (<a href="./references#CD008642-bbs2-0049" title="ChenDC , XuanGW . Chinese medicine diagnosis and treatment in dermatosis and venereal diseases. Beijing: People's Medical Publishing House, 2001. ">Chen 2001</a>). Oral ingestion of CHM is under the guidance of the Chinese medicine pattern differentiation method, known as 'individualised treatment', whilst topical administrations have been devised with little or no consideration of pattern differentiation (<a href="./references#CD008642-bbs2-0055" title="GuoW , YuTG . Research of Chinese medicine treatments for atopic dermatitis [Zhongyiyao zhiliao teyingxing piyan yanjiu jinzhan]. Henan Traditional Chinese Medicine2007;27(4):83‐5. ">Guo 2007</a>; <a href="./references#CD008642-bbs2-0079" title="ZhouF , LiP . Progress in treatment of atopic dermatitis by traditional Chinese medicine. Shaanxi Journal of Traditional Chinese Medicine2008;42(10):83‐6. ">Zhou 2008</a>). </p> </section> <section id="CD008642-sec-0048"> <h3 class="title" id="CD008642-sec-0048">Why it is important to do this review</h3> <p>The Cochrane systematic review on oral ingestion of CHM for eczema was published in 2004 (<a href="./references#CD008642-bbs2-0080" title="ZhangW , LeonardT , Bath‐HextallF , ChambersCA , LeeC , HumphreysR , et al. Chinese herbal medicine for atopic eczema. Cochrane Database of Systematic Reviews2004, Issue 4. [DOI: 10.1002/14651858.CD002291] ">Zhang 2004</a>). It is timely to update this review to take into account new evidence that has emerged in relation to oral ingestion of herbal interventions. Furthermore, there has been no systematic evaluation of the effectiveness and safety of the topical application of CHM for eczema. </p> <p>We decided it would be best to review both oral ingestion and topical CHM since people with eczema are likely to be interested in both types of treatment. We therefore wrote a new protocol to plan for the expanded scope of this review. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD008642-sec-0049" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD008642-sec-0049"></div> <p>To assess the effects of oral ingestion and topical applications of CHM for the management of eczema in children and adults. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD008642-sec-0050" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD008642-sec-0050"></div> <section id="CD008642-sec-0051"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD008642-sec-0052"> <h4 class="title">Types of studies</h4> <p>All randomised controlled clinical trials (RCTs) with or without blinding, regardless of language. </p> </section> <section id="CD008642-sec-0053"> <h4 class="title">Types of participants</h4> <p>We included adults or children (from 1 month to 16 years old) with eczema. We accepted diagnostic criteria, such as the Hanifin and Rajka definition (<a href="./references#CD008642-bbs2-0056" title="HanifinJM , RajkaG . Diagnostic features of atopic dermatitis. Acta Dermato‐Venereologica1980;59(Suppl 92):44‐7. ">Hanifin 1980</a>) or the UK refinement (<a href="./references#CD008642-bbs2-0075" title="WilliamsHC , BurneyPG , HayRJ , ArcherCB , ShipleyMJ , HunterJJ , et al. The U.K. Working Party's diagnostic criteria for atopic dermatitis. I. Derivation of a minimum set of discriminators for atopic dermatitis. British Journal of Dermatology1994;131(3):383‐96. [MEDLINE: 7918015] ">Williams 1994</a>), when using the terms 'atopic eczema' or 'atopic dermatitis'. In the absence of explicit diagnostic criteria, we excluded adults diagnosed with 'eczema' or 'chronic eczema', but accepted children diagnosed with 'eczema' by physicians or dermatologists. </p> </section> <section id="CD008642-sec-0054"> <h4 class="title">Types of interventions</h4> <p>Oral ingestion and topical applications of a single Chinese medicinal herb or formula, manufactured or clinician self‐designed Chinese medicinal formulae (a clinician self‐designed formula is usually composed of different types of Chinese herbs prescribed by a Chinese medicine practitioner who determines the selection of herbs based on a person's condition), compared to the following control interventions: placebo, no intervention, and active controls, including acupuncture or conventional medicines. </p> <p>We also included trials with a combination of oral ingestion and topical interventions.</p> <p>We excluded interventions based on individualised treatment unless there were appropriate control interventions. </p> </section> <section id="CD008642-sec-0055"> <h4 class="title">Types of outcome measures</h4> <section id="CD008642-sec-0056"> <h5 class="title">Primary outcomes</h5> <p> <ol id="CD008642-list-0001"> <li> <p>Percentage of trial participants with at least good or excellent improvement in terms of investigator global score. We included both short‐term (within six weeks) and long‐term (more than six weeks) improvement. </p> </li> <li> <p>Percentage of trial participants with at least good or excellent improvement in terms of participants' or parents' global score. We included both short‐term (within six weeks) and long‐term (more than six weeks) improvement. </p> </li> </ol> </p> </section> <section id="CD008642-sec-0057"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD008642-list-0002"> <li> <p>Changes in participant‐ or parent‐rated global improvement in EASI (Eczema Area and Severity Index), SCORAD (Severity Scoring of Atopic Dermatitis), POEM (Patient‐oriented Eczema Measure), or SASSAD (Six Area, Six Sign Atopic Dermatitis) (<a href="./references#CD008642-bbs2-0070" title="SchmittJ , LanganS , WilliamsHC , European Dermato‐Epidemiology Network. What are the best outcome measurements for atopic eczema? A systematic review. Journal of Allergy &amp; Clinical Immunology2007;120(6):1389‐98. [MEDLINE: 17910890] ">Schmitt 2007</a>) as stated in each of the trials in both the short‐term (within six weeks) and the long‐term (more than six weeks). </p> </li> <li> <p>Changes in participant‐ or parent‐rated global improvement in quality of life, such as CDLQI (Children's Dermatology Life Quality Index) or DLQI (Dermatology Life Quality Index) in both the short‐term (within six weeks) and the long‐term (more than six weeks). </p> </li> <li> <p>Adverse events.</p> </li> </ol> </p> </section> </section> </section> <section id="CD008642-sec-0058"> <h3 class="title">Search methods for identification of studies</h3> <p>We aimed to identify all relevant RCTs regardless of language or publication status (published, unpublished, in press, or in progress). </p> <section id="CD008642-sec-0059"> <h4 class="title">Electronic searches</h4> <p>We searched the following databases up to 11 September 2012:</p> <p> <ul id="CD008642-list-0003"> <li> <p>the Cochrane Skin Group Specialised Register using the following terms: ((Chinese and (herb* or medicin* or traditional or plant*)) or “traditional medicin*” or “traditional therap*” or ((orient* or herbal) and (medicin* or therap*)) or phytotherapy or phytopharmaceutic* or (plant and (medicin* or extract*))) AND (dermatitis OR (besnier* AND prurigo) OR eczema); </p> </li> <li> <p>the Cochrane Central Register of Controlled Trials (CENTRAL), issue 8, 2012, in <i>The Cochrane Library</i> using the search strategy in <a href="./appendices#CD008642-sec-0147">Appendix 1</a>; </p> </li> <li> <p>MEDLINE via OVID (from 1946) using the strategy in <a href="./appendices#CD008642-sec-0148">Appendix 2</a>; </p> </li> <li> <p>EMBASE via OVID (from 1974) using the strategy in <a href="./appendices#CD008642-sec-0149">Appendix 3</a>; </p> </li> <li> <p>AMED via OVID (Allied and Complementary Medicine, from 1985) using the strategy in <a href="./appendices#CD008642-sec-0150">Appendix 4</a>; </p> </li> <li> <p>LILACS (Latin American and Caribbean Health Science Information database, from 1982) using the strategy in <a href="./appendices#CD008642-sec-0151">Appendix 5</a>; and </p> </li> <li> <p>CINAHL via EBSCO (Cumulative Index to Nursing and Allied Health Literature, from 1981) using the search strategy in <a href="./appendices#CD008642-sec-0152">Appendix 6</a>. </p> </li> </ul> </p> <p>A final prepublication search for this review was undertaken on 6 June 2013. Although it has not been possible to incorporate RCTs identified through this search within this review, we listed relevant references under <a href="./references#CD008642-bbs1-0003" title="">Studies awaiting classification</a>. We will incorporate them into the next update of the review. </p> <p>We searched the following databases up to 13 September 2012:</p> <p> <ul id="CD008642-list-0004"> <li> <p>Scopus (from 1996) using the terms (eczema or dermatitis) AND (Chinese) AND (random$);</p> </li> <li> <p>HerbMed® (from 1998) using the terms (eczema or dermatitis) AND (Chinese) AND (random$); and </p> </li> <li> <p>ProQuest (from 1938) using the terms (atopic eczema or atopic dermatitis) AND (Chinese medicine) AND (random$). </p> </li> </ul> </p> <p>We also searched the following databases in the Chinese language up to 13 September 2012: </p> <p> <ul id="CD008642-list-0005"> <li> <p>CQVIP (Chongqing VIP Information Co., Ltd,) Chinese Scientific Journals Fulltext Database (from 1989) using the strategy in <a href="./appendices#CD008642-sec-0153">Appendix 7</a> in Chinese; </p> </li> <li> <p>CNKI (China National Knowledge Infrastructure) (from 1979) using the strategy in <a href="./appendices#CD008642-sec-0154">Appendix 8</a> in Chinese; </p> </li> <li> <p>Wanfang Data (from 1982) using the strategy in <a href="./appendices#CD008642-sec-0155">Appendix 9</a> in Chinese; </p> </li> <li> <p>Chinese Scientific Journal Net (from 1994) (the database has been merged into CQVIP); and </p> </li> <li> <p>China Proceedings of Conference Database (from 1994) (the database has been merged into CQVIP). </p> </li> </ul> </p> <section id="CD008642-sec-0060"> <h5 class="title">Trials Registers</h5> <p>We searched for reports of trials in the following trials databases up to 13 September 2012: </p> <p> <ul id="CD008642-list-0006"> <li> <p>The metaRegister of Controlled Trials (<a href="http://www.controlled-trials.com/" target="_blank">www.controlled‐trials.com</a>). </p> </li> <li> <p>The US National Institutes of Health Ongoing Trials Register (<a href="http://www.clinicaltrials.gov/" target="_blank">www.clinicaltrials.gov</a>). </p> </li> <li> <p>The Australian New Zealand Clinical Trials Registry (<a href="http://www.anzctr.org.au/" target="_blank">www.anzctr.org.au</a>). </p> </li> <li> <p>The World Health Organization International Clinical Trials Registry platform (<a href="http://www.who.int/trialsearch" target="_blank">www.who.int/trialsearch</a>). </p> </li> <li> <p>The Ongoing Skin Trials Register (<a href="http://www.nottingham.ac.uk/ongoingskintrials" target="_blank">www.nottingham.ac.uk/ongoingskintrials</a>). </p> </li> </ul> </p> </section> </section> <section id="CD008642-sec-0061"> <h4 class="title">Searching other resources</h4> <section id="CD008642-sec-0062"> <h5 class="title">Handsearching</h5> <p>We handsearched the conference proceedings ‐ relevant to eczema ‐ of the First World Congress of Chinese Medicine from 2003 onwards. We also handsearched conference proceedings of the Conference of Skin Diseases: Integrating Chinese and Western Medicine 2007, and the 1st International Dermatology Academic Symposium of TCM and Integrated TCM‐WM (traditional Chinese medicine and Western medicine) 2009. </p> </section> <section id="CD008642-sec-0063"> <h5 class="title">Reference lists</h5> <p>We checked the reference lists of all identified RCTs and review articles for further references to relevant trials. </p> </section> <section id="CD008642-sec-0064"> <h5 class="title">Adverse effects</h5> <p>We did not perform a separate search for adverse effects of the target interventions. However, we examined data on adverse effects from the included studies we identified. </p> </section> <section id="CD008642-sec-0065"> <h5 class="title">Correspondence</h5> <p>On 13 December 2011, 18 September 2012, and 17 June 2013, we contacted the clinicians, dermatologists, and experts in traditional Chinese medicine listed in <a href="./appendices#CD008642-sec-0156">Appendix 10</a> and requested information on any unpublished RCTs on our topic. </p> </section> </section> </section> <section id="CD008642-sec-0066"> <h3 class="title" id="CD008642-sec-0066">Data collection and analysis</h3> <p>If the data on the number of participants with each outcome measure were not available in the published paper, we contacted the study author for further information. We also contacted all study authors of included trials for their raw data where they had not reported the outcomes in such a way that meta‐analysis was possible. </p> <section id="CD008642-sec-0067"> <h4 class="title">Selection of studies</h4> <p>Two authors (SG and AWY) selected the trials or studies independently according to the inclusion criteria. We screened papers through reading the titles and abstracts and retrieved full texts of the potential included studies for further assessment. We resolved discrepancies of the assessments by discussion between SG and AWY. The other two team members, HCW and WZ, provided arbitrating advice when we could not achieve a consensus. </p> </section> <section id="CD008642-sec-0068"> <h4 class="title">Data extraction and management</h4> <p>Two authors (SG and AWY) independently extracted the data from the included studies onto a data extraction form developed by the Cochrane Skin Group, which we modified to suit this review. We extracted characteristics of participants, interventions, and outcome measures. Data from each selected study consisted of the number of events (n) and participants (N) for dichotomous data; and number of participants (N), and mean and standard deviations (SD) for continuous data. </p> <p>We resolved discrepancies in data extraction by discussion between SG and AWY or through other arbitrating team members, HCW and WZ, when we could not achieve a consensus. </p> </section> <section id="CD008642-sec-0069"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>We adopted The Cochrane Collaboration's domain‐based evaluation for assessing risk of bias, which included the following domains: </p> <p>(a) sequence generation;<br/> (b) allocation concealment;<br/> (c) blinding of participants, personnel, and outcome assessors;<br/> (d) incomplete outcome data (missing data were analysed by worst‐case scenarios. The funnel plot analysis was tested for potential publication bias); and<br/> (e) selective outcome reporting and other sources of bias.  </p> <p>We presented the risk of bias for each included study as part of its <a href="./references#CD008642-sec-0167" title="">Characteristics of included studies</a> table in the review, as recommended in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD008642-bbs2-0058" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration. Available from www.cochrane‐handbook.org. The Cochrane Collaboration. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). </p> <p>We set an additional quality criterion of whether the study used published and validated scoring systems (i.e. EASI, SCORAD, POEM, or SASSAD) under the heading of "use of published validated scoring systems" to record the severity of the disease (<a href="./references#CD008642-bbs2-0070" title="SchmittJ , LanganS , WilliamsHC , European Dermato‐Epidemiology Network. What are the best outcome measurements for atopic eczema? A systematic review. Journal of Allergy &amp; Clinical Immunology2007;120(6):1389‐98. [MEDLINE: 17910890] ">Schmitt 2007</a>). </p> </section> <section id="CD008642-sec-0070"> <h4 class="title">Measures of treatment effect</h4> <p>The total effectiveness rate and the number of adverse events were dichotomous data. As the included studies compared the events in 2 groups, we expressed dichotomous data as risk ratios (RR) with 95% confidence intervals (CI). A higher total effectiveness rate indicates better improvement of the condition. We planned to express dichotomous data as number needed to treat (NNT). We planned to express NNTB (number needed to treat for an additional beneficial outcome) for beneficial outcome and NNTH (number needed to treat for an additional harmful outcome) for harmful events as recommended by the<i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD008642-bbs2-0058" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration. Available from www.cochrane‐handbook.org. The Cochrane Collaboration. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). The baseline event rate includes the control event rate (CER) and the experimental event rate (EER) for calculation of NNT. We planned to use a plausible range of CERs from the individual trials. An NNTB range of two to four should indicate that the interventions are effective, which should imply a beneficial outcome. </p> <p>The scores of itching VAS, global symptom improvement scores, and QoL were continuous data. We expressed them as difference in means (MD) with 95% CI. As outcome scales used in the included studies were various, we also expressed the continuous data as standardised mean differences (SMD) with 95% CI, where different outcome scales were pooled. </p> <section id="CD008642-sec-0071"> <h5 class="title">Studies with multiple treatment groups</h5> <p>For studies with more than two interventions, we selected the comparison group that met the inclusion criteria. </p> </section> </section> <section id="CD008642-sec-0072"> <h4 class="title">Unit of analysis issues</h4> <p>We considered unit of analysis issues if a study involved measurements on different body parts, such as comparison of a site on one arm versus another site on the other arm for topical interventions. In this case, we treated the study as a 'within‐patient trial', and we performed a separate meta‐analysis as appropriate. </p> <p>For cross‐over trials where participants were given different treatments in random sequence, we planned to undertake a separate meta‐analysis. The results from the first phase could be combined with those from the parallel trials if data were available.     </p> <p>We planned to combine the data from included parallel studies and the first period of included cross‐over studies in the meta‐analysis. We planned to include cross‐over studies only if their methods were appropriate as suggested in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i>. </p> </section> <section id="CD008642-sec-0073"> <h4 class="title">Dealing with missing data</h4> <p>We contacted the trial author of a study for more information if there were any missing data in the trial. We applied intention‐to‐treat (ITT) analysis to the included studies in which there were missing individuals. </p> </section> <section id="CD008642-sec-0074"> <h4 class="title">Assessment of heterogeneity</h4> <p>We assessed heterogeneity (inconsistency) in included studies by using the I² statistic, which describes the percentage of variation across studies due to heterogeneity rather than by chance. </p> </section> <section id="CD008642-sec-0075"> <h4 class="title">Assessment of reporting biases</h4> <p>We tested funnel plot asymmetry where there were more than 10 trials included in the meta‐analysis. </p> </section> <section id="CD008642-sec-0076"> <h4 class="title">Data synthesis</h4> <p>We anticipated that the nature of the interventions would be quite diverse, and it was therefore unlikely that they would all estimate the same treatment effect. It was in fact that the studies in our review estimated different, yet related, intervention effects, and for this reason, we conducted a random‐effects model when attempting to pool data from several studies. We performed the meta‐analyses irrespective of the level of heterogeneity for the purpose of explanation of potential inconsistency across the included studies. When substantial heterogeneity was found (I² statistic greater than 50%), then we explored the sources of such heterogeneity by rechecking the data, and by subgroup analysis based on clinical and methodological diversity factors. </p> <p>We performed meta‐analysis by using the inverse‐variance method in Review Manager 5 (RevMan), as outlined in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i>, for effect estimates from the collected data. </p> <p>We reported studies relating to adverse events quantitatively.</p> </section> <section id="CD008642-sec-0077"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We planned to perform subgroup analyses under the heading of "children (16 years old or under) with eczema versus adults with eczema", and "application of intervention based on Chinese medicine syndrome differentiation versus non‐individualisation formula" where there were at least moderate levels of heterogeneity across the included studies. We investigated the sources of heterogeneity including participant factors (e.g. age, diagnosis, sex, race, comorbidity), treatment factors (e.g. dosage, formulation), study factors (e.g. concordance rates, quality of reporting), and quality control for the Chinese herbal preparations (e.g. source, purity, preparation facilities) to explain such differences.  </p> </section> <section id="CD008642-sec-0078"> <h4 class="title">Sensitivity analysis</h4> <p>We planned to perform sensitivity analyses of the primary outcomes by excluding studies of low methodological quality. Where substantial heterogeneity existed between studies for the primary outcome (I² statistic &gt; 50%), we were to seek sources for such heterogeneity, such as quality of disease definition or composition or dose of the herbal medication, and explore them in sensitivity analyses. However, we were unable to carry out these analyses due to the lack of data. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD008642-sec-0079" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD008642-sec-0079"></div> <section id="CD008642-sec-0080"> <h3 class="title">Description of studies</h3> <section id="CD008642-sec-0081"> <h4 class="title">Results of the search</h4> <p>We identified a total of 1740 records through thorough searches. We excluded 1674 records after screening the titles and abstracts. Of the remaining 66 records, we found that 3 were registered trials, and we classified them as 'ongoing studies'. We retrieved full texts of the remaining 63 records. Of these, we excluded 20 as they were not randomised controlled trials. We excluded another four studies because their comparison interventions did not meet the inclusion criteria of this review (see <a href="#CD008642-sec-0095">Excluded studies</a>). We need further information about nine studies in order for us to make a decision about their inclusion or exclusion. We listed these in the '<a href="./references#CD008642-sec-0169" title="">Characteristics of studies awaiting classification</a>' tables while we wait for further details from the trial investigators. Of the remaining 30 records, we found 1 was a protocol for a study that has been completed, but no final report has been published, and we added this to the 3 records we found that were ongoing trials. We listed details of these four registered trials in the '<a href="./references#CD008642-sec-0170" title="">Characteristics of ongoing studies</a>' tables and hope that these can be included in a future revision of this review once the trial reports are published. We included 28 studies (from 29 records; 1 study was reported twice, and we have included the 2 identical trials under the same study ID: <a href="./references#CD008642-bbs2-0006" title="HonKL , LeungTF , NgPC , LamMCA , KamWYC , WongKY , et al. Efficacy and tolerability of a Chinese herbal medicine concoction for treatment of atopic dermatitis: a randomized, double‐blind, placebo‐controlled study. British Journal of Dermatology2007;157(2):357‐63. [MEDLINE: 17501956] HonKLE , LeungTF , NgPC , LamMCA , KamWYC , WongKY , et al. Therapeutic effect and safety of a traditional Chinese medicine for atopic dermatitis in children: a randomised, double‐blind, placebo‐controlled study. Hong Kong Medical Journal2011;17(1 Suppl 2):38‐40. ">Hon 2007</a>). We summarised the screening process in our 'Study selection flow diagram' (<a href="#CD008642-fig-0001">Figure 1</a>). </p> <div class="figure" id="CD008642-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study selection flow diagram" data-id="CD008642-fig-0001" src="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/image_n/nCD008642-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study selection flow diagram</p> </div> </div> </div> </section> <section id="CD008642-sec-0082"> <h4 class="title">Included studies</h4> <p>We included 28 studies, with a total of 2306 participants.</p> <section id="CD008642-sec-0083"> <h5 class="title">Design</h5> <p>All 28 included studies were randomised controlled parallel clinical studies with oral ingestion or topical applications of CHM for eczema, except the <a href="./references#CD008642-bbs2-0010" title="LinY , ChenDC . Efficacy of anti‐inflammatory moisturising washing formula for atopic dermatitis and its biological evaluation. Guangzhou University of Chinese Medicine, Guangzhou [PhD thesis]2010. ">Lin 2010</a> study, which used CHM topically on a randomised selected arm or leg of the participant for comparison with the other non‐treatment site on the same participant.  </p> <p>None of the included studies were cross‐over trials, but one study (<a href="./references#CD008642-bbs2-0010" title="LinY , ChenDC . Efficacy of anti‐inflammatory moisturising washing formula for atopic dermatitis and its biological evaluation. Guangzhou University of Chinese Medicine, Guangzhou [PhD thesis]2010. ">Lin 2010</a>) was a within‐patient trial, and we treated data as if they were obtained from the first phase of a cross‐over trial (<a href="./references#CD008642-bbs2-0058" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration. Available from www.cochrane‐handbook.org. The Cochrane Collaboration. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>).  </p> <p>The sample sizes of the studies ranged from 25 to 220, with a total of 2306 participants aged from 12 days to 65 years. </p> <p>We listed details of the included studies in the '<a href="./references#CD008642-sec-0167" title="">Characteristics of included studies</a>' tables. </p> </section> <section id="CD008642-sec-0084"> <h5 class="title">Setting</h5> <p>All of the included studies were conducted in public hospitals (most of them were in Chinese medicine teaching hospitals) in mainland China, Hong Kong, or Taiwan, where Chinese medicine has a long history of practice and widespread applications in the healthcare system. The majority of the included studies were published in Chinese. Two studies were printed in English (<a href="./references#CD008642-bbs2-0004" title="ChengHM , ChiangLC , JanYM , ChenGW , LiTC . The efficacy and safety of a Chinese herbal product (Xiao‐Feng‐San) for the treatment of refractory atopic dermatitis: a randomized, double‐blind, placebo‐controlled trial. International Archives of Allergy &amp; Immunology2011;155(2):141‐8. [DOI: 10.1159/000318861] ">Cheng 2010</a>; <a href="./references#CD008642-bbs2-0006" title="HonKL , LeungTF , NgPC , LamMCA , KamWYC , WongKY , et al. Efficacy and tolerability of a Chinese herbal medicine concoction for treatment of atopic dermatitis: a randomized, double‐blind, placebo‐controlled study. British Journal of Dermatology2007;157(2):357‐63. [MEDLINE: 17501956] HonKLE , LeungTF , NgPC , LamMCA , KamWYC , WongKY , et al. Therapeutic effect and safety of a traditional Chinese medicine for atopic dermatitis in children: a randomised, double‐blind, placebo‐controlled study. Hong Kong Medical Journal2011;17(1 Suppl 2):38‐40. ">Hon 2007</a>). </p> </section> <section id="CD008642-sec-0085"> <h5 class="title">Treatment duration</h5> <p>Treatment duration ranged from 5 days to 16 weeks in the included studies. Among the 28 included studies, 13 studies reported follow‐up, and the follow‐up periods ranged from 4 to 52 weeks after treatment stopped.  </p> </section> <section id="CD008642-sec-0086"> <h5 class="title">Funding</h5> <p>Eight studies reported receiving funding or support from governments (<a href="./references#CD008642-bbs2-0004" title="ChengHM , ChiangLC , JanYM , ChenGW , LiTC . The efficacy and safety of a Chinese herbal product (Xiao‐Feng‐San) for the treatment of refractory atopic dermatitis: a randomized, double‐blind, placebo‐controlled trial. International Archives of Allergy &amp; Immunology2011;155(2):141‐8. [DOI: 10.1159/000318861] ">Cheng 2010</a>; <a href="./references#CD008642-bbs2-0005" title="GongXH , KuangL , LiuX . Clinical observation of Liangxue Xiaofeng formula for adult atopic dermatitis. Journal of TCM University of Hunan2010;30(3):61‐3. ">Gong 2010</a>; <a href="./references#CD008642-bbs2-0006" title="HonKL , LeungTF , NgPC , LamMCA , KamWYC , WongKY , et al. Efficacy and tolerability of a Chinese herbal medicine concoction for treatment of atopic dermatitis: a randomized, double‐blind, placebo‐controlled study. British Journal of Dermatology2007;157(2):357‐63. [MEDLINE: 17501956] HonKLE , LeungTF , NgPC , LamMCA , KamWYC , WongKY , et al. Therapeutic effect and safety of a traditional Chinese medicine for atopic dermatitis in children: a randomised, double‐blind, placebo‐controlled study. Hong Kong Medical Journal2011;17(1 Suppl 2):38‐40. ">Hon 2007</a>; <a href="./references#CD008642-bbs2-0013" title="MaYB , SunLY , WangP , ZhangGZ , CaiNN . Clinical observation of combination of Jianpi Runfu decoction and topical application of Gancao oil for atopic dermatitis with syndrome of spleen deficiency and blood dryness. Beijing Journal of Traditional Chinese Medicine2010;29(9):680‐2. ">Ma 2010</a>; <a href="./references#CD008642-bbs2-0015" title="SunXD . Evaluation of efficacy and affect of reoccurrence of Jianpi Shenshi granules for atopic dermatitis [Clinical effect of invigorating spleen and excreting dampness granules in treating atopic dermatitis and its influence for recurrence of the patient]. Chinese Journal of Dermatovenerology Integrated Traditional and Western Medicine2009;8(6):335‐7. ">Sun 2009</a>; <a href="./references#CD008642-bbs2-0020" title="XueSQ , TanJH . Clinical observation of Shengxue Runfu decoction with modifications for childhood atopic dermatitis. Journal of New Chinese Medicine2011;43(2):94‐5. ">Xue 2011</a>; <a href="./references#CD008642-bbs2-0021" title="YangY , SunJL , FengYL , YangYF , WangLX . Analysis of efficacy of Chinese herbs Jianpi Zhiyang granules with Pibo Xiaoyan Xuanshi ointment for atopic dermatitis. Chinese Journal of Dermatovenerology Integrated Traditional &amp; Western Medicine2007;6(3):135‐7. ">Yang 2007</a>; <a href="./references#CD008642-bbs2-0023" title="YuTG , ZhuJT , XuJL , ZhuangYR , ShenB , WuBL , et al. Clincial and laboratory study of Piyan Xiaojingyin granules II for atopic dermatitis. Journal of Traditional Chinese Medicine1999;40(3):165‐7. ">Yu 1999</a>). </p> </section> <section id="CD008642-sec-0087"> <h5 class="title">Interventions</h5> <p>All of the studies used a combination of CHM originated from plants or animal or mineral products as an active intervention. </p> <section id="CD008642-sec-0088"> <h6 class="title">1. CHM versus placebo</h6> <p>We found four studies that compared CHM to placebo (<a href="./references#CD008642-bbs2-0002" title="ChaoQ , XiaoJG . Research of Chinese herbal medicines for infantile eczema. Qingdao University, Qingdao [Masters thesis]2003. ">Chao 2003</a>; <a href="./references#CD008642-bbs2-0004" title="ChengHM , ChiangLC , JanYM , ChenGW , LiTC . The efficacy and safety of a Chinese herbal product (Xiao‐Feng‐San) for the treatment of refractory atopic dermatitis: a randomized, double‐blind, placebo‐controlled trial. International Archives of Allergy &amp; Immunology2011;155(2):141‐8. [DOI: 10.1159/000318861] ">Cheng 2010</a>; <a href="./references#CD008642-bbs2-0006" title="HonKL , LeungTF , NgPC , LamMCA , KamWYC , WongKY , et al. Efficacy and tolerability of a Chinese herbal medicine concoction for treatment of atopic dermatitis: a randomized, double‐blind, placebo‐controlled study. British Journal of Dermatology2007;157(2):357‐63. [MEDLINE: 17501956] HonKLE , LeungTF , NgPC , LamMCA , KamWYC , WongKY , et al. Therapeutic effect and safety of a traditional Chinese medicine for atopic dermatitis in children: a randomised, double‐blind, placebo‐controlled study. Hong Kong Medical Journal2011;17(1 Suppl 2):38‐40. ">Hon 2007</a>; <a href="./references#CD008642-bbs2-0015" title="SunXD . Evaluation of efficacy and affect of reoccurrence of Jianpi Shenshi granules for atopic dermatitis [Clinical effect of invigorating spleen and excreting dampness granules in treating atopic dermatitis and its influence for recurrence of the patient]. Chinese Journal of Dermatovenerology Integrated Traditional and Western Medicine2009;8(6):335‐7. ">Sun 2009</a>). Three studies used oral ingestion of interventions (<a href="./references#CD008642-bbs2-0004" title="ChengHM , ChiangLC , JanYM , ChenGW , LiTC . The efficacy and safety of a Chinese herbal product (Xiao‐Feng‐San) for the treatment of refractory atopic dermatitis: a randomized, double‐blind, placebo‐controlled trial. International Archives of Allergy &amp; Immunology2011;155(2):141‐8. [DOI: 10.1159/000318861] ">Cheng 2010</a>; <a href="./references#CD008642-bbs2-0006" title="HonKL , LeungTF , NgPC , LamMCA , KamWYC , WongKY , et al. Efficacy and tolerability of a Chinese herbal medicine concoction for treatment of atopic dermatitis: a randomized, double‐blind, placebo‐controlled study. British Journal of Dermatology2007;157(2):357‐63. [MEDLINE: 17501956] HonKLE , LeungTF , NgPC , LamMCA , KamWYC , WongKY , et al. Therapeutic effect and safety of a traditional Chinese medicine for atopic dermatitis in children: a randomised, double‐blind, placebo‐controlled study. Hong Kong Medical Journal2011;17(1 Suppl 2):38‐40. ">Hon 2007</a>; <a href="./references#CD008642-bbs2-0015" title="SunXD . Evaluation of efficacy and affect of reoccurrence of Jianpi Shenshi granules for atopic dermatitis [Clinical effect of invigorating spleen and excreting dampness granules in treating atopic dermatitis and its influence for recurrence of the patient]. Chinese Journal of Dermatovenerology Integrated Traditional and Western Medicine2009;8(6):335‐7. ">Sun 2009</a>), and one study administered the interventions via topical application (<a href="./references#CD008642-bbs2-0002" title="ChaoQ , XiaoJG . Research of Chinese herbal medicines for infantile eczema. Qingdao University, Qingdao [Masters thesis]2003. ">Chao 2003</a>). </p> <p>The <a href="./references#CD008642-bbs2-0002" title="ChaoQ , XiaoJG . Research of Chinese herbal medicines for infantile eczema. Qingdao University, Qingdao [Masters thesis]2003. ">Chao 2003</a> study was a four‐arm parallel randomised controlled trial. It treated 120 children aged from 1 to 38 months (mean = 7 months) with 5% (1st arm) or 10% (2nd arm) of Huangbai Zicao Diyu cream, econazole nitrate cream (Pevisone®) (3rd arm), or placebo (petroleum jelly) (4th arm), respectively, for 2 to 3 weeks. We did not use data from the 1st arm as the 2nd arm showed a higher effectiveness rate than the 1st arm. We analysed data from the 2nd arm compared to the 4th arm (CHM versus placebo) and the 2nd arm compared to the 3rd arm (CHM versus conventional medicines) in the <a href="#CD008642-sec-0102">Effects of interventions</a> section. </p> <p>The <a href="./references#CD008642-bbs2-0004" title="ChengHM , ChiangLC , JanYM , ChenGW , LiTC . The efficacy and safety of a Chinese herbal product (Xiao‐Feng‐San) for the treatment of refractory atopic dermatitis: a randomized, double‐blind, placebo‐controlled trial. International Archives of Allergy &amp; Immunology2011;155(2):141‐8. [DOI: 10.1159/000318861] ">Cheng 2010</a> study randomised 71 participants with a mean age of 13 in a ratio of 2:1 who were treated with Chinese herbal decoction of Xiao‐Feng‐San granules or placebo for 8 weeks. Follow‐up assessment was done after an eight‐week treatment period. The <a href="./references#CD008642-bbs2-0006" title="HonKL , LeungTF , NgPC , LamMCA , KamWYC , WongKY , et al. Efficacy and tolerability of a Chinese herbal medicine concoction for treatment of atopic dermatitis: a randomized, double‐blind, placebo‐controlled study. British Journal of Dermatology2007;157(2):357‐63. [MEDLINE: 17501956] HonKLE , LeungTF , NgPC , LamMCA , KamWYC , WongKY , et al. Therapeutic effect and safety of a traditional Chinese medicine for atopic dermatitis in children: a randomised, double‐blind, placebo‐controlled study. Hong Kong Medical Journal2011;17(1 Suppl 2):38‐40. ">Hon 2007</a> study recruited a total of 85 participants aged from 5 to 21 years (mean = 11 years) with moderate‐to‐severe eczema (objective SCORAD &gt; 15). Chinese herbal medicine capsules containing 5 Chinese herbs or placebo were used for 12 weeks, and the study conducted follow‐up at week 16 of the trial period. The <a href="./references#CD008642-bbs2-0015" title="SunXD . Evaluation of efficacy and affect of reoccurrence of Jianpi Shenshi granules for atopic dermatitis [Clinical effect of invigorating spleen and excreting dampness granules in treating atopic dermatitis and its influence for recurrence of the patient]. Chinese Journal of Dermatovenerology Integrated Traditional and Western Medicine2009;8(6):335‐7. ">Sun 2009</a> study prescribed Jianpi Shenshi granules with 10 Chinese herbs or placebo to 25 participants aged from 3 to 20 years old (mean = 9 years) for 4 weeks. Follow‐up assessment was conducted at 24 weeks after the treatment period. All four studies allowed other medicines in both groups. </p> </section> <section id="CD008642-sec-0089"> <h6 class="title">2. CHM versus conventional medicines (drugs)</h6> <p>We found 22 studies plus the <a href="./references#CD008642-bbs2-0002" title="ChaoQ , XiaoJG . Research of Chinese herbal medicines for infantile eczema. Qingdao University, Qingdao [Masters thesis]2003. ">Chao 2003</a> study where one of its 4 arms compared the effects of CHM to drugs. </p> <section id="CD008642-sec-0090"> <p><b>a) Oral ingestion (five studies)</b></p> <p>There were 62 participants aged from 10 to 52 years old, with a mean age of 20 years, randomly assigned to the treatment or control group in the <a href="./references#CD008642-bbs2-0008" title="JinPZ , YeQH , ShenM . Observation of efficacy of Jianpi Zhiyang granules for 32 cases with atopic dermatitis. Henan Traditional Chinese Medicine2007;27(12):61‐2. ">Jin 2007</a> study. Jianpi Zhiyang granules with 12 CHMs or loratadine tablet (an antihistamine medication) were given to the participants for 4 weeks. </p> <p>The <a href="./references#CD008642-bbs2-0012" title="LuoFJ , WeiYG . Evaluation of efficacy of Xiaofengsan with modifications for atopic dermatitis. Nanjing University of Chinese Medicine, Nanjing [Masters thesis]2010. ">Luo 2010</a> study recruited 62 children with a mean age of 9, who they treated with Xiao‐Feng‐San decoction and individualised modifications, loratadine, or another antihistamine drug for 16 weeks. </p> <p>The <a href="./references#CD008642-bbs2-0022" title="YangXS , YeJZ , LiK . Clinical efficacy of Jianpi Yangxue Qufeng method for atopic dermatitis and its affect for skin barrier function [The effects of the clinical efficacy of method of strengthening spleen and enriching blood eliminating wind in treatment of chronic atopic dermatitis]. Journal of Yunnan University of Traditional Chinese Medicine2009;32(3):5‐7. ">Yang 2009</a> study used a formula containing 9 herbs and recruited 60 children or adults aged from 4 to 27 years, with a mean age of 16, for 4 weeks of treatment. The <a href="./references#CD008642-bbs2-0022" title="YangXS , YeJZ , LiK . Clinical efficacy of Jianpi Yangxue Qufeng method for atopic dermatitis and its affect for skin barrier function [The effects of the clinical efficacy of method of strengthening spleen and enriching blood eliminating wind in treatment of chronic atopic dermatitis]. Journal of Yunnan University of Traditional Chinese Medicine2009;32(3):5‐7. ">Yang 2009</a> study also used the loratadine tablet as the control intervention. </p> <p>The <a href="./references#CD008642-bbs2-0023" title="YuTG , ZhuJT , XuJL , ZhuangYR , ShenB , WuBL , et al. Clincial and laboratory study of Piyan Xiaojingyin granules II for atopic dermatitis. Journal of Traditional Chinese Medicine1999;40(3):165‐7. ">Yu 1999</a> study had the largest sample size (220 participants) among the 28 included studies. Piyan Xiaojingyin granules II composed of more than 5 herbs were given to participants aged from 5 to 53 years old (mean = 13 years). The loratadine tablet was the control intervention, and both groups were supplied with saline or zinc oxide cream for 12 weeks. The study conducted follow‐up assessment at 52 weeks after the treatment period. </p> <p>The <a href="./references#CD008642-bbs2-0026" title="ZhangCJ . Clinical observation of Zhiyin Qingre method for 30 cases with atopic dermatitis. Guiding Journal of Traditional Chinese Medicine &amp; Pharmacy2011;17(8):22‐4. ">Zhang 2011</a> study reported that they used a clinician self‐designed CHM formula with modifications based on individual cases or levocetirizine dihydrochloride tablets (an antihistamine medication) for treatment of 56 children aged from 2.5 to 14 years old (with a mean age of 7 years) for 8 weeks. The study conducted follow‐up assessment at 24 weeks after the 8‐week treatment period. </p> </section> <section id="CD008642-sec-0091"> <p><b>b) Topical application (six studies)</b></p> <p>The <a href="./references#CD008642-bbs2-0002" title="ChaoQ , XiaoJG . Research of Chinese herbal medicines for infantile eczema. Qingdao University, Qingdao [Masters thesis]2003. ">Chao 2003</a> study compared the effects of CHM to econazole nitrate cream (Pevisone®), which was composed of 1% of econazole nitrate (antifungal medication) and 0.1% of triamcinolone acetonide (corticosteroid) in its 3rd arm. </p> <p>The <a href="./references#CD008642-bbs2-0003" title="ChenH . Clinical observation of Huanglian Qingdai cream for infantile eczema. Journal of Sichuan of Traditional Chinese Medicine2011;29(6):88‐9. ">Chen 2011</a> study randomly entered 100 children (aged from 58 days to 2 years old) into the treatment or control groups, and they were treated with Huanglian Qingdai cream made from 6 herbs or mometasone furoate cream (a corticosteroid) for 2 weeks. </p> <p>There were 65 boys and girls aged from 12 days to 11 months (mean = 5 months) in the <a href="./references#CD008642-bbs2-0017" title="WangP , CaiL , XuJJ . Observation of efficacy of Chushi Zhiyang ointment for infantile eczema. Journal of Sichuan of Traditional Chinese Medicine2008;26(9):92‐3. ">Wang 2008</a> study, which used Chushi Zhiyang ointment, a manufactured CHM product made up of 13 Chinese herbs, topically for 1 week. The study employed vitamin B₆ cream (a moisturising agent) as the control intervention. </p> <p>The <a href="./references#CD008642-bbs2-0007" title="HuangZK , ChenP , WeiWN . Observation of efficacy of Chushi Zhiyang cream for atopic dermatitis. Modern Journal of Integrated Traditional Chinese &amp; Western Medicine2010;19(21):2647‐8. ">Huang 2010</a> study recruited 195 participants aged from 3 months to 22 years old, with a mean age of 12 years, who were treated with Chushi Zhiyang ointment, which was the same CHM product used in the <a href="./references#CD008642-bbs2-0017" title="WangP , CaiL , XuJJ . Observation of efficacy of Chushi Zhiyang ointment for infantile eczema. Journal of Sichuan of Traditional Chinese Medicine2008;26(9):92‐3. ">Wang 2008</a> study, or clobetasol propionate ointment (a corticosteroid) for 2 weeks. The study performed follow‐up assessment at 12 weeks after the treatment period. </p> <p>The <a href="./references#CD008642-bbs2-0027" title="ZhouYZ . Observation of clinical efficacy of Canger Kushen lotion for 88 cases with infantile eczema. Guide of China Medicine2011;9(25):115‐6. ">Zhou 2011</a> study treated 176 children aged 3 to 38 months old (mean = 10 months) with Cang Er Kushen lotion, which had 13 Chinese herbs, or calamine lotion (an anti‐itching agent), which they used topically as the control intervention for 2 weeks. The study conducted follow‐up assessment 24 weeks after the treatment period. </p> <p>The <a href="./references#CD008642-bbs2-0028" title="ZouGM , XieB . Clincial study of Fufang Sanhuang lotion for infantile eczema. Liaoning Journal of Traditional Chinese Medicine2011;38(2):297‐9. ">Zou 2011</a> study randomised 50 children aged from 3 to 36 months, with a mean age of 16 months. Moist dressing with a CHM lotion composed of nine herbs and topical application with the same herbal powder mixed with sesame oil were used for two weeks. Boric acid solution (an antiseptic agent) and zinc oxide cream (a moisturising agent) served as control interventions. </p> </section> <section id="CD008642-sec-0092"> <p><b>c) Combination of oral ingestion and topical application (twelve studies)</b></p> <p>The included studies in this group used CHM by oral ingestion and topical application in their treatment groups for comparison of the effect to the control groups. </p> <p>The <a href="./references#CD008642-bbs2-0001" title="CaoM , WeiYG . Clinical study of Zhuling Jianpi Huashi decoction for atopic dermatitis. Nanjing University of Chinese Medicine, Nanjing [Masters thesis]2009. ">Cao 2009</a> study treated 56 children aged from 2 to 16 years (mean = 8 years) with Zhuling Jianpi Huashi decoction (which could be modified when the condition of an individual participant changed) or with oral ingestion of cetirizine hydrochloride drops (an antihistamine medication) for 1 to 4 weeks. There were 12 herbs in the Zhuling Jianpi Huashi decoction used in this study. The <a href="./references#CD008642-bbs2-0024" title="ZhangQS , WeiYG . Clinical study of Jianpi Huashi formula for childhood atopic dermatitis. Nanjing University of Chinese Medicine, Nanjing [Masters thesis]2005. ">Zhang 2005</a> study also evaluated the same CHM decoction (although the name of the formula was changed). </p> <p>The <a href="./references#CD008642-bbs2-0005" title="GongXH , KuangL , LiuX . Clinical observation of Liangxue Xiaofeng formula for adult atopic dermatitis. Journal of TCM University of Hunan2010;30(3):61‐3. ">Gong 2010</a> study randomised 56 adults aged from 16 to 65 years old (mean = 37 years) into the treatment or control group and treated them with Liangxue Xiaofeng decoction composed of 13 herbs or oral ingestion of desloratidine (an antihistamine medication) for 4 weeks. </p> <p>The <a href="./references#CD008642-bbs2-0009" title="LangN , YaoCH , BoYJ , ChiHY , TuYY , HuangYZ . Treatment of blood deficiency with wind dryness type of atopic dermatitis with combination of Shengui decoction and Shidu ointment. Chinese Journal of Dermatovenerology Integrated Traditional &amp; West Medicine2007;6(1):22‐3. ">Lang 2007</a> study used Shengui decoction with 8 herbs and Shidu ointment for the treatment group for 4 weeks, and oral ingestion of loratadine tablets and 1% hydrocortisone cream (a corticosteroid) topically as control interventions for 72 participants aged from 3 to 34 years old (mean = 17 years). </p> <p>The <a href="./references#CD008642-bbs2-0011" title="LiuHC . Investigation of efficacy of Chinese medicine for atopic dermatitis. Hua‐xia Medicine2005;25(3):208‐9. ">Liu 2005</a> study recruited 184 children and adults aged from 3 months to 42 years old (mean not provided) for 4 to 8 weeks of treatment. The participants were treated with oral ingestion of Cangyi decoction with individualised modifications and Qingdai ointment and Huangbai lotion topically in the treatment group, or they were treated with terfenadine tablet (an antihistamine medication) and 0.025% dexamethasone cream (a corticosteroid) as control interventions. There were 12 herbs in the Cangyi decoction, and the ingredients of the topically used CHM interventions were unknown in this study. </p> <p>The <a href="./references#CD008642-bbs2-0013" title="MaYB , SunLY , WangP , ZhangGZ , CaiNN . Clinical observation of combination of Jianpi Runfu decoction and topical application of Gancao oil for atopic dermatitis with syndrome of spleen deficiency and blood dryness. Beijing Journal of Traditional Chinese Medicine2010;29(9):680‐2. ">Ma 2010</a> study treated 82 children and adults aged from 7 to 33 years old (mean = 18 years) with loratadine tablet or Jianpi Runfu decoction containing 11 herbs. The oral ingestion of CHM could be modified based on the individual's condition in the study, and Zicao oil or butyl flufenamate cream (an anti‐inflammatory medication) was also used topically in the treatment group or control group, respectively, for four weeks. </p> <p>The <a href="./references#CD008642-bbs2-0016" title="TianF , HeT . Observation of efficacy of Fuyang granules for infantile eczema. Liaoning Journal of Traditional Chinese Medicine2005;32(8):810‐1. ">Tian 2005</a> study treated 100 participants (did not report the range of age) with oral ingestion of Fuyang granules composed of 5 herbs and used the same formula for topical application or oral ingestion of cyproheptadine tablet (an antihistamine medication) plus 3% sulphur cream (an antiseptic agent) externally for only 5 days. </p> <p>The <a href="./references#CD008642-bbs2-0018" title="XiaoM , AiRD . Observation of clinical efficacy of combination of Machixian decoction and topical application of Chinese herbs for atopic dermatitis and evaluation of IgE level in serum. Chengdu University of Chinese Medicine, Chengdu [Masters thesis]2008. ">Xiao 2008</a> study used oral ingestion and external application of Machixian decoction as a basic formula, which was modified according to an individual's condition. The control interventions were chlorphenamine tablet (an antihistamine medication) and 3% boric acid solution. There were a total of 52 participants aged from 3 to 23 years old (mean = 13 years) in this study, and treatment duration was 8 weeks with follow‐up assessment at 12 weeks after the treatment period. </p> <p>The <a href="./references#CD008642-bbs2-0019" title="XiaoWM , LiG , LuoB , ZhuQJ . Observation of efficacy of Huailian decoction for atopic dermatitis. Journal of China Traditional Chinese Medicine Information2011;3(3):37‐9. ">Xiao 2011</a> study recruited 60 participants aged from 2 to 60 years old (mean = 12 years) and provided 4 weeks of treatment with Huailian decoction composed of 12 herbs, and loratadine tablet was the control oral ingestion intervention. External use of nitrofurazone, calamine, menthol, and CHM ointment were also provided to both groups. </p> <p>The <a href="./references#CD008642-bbs2-0020" title="XueSQ , TanJH . Clinical observation of Shengxue Runfu decoction with modifications for childhood atopic dermatitis. Journal of New Chinese Medicine2011;43(2):94‐5. ">Xue 2011</a> study used Shengxue Runfu decoction composed of 15 herbs. The formula could be modified depending upon an individual's condition, and loratadine was the control oral ingestion intervention for an 8‐week treatment. There were 63 boys and girls ranged from 2 to 12 years old (mean = 7 years) in this study. Topical application of CHM ointment and emollients were employed for both groups. </p> <p>The <a href="./references#CD008642-bbs2-0021" title="YangY , SunJL , FengYL , YangYF , WangLX . Analysis of efficacy of Chinese herbs Jianpi Zhiyang granules with Pibo Xiaoyan Xuanshi ointment for atopic dermatitis. Chinese Journal of Dermatovenerology Integrated Traditional &amp; Western Medicine2007;6(3):135‐7. ">Yang 2007</a> study used the same oral ingestion of CHM intervention as the <a href="./references#CD008642-bbs2-0008" title="JinPZ , YeQH , ShenM . Observation of efficacy of Jianpi Zhiyang granules for 32 cases with atopic dermatitis. Henan Traditional Chinese Medicine2007;27(12):61‐2. ">Jin 2007</a> study. The two studies were conducted at the same department of a Chinese medicine hospital in Shenzhen, China. The <a href="./references#CD008642-bbs2-0021" title="YangY , SunJL , FengYL , YangYF , WangLX . Analysis of efficacy of Chinese herbs Jianpi Zhiyang granules with Pibo Xiaoyan Xuanshi ointment for atopic dermatitis. Chinese Journal of Dermatovenerology Integrated Traditional &amp; Western Medicine2007;6(3):135‐7. ">Yang 2007</a> study however also used CHM ointment topically with a total of 64 participants from 5 to 25 years old (mean = 7 years) who were treated with Chinese herbs or oral ingestion of loratadine tablet and 1% hydrocortisone butyrate cream (a corticosteroid) for 4 weeks. </p> <p>The <a href="./references#CD008642-bbs2-0024" title="ZhangQS , WeiYG . Clinical study of Jianpi Huashi formula for childhood atopic dermatitis. Nanjing University of Chinese Medicine, Nanjing [Masters thesis]2005. ">Zhang 2005</a> study recruited 45 children under 16 years old (mean = 8 years) and compared the efficacy of a CHM decoction to chlorpheniramine tablet for 12 weeks in 3 groups of participants. In this study, CHM lotion or CHM ointment were also used topically according to an individual's condition in all the groups. </p> <p>Finally, the <a href="./references#CD008642-bbs2-0025" title="ZhangXJ , SongXL . Observation of clinical efficacy of Xiao'er Huashi decoction for infantile eczema. Proceedings of the First International Dermatology Academic Symposium of TCM and Integrated TCM‐WM. Beijing: World Federation of Chinese Medicine Societies, 2009:297‐9. ">Zhang 2009</a> study treated 61 children aged from 2 to 12 years old (mean not provided) with Xiao'er Huashi decoction (composed of 13 herbs) or loratadine granules for 4 weeks. External use of CHM lotion and CHM cream were provided to both groups. </p> </section> </section> <section id="CD008642-sec-0093"> <h6 class="title">3. Combination of oral and topical CHM interventions versus same oral CHM alone</h6> <p>We found two studies comparing the effects of a combination of oral and topical CHM to the same oral CHM formula alone (<a href="./references#CD008642-bbs2-0010" title="LinY , ChenDC . Efficacy of anti‐inflammatory moisturising washing formula for atopic dermatitis and its biological evaluation. Guangzhou University of Chinese Medicine, Guangzhou [PhD thesis]2010. ">Lin 2010</a>; <a href="./references#CD008642-bbs2-0014" title="RaoMR , WeiYG . Clinical study of Qingxin Peitu method for atopic dermatitis. Nanjing University of Chinese Medicine, Nanjing [Masters thesis]2010. ">Rao 2010</a>). The <a href="./references#CD008642-bbs2-0010" title="LinY , ChenDC . Efficacy of anti‐inflammatory moisturising washing formula for atopic dermatitis and its biological evaluation. Guangzhou University of Chinese Medicine, Guangzhou [PhD thesis]2010. ">Lin 2010</a> study used Runfu Xiaoyan lotion composed of 4 herbs applied externally on a randomly selected site of the limb (which had received no previous treatment with regard to the topical intervention) of 23 participants aged from 11 months to 27 years old (mean = 10 years) for 2 weeks. The <a href="./references#CD008642-bbs2-0010" title="LinY , ChenDC . Efficacy of anti‐inflammatory moisturising washing formula for atopic dermatitis and its biological evaluation. Guangzhou University of Chinese Medicine, Guangzhou [PhD thesis]2010. ">Lin 2010</a> study also used oral ingestion of Qingxin Peitu decoction for moderate and severe cases. </p> <p>The <a href="./references#CD008642-bbs2-0014" title="RaoMR , WeiYG . Clinical study of Qingxin Peitu method for atopic dermatitis. Nanjing University of Chinese Medicine, Nanjing [Masters thesis]2010. ">Rao 2010</a> study was a 3‐arm parallel controlled design of 12 weeks' treatment duration, which recruited 30 participants aged from 7 to 25 years old (mean = 15 years). The treatment group (the first arm) received Qingxin Peitu decoction with individualised modifications plus external use of Qingxin Peitu lotion. The second‐arm group was treated with the same oral ingestion of the intervention but no topical intervention, and the third‐arm group used oral ingestion of placebo plus oral ingestion of cetirizine hydrochloride tablet and topical application of mometasone furoate cream. We did not use data from the third‐arm group in this review as there was no appropriate comparator for this group. </p> </section> </section> <section id="CD008642-sec-0094"> <h5 class="title">Outcomes</h5> <p>With regard to our first primary outcome, the trial investigators in most of the included studies converted the measure score into effectiveness rate without reporting the actual score. Thus, we accepted that a 'recovery' was where there was &gt; 90% reduction of the investigator global score, and a 'significant improvement' was &gt; 70% reduction of the score as stated by the trial investigator(s). A total effectiveness rate was a sum of effectiveness rates expressed as 'recovery' and 'significant' by the trial investigator(s) of the included studies. A higher total effectiveness rate indicates better improvement of the condition. </p> <p>With regard to our second primary outcome, most of the included studies measured severity of itching score and expressed this as a participant‐rated visual analogue score (VAS). Thereafter, we extracted continuous data in mean values, standard deviations (SD), and total numbers of events assessed at the end point of the trial as one of the primary outcome measures to replace the percentage of trial participants that we planned. </p> <p>With regard to our third secondary outcome, we extracted adverse events in a data extraction form for all included studies. A severe adverse event was an adverse effect that led a participant to withdraw from the study. A minor adverse event was one reported by the participant or clinician but that was not serious and the person still completed the treatment. </p> <p>With regard to short‐term or long‐term improvement of a relevant outcome, the short‐term improvement was an outcome measured within six weeks in the follow‐up period after stopping the treatment. The long‐term improvement was an outcome measured more than six weeks into the follow‐up period after stopping the treatment. </p> </section> </section> <section id="CD008642-sec-0095"> <h4 class="title">Excluded studies</h4> <p>We excluded four studies because their comparison interventions did not meet the inclusion criteria of this review. Please see the '<a href="./references#CD008642-sec-0168" title="">Characteristics of excluded studies</a>' tables. </p> </section> </section> <section id="CD008642-sec-0096"> <h3 class="title">Risk of bias in included studies</h3> <p>Two authors (SG and AWY) independently assessed the risk of bias in the included studies and resolved discrepancies of the assessments by discussion. The other two team members, HCW and WZ, provided arbitrating advice when a consensus could not be achieved. We assessed risk of bias and provided a brief rationale for our judgment for each study (see the 'Risk of bias' tables, which are an extension of the '<a href="./references#CD008642-sec-0167" title="">Characteristics of included studies</a>' tables). Overall, the risk of bias in the included studies was high for blinding of participants and research personnel and unclear for the other domains. Our judgements according to the published data about each 'Risk of bias' item presented as percentages across all included studies are shown in <a href="#CD008642-fig-0002">Figure 2</a>. We summarised our judgements, which we based on The Cochrane Collaboration's domain‐based evaluation for "assessing risk of bias" about each 'Risk of bias' item for each included study, in <a href="#CD008642-fig-0003">Figure 3</a>. </p> <div class="figure" id="CD008642-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="'Risk of bias' graph: review authors' judgements about each 'Risk of bias' item presented as percentages across all included studies" data-id="CD008642-fig-0002" src="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/image_n/nCD008642-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each 'Risk of bias' item presented as percentages across all included studies </p> </div> </div> </div> <div class="figure" id="CD008642-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="'Risk of bias' summary: review authors' judgements about each 'Risk of bias' item for each included study" data-id="CD008642-fig-0003" src="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/image_n/nCD008642-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each 'Risk of bias' item for each included study </p> </div> </div> </div> <section id="CD008642-sec-0097"> <h4 class="title">Allocation</h4> <p>Almost half of the included studies (13/28) did not state how they generated allocation sequences (<a href="./references#CD008642-bbs2-0002" title="ChaoQ , XiaoJG . Research of Chinese herbal medicines for infantile eczema. Qingdao University, Qingdao [Masters thesis]2003. ">Chao 2003</a>; <a href="./references#CD008642-bbs2-0003" title="ChenH . Clinical observation of Huanglian Qingdai cream for infantile eczema. Journal of Sichuan of Traditional Chinese Medicine2011;29(6):88‐9. ">Chen 2011</a>; <a href="./references#CD008642-bbs2-0008" title="JinPZ , YeQH , ShenM . Observation of efficacy of Jianpi Zhiyang granules for 32 cases with atopic dermatitis. Henan Traditional Chinese Medicine2007;27(12):61‐2. ">Jin 2007</a>; <a href="./references#CD008642-bbs2-0011" title="LiuHC . Investigation of efficacy of Chinese medicine for atopic dermatitis. Hua‐xia Medicine2005;25(3):208‐9. ">Liu 2005</a>; <a href="./references#CD008642-bbs2-0015" title="SunXD . Evaluation of efficacy and affect of reoccurrence of Jianpi Shenshi granules for atopic dermatitis [Clinical effect of invigorating spleen and excreting dampness granules in treating atopic dermatitis and its influence for recurrence of the patient]. Chinese Journal of Dermatovenerology Integrated Traditional and Western Medicine2009;8(6):335‐7. ">Sun 2009</a>; <a href="./references#CD008642-bbs2-0016" title="TianF , HeT . Observation of efficacy of Fuyang granules for infantile eczema. Liaoning Journal of Traditional Chinese Medicine2005;32(8):810‐1. ">Tian 2005</a>; <a href="./references#CD008642-bbs2-0017" title="WangP , CaiL , XuJJ . Observation of efficacy of Chushi Zhiyang ointment for infantile eczema. Journal of Sichuan of Traditional Chinese Medicine2008;26(9):92‐3. ">Wang 2008</a>; <a href="./references#CD008642-bbs2-0018" title="XiaoM , AiRD . Observation of clinical efficacy of combination of Machixian decoction and topical application of Chinese herbs for atopic dermatitis and evaluation of IgE level in serum. Chengdu University of Chinese Medicine, Chengdu [Masters thesis]2008. ">Xiao 2008</a>; <a href="./references#CD008642-bbs2-0020" title="XueSQ , TanJH . Clinical observation of Shengxue Runfu decoction with modifications for childhood atopic dermatitis. Journal of New Chinese Medicine2011;43(2):94‐5. ">Xue 2011</a>; <a href="./references#CD008642-bbs2-0021" title="YangY , SunJL , FengYL , YangYF , WangLX . Analysis of efficacy of Chinese herbs Jianpi Zhiyang granules with Pibo Xiaoyan Xuanshi ointment for atopic dermatitis. Chinese Journal of Dermatovenerology Integrated Traditional &amp; Western Medicine2007;6(3):135‐7. ">Yang 2007</a>; <a href="./references#CD008642-bbs2-0023" title="YuTG , ZhuJT , XuJL , ZhuangYR , ShenB , WuBL , et al. Clincial and laboratory study of Piyan Xiaojingyin granules II for atopic dermatitis. Journal of Traditional Chinese Medicine1999;40(3):165‐7. ">Yu 1999</a>; <a href="./references#CD008642-bbs2-0024" title="ZhangQS , WeiYG . Clinical study of Jianpi Huashi formula for childhood atopic dermatitis. Nanjing University of Chinese Medicine, Nanjing [Masters thesis]2005. ">Zhang 2005</a>; <a href="./references#CD008642-bbs2-0025" title="ZhangXJ , SongXL . Observation of clinical efficacy of Xiao'er Huashi decoction for infantile eczema. Proceedings of the First International Dermatology Academic Symposium of TCM and Integrated TCM‐WM. Beijing: World Federation of Chinese Medicine Societies, 2009:297‐9. ">Zhang 2009</a>). Of the 28 included studies, only 2 studies explicitly explained the procedures for allocation concealment of randomised codes for avoiding potential selection bias (<a href="./references#CD008642-bbs2-0004" title="ChengHM , ChiangLC , JanYM , ChenGW , LiTC . The efficacy and safety of a Chinese herbal product (Xiao‐Feng‐San) for the treatment of refractory atopic dermatitis: a randomized, double‐blind, placebo‐controlled trial. International Archives of Allergy &amp; Immunology2011;155(2):141‐8. [DOI: 10.1159/000318861] ">Cheng 2010</a>; <a href="./references#CD008642-bbs2-0006" title="HonKL , LeungTF , NgPC , LamMCA , KamWYC , WongKY , et al. Efficacy and tolerability of a Chinese herbal medicine concoction for treatment of atopic dermatitis: a randomized, double‐blind, placebo‐controlled study. British Journal of Dermatology2007;157(2):357‐63. [MEDLINE: 17501956] HonKLE , LeungTF , NgPC , LamMCA , KamWYC , WongKY , et al. Therapeutic effect and safety of a traditional Chinese medicine for atopic dermatitis in children: a randomised, double‐blind, placebo‐controlled study. Hong Kong Medical Journal2011;17(1 Suppl 2):38‐40. ">Hon 2007</a>). Both studies used an independent party to provide randomised codes, which were generated by a computer program. The <a href="./references#CD008642-bbs2-0004" title="ChengHM , ChiangLC , JanYM , ChenGW , LiTC . The efficacy and safety of a Chinese herbal product (Xiao‐Feng‐San) for the treatment of refractory atopic dermatitis: a randomized, double‐blind, placebo‐controlled trial. International Archives of Allergy &amp; Immunology2011;155(2):141‐8. [DOI: 10.1159/000318861] ">Cheng 2010</a> study placed the random codes in an envelope. In the <a href="./references#CD008642-bbs2-0006" title="HonKL , LeungTF , NgPC , LamMCA , KamWYC , WongKY , et al. Efficacy and tolerability of a Chinese herbal medicine concoction for treatment of atopic dermatitis: a randomized, double‐blind, placebo‐controlled study. British Journal of Dermatology2007;157(2):357‐63. [MEDLINE: 17501956] HonKLE , LeungTF , NgPC , LamMCA , KamWYC , WongKY , et al. Therapeutic effect and safety of a traditional Chinese medicine for atopic dermatitis in children: a randomised, double‐blind, placebo‐controlled study. Hong Kong Medical Journal2011;17(1 Suppl 2):38‐40. ">Hon 2007</a> study, the trial investigator did not break the codes of any participant until the trial was completed. </p> </section> <section id="CD008642-sec-0098"> <h4 class="title">Blinding</h4> <p>Blinding of participants and personnel involved in direct contact with the participants is important for minimising bias from subjective outcome measures (<a href="./references#CD008642-bbs2-0074" title="TalJ . Strategy and statistics in clinical trials: a non‐statisticians guide to thinking, designing and executing. Amsterdam: Elsevier, 2011. ">Tal 2011</a>). </p> <p>One of the most common quoted subjective outcome measures in eczema was VAS for itching severity. About 89% of the included studies (25/28) did not use blinding either on the participants or on the trial investigators, which implied the highest risk of bias within the assessed domains. Although the <a href="./references#CD008642-bbs2-0015" title="SunXD . Evaluation of efficacy and affect of reoccurrence of Jianpi Shenshi granules for atopic dermatitis [Clinical effect of invigorating spleen and excreting dampness granules in treating atopic dermatitis and its influence for recurrence of the patient]. Chinese Journal of Dermatovenerology Integrated Traditional and Western Medicine2009;8(6):335‐7. ">Sun 2009</a> study claimed that the trial was a double‐blind design, there was only one author in the published paper with absence of acknowledgment of other personnel. We were not sure how the blinding was implemented in this study. Only two studies employed the double‐blind design and provided clear description of blinding methods (<a href="./references#CD008642-bbs2-0004" title="ChengHM , ChiangLC , JanYM , ChenGW , LiTC . The efficacy and safety of a Chinese herbal product (Xiao‐Feng‐San) for the treatment of refractory atopic dermatitis: a randomized, double‐blind, placebo‐controlled trial. International Archives of Allergy &amp; Immunology2011;155(2):141‐8. [DOI: 10.1159/000318861] ">Cheng 2010</a>; <a href="./references#CD008642-bbs2-0006" title="HonKL , LeungTF , NgPC , LamMCA , KamWYC , WongKY , et al. Efficacy and tolerability of a Chinese herbal medicine concoction for treatment of atopic dermatitis: a randomized, double‐blind, placebo‐controlled study. British Journal of Dermatology2007;157(2):357‐63. [MEDLINE: 17501956] HonKLE , LeungTF , NgPC , LamMCA , KamWYC , WongKY , et al. Therapeutic effect and safety of a traditional Chinese medicine for atopic dermatitis in children: a randomised, double‐blind, placebo‐controlled study. Hong Kong Medical Journal2011;17(1 Suppl 2):38‐40. ">Hon 2007</a>). </p> <p>Blinding of the outcome assessors was another overall weakness of methodology in the included studies. Most of the included studies (82%; 23/28) did not state whether they had used blinding in assessments of outcomes. In many situations, the appearance and administration of the two compared interventions were different in the trial, e.g. Chinese herbal decoction versus Western medications, which made blinding impossible even though the study did not particularly state that it did not use blinding. The <a href="./references#CD008642-bbs2-0001" title="CaoM , WeiYG . Clinical study of Zhuling Jianpi Huashi decoction for atopic dermatitis. Nanjing University of Chinese Medicine, Nanjing [Masters thesis]2009. ">Cao 2009</a> and <a href="./references#CD008642-bbs2-0012" title="LuoFJ , WeiYG . Evaluation of efficacy of Xiaofengsan with modifications for atopic dermatitis. Nanjing University of Chinese Medicine, Nanjing [Masters thesis]2010. ">Luo 2010</a> studies declared that they did not require blinding. Only three studies appropriately blinded the chief investigators of the trials from awareness of the interventions used, when they performed outcome assessments or used a third party to carry out such assessments (<a href="./references#CD008642-bbs2-0004" title="ChengHM , ChiangLC , JanYM , ChenGW , LiTC . The efficacy and safety of a Chinese herbal product (Xiao‐Feng‐San) for the treatment of refractory atopic dermatitis: a randomized, double‐blind, placebo‐controlled trial. International Archives of Allergy &amp; Immunology2011;155(2):141‐8. [DOI: 10.1159/000318861] ">Cheng 2010</a>; <a href="./references#CD008642-bbs2-0006" title="HonKL , LeungTF , NgPC , LamMCA , KamWYC , WongKY , et al. Efficacy and tolerability of a Chinese herbal medicine concoction for treatment of atopic dermatitis: a randomized, double‐blind, placebo‐controlled study. British Journal of Dermatology2007;157(2):357‐63. [MEDLINE: 17501956] HonKLE , LeungTF , NgPC , LamMCA , KamWYC , WongKY , et al. Therapeutic effect and safety of a traditional Chinese medicine for atopic dermatitis in children: a randomised, double‐blind, placebo‐controlled study. Hong Kong Medical Journal2011;17(1 Suppl 2):38‐40. ">Hon 2007</a>; <a href="./references#CD008642-bbs2-0014" title="RaoMR , WeiYG . Clinical study of Qingxin Peitu method for atopic dermatitis. Nanjing University of Chinese Medicine, Nanjing [Masters thesis]2010. ">Rao 2010</a>). </p> </section> <section id="CD008642-sec-0099"> <h4 class="title">Incomplete outcome data</h4> <p>There was unclear risk of bias among the included studies as the numbers of participants randomised and analysed were identical in 75% of the included studies, and it seems that there were no incomplete outcome data in those studies. High risk of attrition bias (a bias associated with withdrawal or dropout of participants in a study) existed as there were withdrawals or dropouts in the studies of <a href="./references#CD008642-bbs2-0002" title="ChaoQ , XiaoJG . Research of Chinese herbal medicines for infantile eczema. Qingdao University, Qingdao [Masters thesis]2003. ">Chao 2003</a>; <a href="./references#CD008642-bbs2-0009" title="LangN , YaoCH , BoYJ , ChiHY , TuYY , HuangYZ . Treatment of blood deficiency with wind dryness type of atopic dermatitis with combination of Shengui decoction and Shidu ointment. Chinese Journal of Dermatovenerology Integrated Traditional &amp; West Medicine2007;6(1):22‐3. ">Lang 2007</a>; <a href="./references#CD008642-bbs2-0010" title="LinY , ChenDC . Efficacy of anti‐inflammatory moisturising washing formula for atopic dermatitis and its biological evaluation. Guangzhou University of Chinese Medicine, Guangzhou [PhD thesis]2010. ">Lin 2010</a>; and <a href="./references#CD008642-bbs2-0020" title="XueSQ , TanJH . Clinical observation of Shengxue Runfu decoction with modifications for childhood atopic dermatitis. Journal of New Chinese Medicine2011;43(2):94‐5. ">Xue 2011</a>, and these studies did not use ITT. The <a href="./references#CD008642-bbs2-0004" title="ChengHM , ChiangLC , JanYM , ChenGW , LiTC . The efficacy and safety of a Chinese herbal product (Xiao‐Feng‐San) for the treatment of refractory atopic dermatitis: a randomized, double‐blind, placebo‐controlled trial. International Archives of Allergy &amp; Immunology2011;155(2):141‐8. [DOI: 10.1159/000318861] ">Cheng 2010</a>; <a href="./references#CD008642-bbs2-0006" title="HonKL , LeungTF , NgPC , LamMCA , KamWYC , WongKY , et al. Efficacy and tolerability of a Chinese herbal medicine concoction for treatment of atopic dermatitis: a randomized, double‐blind, placebo‐controlled study. British Journal of Dermatology2007;157(2):357‐63. [MEDLINE: 17501956] HonKLE , LeungTF , NgPC , LamMCA , KamWYC , WongKY , et al. Therapeutic effect and safety of a traditional Chinese medicine for atopic dermatitis in children: a randomised, double‐blind, placebo‐controlled study. Hong Kong Medical Journal2011;17(1 Suppl 2):38‐40. ">Hon 2007</a>; and <a href="./references#CD008642-bbs2-0013" title="MaYB , SunLY , WangP , ZhangGZ , CaiNN . Clinical observation of combination of Jianpi Runfu decoction and topical application of Gancao oil for atopic dermatitis with syndrome of spleen deficiency and blood dryness. Beijing Journal of Traditional Chinese Medicine2010;29(9):680‐2. ">Ma 2010</a> studies reported data for withdrawals and dropouts, and they used the ITT principle in the final statistical calculations. Therefore, we considered the risk of bias at a low level. </p> </section> <section id="CD008642-sec-0100"> <h4 class="title">Selective reporting</h4> <p>In the <a href="./references#CD008642-bbs2-0007" title="HuangZK , ChenP , WeiWN . Observation of efficacy of Chushi Zhiyang cream for atopic dermatitis. Modern Journal of Integrated Traditional Chinese &amp; Western Medicine2010;19(21):2647‐8. ">Huang 2010</a> study, the trial investigators claimed full blood counts (they performed liver and renal function tests after the two‐week treatment period), but we could not find the results of those tests in their study. We were unable to assess the outcome reporting bias because of insufficient information in the rest of the 27 included studies. </p> </section> <section id="CD008642-sec-0101"> <h4 class="title">Other potential sources of bias</h4> <p>We set "use of published validated scoring systems" to assess potential sources of bias and found that more than 64% (18/28) of the included studies used published and validated scoring systems, including EASI, SAASAD, or SCORAD, as outcome measures. Five included studies did not use any published and validated scoring system, and we considered these studies at a high risk of bias (<a href="./references#CD008642-bbs2-0011" title="LiuHC . Investigation of efficacy of Chinese medicine for atopic dermatitis. Hua‐xia Medicine2005;25(3):208‐9. ">Liu 2005</a>; <a href="./references#CD008642-bbs2-0016" title="TianF , HeT . Observation of efficacy of Fuyang granules for infantile eczema. Liaoning Journal of Traditional Chinese Medicine2005;32(8):810‐1. ">Tian 2005</a>; <a href="./references#CD008642-bbs2-0017" title="WangP , CaiL , XuJJ . Observation of efficacy of Chushi Zhiyang ointment for infantile eczema. Journal of Sichuan of Traditional Chinese Medicine2008;26(9):92‐3. ">Wang 2008</a>; <a href="./references#CD008642-bbs2-0027" title="ZhouYZ . Observation of clinical efficacy of Canger Kushen lotion for 88 cases with infantile eczema. Guide of China Medicine2011;9(25):115‐6. ">Zhou 2011</a>; <a href="./references#CD008642-bbs2-0028" title="ZouGM , XieB . Clincial study of Fufang Sanhuang lotion for infantile eczema. Liaoning Journal of Traditional Chinese Medicine2011;38(2):297‐9. ">Zou 2011</a>). Four studies used a scoring system developed by the trial investigator(s) for measurement of outcomes (<a href="./references#CD008642-bbs2-0002" title="ChaoQ , XiaoJG . Research of Chinese herbal medicines for infantile eczema. Qingdao University, Qingdao [Masters thesis]2003. ">Chao 2003</a>; <a href="./references#CD008642-bbs2-0003" title="ChenH . Clinical observation of Huanglian Qingdai cream for infantile eczema. Journal of Sichuan of Traditional Chinese Medicine2011;29(6):88‐9. ">Chen 2011</a>; <a href="./references#CD008642-bbs2-0022" title="YangXS , YeJZ , LiK . Clinical efficacy of Jianpi Yangxue Qufeng method for atopic dermatitis and its affect for skin barrier function [The effects of the clinical efficacy of method of strengthening spleen and enriching blood eliminating wind in treatment of chronic atopic dermatitis]. Journal of Yunnan University of Traditional Chinese Medicine2009;32(3):5‐7. ">Yang 2009</a>; <a href="./references#CD008642-bbs2-0023" title="YuTG , ZhuJT , XuJL , ZhuangYR , ShenB , WuBL , et al. Clincial and laboratory study of Piyan Xiaojingyin granules II for atopic dermatitis. Journal of Traditional Chinese Medicine1999;40(3):165‐7. ">Yu 1999</a>). We were not able to assess the validation of those trial investigators' self‐developed scoring systems; thus, we classed the risk of bias as unclear. The <a href="./references#CD008642-bbs2-0004" title="ChengHM , ChiangLC , JanYM , ChenGW , LiTC . The efficacy and safety of a Chinese herbal product (Xiao‐Feng‐San) for the treatment of refractory atopic dermatitis: a randomized, double‐blind, placebo‐controlled trial. International Archives of Allergy &amp; Immunology2011;155(2):141‐8. [DOI: 10.1159/000318861] ">Cheng 2010</a> study claimed to use a "standardised scoring system"; again, we were unable to assess whether the system had been validated, although the scoring system had been previously used and published in other trials, so we classed the risk of bias as unclear in this study, too. </p> <p>None of the included studies used POEM for scoring the severity of the condition.</p> </section> </section> <section id="CD008642-sec-0102"> <h3 class="title" id="CD008642-sec-0102">Effects of interventions</h3> <p>See: <a href="./full#CD008642-tbl-0001"><b>Summary of findings for the main comparison</b> CHM compared to placebo</a>; <a href="./full#CD008642-tbl-0002"><b>Summary of findings 2</b> CHM compared to drugs</a>; <a href="./full#CD008642-tbl-0003"><b>Summary of findings 3</b> Combination of oral and topical CHM compared to same oral CHM</a> </p> <section id="CD008642-sec-0103"> <h4 class="title">I. CHM versus placebo</h4> <section id="CD008642-sec-0104"> <h5 class="title">1. Primary outcomes</h5> <section id="CD008642-sec-0105"> <h6 class="title">a) Total effectiveness rate</h6> <p>The <a href="./references#CD008642-bbs2-0002" title="ChaoQ , XiaoJG . Research of Chinese herbal medicines for infantile eczema. Qingdao University, Qingdao [Masters thesis]2003. ">Chao 2003</a> study showed that there was a statistically significant increase in total effectiveness rate (those participants with 'recovery' or 'significant improvement') in the CHM group treated with 10% strength CHM cream compared to those in the control group using petroleum jelly (Vaseline) at the end of the 3‐week treatment period. We decided to include the full strength (10%) CHM cream for analysis in this review. The <a href="./references#CD008642-bbs2-0015" title="SunXD . Evaluation of efficacy and affect of reoccurrence of Jianpi Shenshi granules for atopic dermatitis [Clinical effect of invigorating spleen and excreting dampness granules in treating atopic dermatitis and its influence for recurrence of the patient]. Chinese Journal of Dermatovenerology Integrated Traditional and Western Medicine2009;8(6):335‐7. ">Sun 2009</a> study recorded no effect in the sum of 'recovery' and 'significant improvement' events in both groups at the end of the four‐week treatment period. </p> <p>We pooled data from these 2 studies using the statistical method of inverse‐variance with the random‐effects analysis model and expressed an estimate of their overall effects as RR with 95% CI, which showed a statistically significant effect of the CHM intervention (RR 2.09, 95% CI 1.32 to 3.32; see <a href="./references#CD008642-fig-0007" title="">Analysis 1.1</a>). </p> <p>The <a href="./references#CD008642-bbs2-0002" title="ChaoQ , XiaoJG . Research of Chinese herbal medicines for infantile eczema. Qingdao University, Qingdao [Masters thesis]2003. ">Chao 2003</a> study did not report short‐term or long‐term improvement. The <a href="./references#CD008642-bbs2-0015" title="SunXD . Evaluation of efficacy and affect of reoccurrence of Jianpi Shenshi granules for atopic dermatitis [Clinical effect of invigorating spleen and excreting dampness granules in treating atopic dermatitis and its influence for recurrence of the patient]. Chinese Journal of Dermatovenerology Integrated Traditional and Western Medicine2009;8(6):335‐7. ">Sun 2009</a> study reported long‐term improvement (24 weeks after stopping the treatment) assessed with 'Recurrence rate'. We did not perform further analysis of the data as the 'Recurrence rate' was not a prespecified outcome of this review. </p> <p>The <a href="./references#CD008642-bbs2-0004" title="ChengHM , ChiangLC , JanYM , ChenGW , LiTC . The efficacy and safety of a Chinese herbal product (Xiao‐Feng‐San) for the treatment of refractory atopic dermatitis: a randomized, double‐blind, placebo‐controlled trial. International Archives of Allergy &amp; Immunology2011;155(2):141‐8. [DOI: 10.1159/000318861] ">Cheng 2010</a> and <a href="./references#CD008642-bbs2-0006" title="HonKL , LeungTF , NgPC , LamMCA , KamWYC , WongKY , et al. Efficacy and tolerability of a Chinese herbal medicine concoction for treatment of atopic dermatitis: a randomized, double‐blind, placebo‐controlled study. British Journal of Dermatology2007;157(2):357‐63. [MEDLINE: 17501956] HonKLE , LeungTF , NgPC , LamMCA , KamWYC , WongKY , et al. Therapeutic effect and safety of a traditional Chinese medicine for atopic dermatitis in children: a randomised, double‐blind, placebo‐controlled study. Hong Kong Medical Journal2011;17(1 Suppl 2):38‐40. ">Hon 2007</a> studies did not report the outcomes as 'effectiveness rate'. </p> </section> <section id="CD008642-sec-0106"> <h6 class="title">b) Severity of itching score measured by VAS</h6> <p>The <a href="./references#CD008642-bbs2-0004" title="ChengHM , ChiangLC , JanYM , ChenGW , LiTC . The efficacy and safety of a Chinese herbal product (Xiao‐Feng‐San) for the treatment of refractory atopic dermatitis: a randomized, double‐blind, placebo‐controlled trial. International Archives of Allergy &amp; Immunology2011;155(2):141‐8. [DOI: 10.1159/000318861] ">Cheng 2010</a> study reported the improvement of itching in scores (scale from 0 to 4). The score was expressed as least‐squares mean ± the standard error (SE) change from baseline for each intervention group following the eight‐week treatment period. The <a href="./references#CD008642-bbs2-0004" title="ChengHM , ChiangLC , JanYM , ChenGW , LiTC . The efficacy and safety of a Chinese herbal product (Xiao‐Feng‐San) for the treatment of refractory atopic dermatitis: a randomized, double‐blind, placebo‐controlled trial. International Archives of Allergy &amp; Immunology2011;155(2):141‐8. [DOI: 10.1159/000318861] ">Cheng 2010</a> study also provided data of baseline median (interquartile range (IQ)) per group. We did not use the SEs provided as they were too narrow. We pooled the data by using an alternative SD estimated from the baseline data (calculation from baseline IQ range: SD = IQ/1.35) to ensure the least‐squares means did not receive too much weight in the meta‐analysis (<a href="./references#CD008642-bbs2-0058" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration. Available from www.cochrane‐handbook.org. The Cochrane Collaboration. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). The <a href="./references#CD008642-bbs2-0015" title="SunXD . Evaluation of efficacy and affect of reoccurrence of Jianpi Shenshi granules for atopic dermatitis [Clinical effect of invigorating spleen and excreting dampness granules in treating atopic dermatitis and its influence for recurrence of the patient]. Chinese Journal of Dermatovenerology Integrated Traditional and Western Medicine2009;8(6):335‐7. ">Sun 2009</a> study also used VAS (scale unknown) to assess the severity of itching at the end of the four‐week treatment period but did not report scale. We pooled the data and expressed as SMD with 95% CI due to different outcome scales being used in these 2 studies (SMD ‐1.53, 95% CI ‐2.64 to ‐0.41; see <a href="./references#CD008642-fig-0008" title="">Analysis 1.2</a>). As the <a href="./references#CD008642-bbs2-0004" title="ChengHM , ChiangLC , JanYM , ChenGW , LiTC . The efficacy and safety of a Chinese herbal product (Xiao‐Feng‐San) for the treatment of refractory atopic dermatitis: a randomized, double‐blind, placebo‐controlled trial. International Archives of Allergy &amp; Immunology2011;155(2):141‐8. [DOI: 10.1159/000318861] ">Cheng 2010</a> study reported improvement of VAS without the actual score and the <a href="./references#CD008642-bbs2-0015" title="SunXD . Evaluation of efficacy and affect of reoccurrence of Jianpi Shenshi granules for atopic dermatitis [Clinical effect of invigorating spleen and excreting dampness granules in treating atopic dermatitis and its influence for recurrence of the patient]. Chinese Journal of Dermatovenerology Integrated Traditional and Western Medicine2009;8(6):335‐7. ">Sun 2009</a> study recorded decrease of VAS at end point, we multiplied the mean in the <a href="./references#CD008642-bbs2-0004" title="ChengHM , ChiangLC , JanYM , ChenGW , LiTC . The efficacy and safety of a Chinese herbal product (Xiao‐Feng‐San) for the treatment of refractory atopic dermatitis: a randomized, double‐blind, placebo‐controlled trial. International Archives of Allergy &amp; Immunology2011;155(2):141‐8. [DOI: 10.1159/000318861] ">Cheng 2010</a> study by ‐1 to ensure the 2 outcomes were in the same direction (<a href="./references#CD008642-bbs2-0051" title="DeeksJJ , HigginsJPT , Altman DG(editors) . Chapter 9: Analysing data and undertaking meta‐analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Deeks 2011</a>). Both studies showed favourable results towards the CHM groups. </p> <p>The <a href="./references#CD008642-bbs2-0004" title="ChengHM , ChiangLC , JanYM , ChenGW , LiTC . The efficacy and safety of a Chinese herbal product (Xiao‐Feng‐San) for the treatment of refractory atopic dermatitis: a randomized, double‐blind, placebo‐controlled trial. International Archives of Allergy &amp; Immunology2011;155(2):141‐8. [DOI: 10.1159/000318861] ">Cheng 2010</a> study reported short‐term improvement (four weeks after stopping the treatment) and stated that better scores of itching were seen in the CHM group, but it did not provide details of data. </p> <p>We found no record of severity of itching score in the <a href="./references#CD008642-bbs2-0002" title="ChaoQ , XiaoJG . Research of Chinese herbal medicines for infantile eczema. Qingdao University, Qingdao [Masters thesis]2003. ">Chao 2003</a> and <a href="./references#CD008642-bbs2-0006" title="HonKL , LeungTF , NgPC , LamMCA , KamWYC , WongKY , et al. Efficacy and tolerability of a Chinese herbal medicine concoction for treatment of atopic dermatitis: a randomized, double‐blind, placebo‐controlled study. British Journal of Dermatology2007;157(2):357‐63. [MEDLINE: 17501956] HonKLE , LeungTF , NgPC , LamMCA , KamWYC , WongKY , et al. Therapeutic effect and safety of a traditional Chinese medicine for atopic dermatitis in children: a randomised, double‐blind, placebo‐controlled study. Hong Kong Medical Journal2011;17(1 Suppl 2):38‐40. ">Hon 2007</a> studies. </p> </section> </section> <section id="CD008642-sec-0107"> <h5 class="title">2. Secondary outcomes</h5> <section id="CD008642-sec-0108"> <h6 class="title">a) Overall severity score measured by the scoring system (e.g. EASI, SAASAD, or SCORAD)</h6> <p>The <a href="./references#CD008642-bbs2-0002" title="ChaoQ , XiaoJG . Research of Chinese herbal medicines for infantile eczema. Qingdao University, Qingdao [Masters thesis]2003. ">Chao 2003</a> study used a self‐developed scoring system and recorded the score at end point in the CHM group (2nd arm) and control group (4th arm). The <a href="./references#CD008642-bbs2-0004" title="ChengHM , ChiangLC , JanYM , ChenGW , LiTC . The efficacy and safety of a Chinese herbal product (Xiao‐Feng‐San) for the treatment of refractory atopic dermatitis: a randomized, double‐blind, placebo‐controlled trial. International Archives of Allergy &amp; Immunology2011;155(2):141‐8. [DOI: 10.1159/000318861] ">Cheng 2010</a> study reported improvement in clinical lesion scores, which were expressed as least‐squares means ± SE at the end of the eight‐week treatment period. We analysed the data by using an alternative SD as outlined above. The <a href="./references#CD008642-bbs2-0006" title="HonKL , LeungTF , NgPC , LamMCA , KamWYC , WongKY , et al. Efficacy and tolerability of a Chinese herbal medicine concoction for treatment of atopic dermatitis: a randomized, double‐blind, placebo‐controlled study. British Journal of Dermatology2007;157(2):357‐63. [MEDLINE: 17501956] HonKLE , LeungTF , NgPC , LamMCA , KamWYC , WongKY , et al. Therapeutic effect and safety of a traditional Chinese medicine for atopic dermatitis in children: a randomised, double‐blind, placebo‐controlled study. Hong Kong Medical Journal2011;17(1 Suppl 2):38‐40. ">Hon 2007</a> study reported the SCORAD score at the end of the 12‐week treatment period in both groups and stated that there was no significant difference between the 2 groups. The <a href="./references#CD008642-bbs2-0015" title="SunXD . Evaluation of efficacy and affect of reoccurrence of Jianpi Shenshi granules for atopic dermatitis [Clinical effect of invigorating spleen and excreting dampness granules in treating atopic dermatitis and its influence for recurrence of the patient]. Chinese Journal of Dermatovenerology Integrated Traditional and Western Medicine2009;8(6):335‐7. ">Sun 2009</a> study also used SCORAD to measure the outcomes and claimed that a significant difference in the treatment and control groups at the end of the treatment period was observed, and the effect in the CHM group was superior to the control group. We pooled data from those 4 studies and recorded a significant difference (SMD ‐0.88, 95% CI ‐1.67 to ‐0.09; see <a href="./references#CD008642-fig-0009" title="">Analysis 1.3</a>). </p> <p>The <a href="./references#CD008642-bbs2-0004" title="ChengHM , ChiangLC , JanYM , ChenGW , LiTC . The efficacy and safety of a Chinese herbal product (Xiao‐Feng‐San) for the treatment of refractory atopic dermatitis: a randomized, double‐blind, placebo‐controlled trial. International Archives of Allergy &amp; Immunology2011;155(2):141‐8. [DOI: 10.1159/000318861] ">Cheng 2010</a> study reported short‐term improvement (four weeks after stopping the treatment) and stated that improved clinical lesion scores were seen in the CHM group; however, no data were provided. The <a href="./references#CD008642-bbs2-0006" title="HonKL , LeungTF , NgPC , LamMCA , KamWYC , WongKY , et al. Efficacy and tolerability of a Chinese herbal medicine concoction for treatment of atopic dermatitis: a randomized, double‐blind, placebo‐controlled study. British Journal of Dermatology2007;157(2):357‐63. [MEDLINE: 17501956] HonKLE , LeungTF , NgPC , LamMCA , KamWYC , WongKY , et al. Therapeutic effect and safety of a traditional Chinese medicine for atopic dermatitis in children: a randomised, double‐blind, placebo‐controlled study. Hong Kong Medical Journal2011;17(1 Suppl 2):38‐40. ">Hon 2007</a> study reported that no short‐term improvement was observed as there was no difference between the 2 groups 4 weeks after stopping the treatment (MD 3.40, 95% CI ‐5.70 to 12.50; see <a href="./references#CD008642-fig-0010" title="">Analysis 1.4</a>). The <a href="./references#CD008642-bbs2-0002" title="ChaoQ , XiaoJG . Research of Chinese herbal medicines for infantile eczema. Qingdao University, Qingdao [Masters thesis]2003. ">Chao 2003</a> and <a href="./references#CD008642-bbs2-0015" title="SunXD . Evaluation of efficacy and affect of reoccurrence of Jianpi Shenshi granules for atopic dermatitis [Clinical effect of invigorating spleen and excreting dampness granules in treating atopic dermatitis and its influence for recurrence of the patient]. Chinese Journal of Dermatovenerology Integrated Traditional and Western Medicine2009;8(6):335‐7. ">Sun 2009</a> studies did not report short‐term or long‐term improvement in overall severity score. </p> </section> <section id="CD008642-sec-0109"> <h6 class="title">b) QoL index</h6> <p>The <a href="./references#CD008642-bbs2-0006" title="HonKL , LeungTF , NgPC , LamMCA , KamWYC , WongKY , et al. Efficacy and tolerability of a Chinese herbal medicine concoction for treatment of atopic dermatitis: a randomized, double‐blind, placebo‐controlled study. British Journal of Dermatology2007;157(2):357‐63. [MEDLINE: 17501956] HonKLE , LeungTF , NgPC , LamMCA , KamWYC , WongKY , et al. Therapeutic effect and safety of a traditional Chinese medicine for atopic dermatitis in children: a randomised, double‐blind, placebo‐controlled study. Hong Kong Medical Journal2011;17(1 Suppl 2):38‐40. ">Hon 2007</a> study reported improvement in CDLQI score in the CHM group at the end of the 12‐week treatment period (MD ‐2.50, 95% CI ‐4.77 to ‐0.23; see <a href="./references#CD008642-fig-0011" title="">Analysis 1.5</a>). The <a href="./references#CD008642-bbs2-0006" title="HonKL , LeungTF , NgPC , LamMCA , KamWYC , WongKY , et al. Efficacy and tolerability of a Chinese herbal medicine concoction for treatment of atopic dermatitis: a randomized, double‐blind, placebo‐controlled study. British Journal of Dermatology2007;157(2):357‐63. [MEDLINE: 17501956] HonKLE , LeungTF , NgPC , LamMCA , KamWYC , WongKY , et al. Therapeutic effect and safety of a traditional Chinese medicine for atopic dermatitis in children: a randomised, double‐blind, placebo‐controlled study. Hong Kong Medical Journal2011;17(1 Suppl 2):38‐40. ">Hon 2007</a> study also stated that there was a short‐term improvement in CDLQI 4 weeks after stopping the treatment, but this claim was not supported by the statistical analysis (MD ‐1.30, 95% CI ‐3.51 to 0.91; see <a href="./references#CD008642-fig-0012" title="">Analysis 1.6</a>). </p> <p>The <a href="./references#CD008642-bbs2-0002" title="ChaoQ , XiaoJG . Research of Chinese herbal medicines for infantile eczema. Qingdao University, Qingdao [Masters thesis]2003. ">Chao 2003</a>; <a href="./references#CD008642-bbs2-0004" title="ChengHM , ChiangLC , JanYM , ChenGW , LiTC . The efficacy and safety of a Chinese herbal product (Xiao‐Feng‐San) for the treatment of refractory atopic dermatitis: a randomized, double‐blind, placebo‐controlled trial. International Archives of Allergy &amp; Immunology2011;155(2):141‐8. [DOI: 10.1159/000318861] ">Cheng 2010</a>; and <a href="./references#CD008642-bbs2-0015" title="SunXD . Evaluation of efficacy and affect of reoccurrence of Jianpi Shenshi granules for atopic dermatitis [Clinical effect of invigorating spleen and excreting dampness granules in treating atopic dermatitis and its influence for recurrence of the patient]. Chinese Journal of Dermatovenerology Integrated Traditional and Western Medicine2009;8(6):335‐7. ">Sun 2009</a> studies did not use a QoL index to measure the outcomes. </p> </section> <section id="CD008642-sec-0110"> <h6 class="title">c) Adverse events</h6> <p>There were two minor adverse events in the CHM group in the <a href="./references#CD008642-bbs2-0002" title="ChaoQ , XiaoJG . Research of Chinese herbal medicines for infantile eczema. Qingdao University, Qingdao [Masters thesis]2003. ">Chao 2003</a> study. The <a href="./references#CD008642-bbs2-0004" title="ChengHM , ChiangLC , JanYM , ChenGW , LiTC . The efficacy and safety of a Chinese herbal product (Xiao‐Feng‐San) for the treatment of refractory atopic dermatitis: a randomized, double‐blind, placebo‐controlled trial. International Archives of Allergy &amp; Immunology2011;155(2):141‐8. [DOI: 10.1159/000318861] ">Cheng 2010</a> study reported that one participant had transient elevation of aspartate aminotransferase (AST); the trial investigators did not state in which group the participant was assessed. There were two participants in the treatment group who complained of gastrointestinal upset in the first week of the treatment, but the participants were able to complete the whole trial (<a href="./references#CD008642-bbs2-0004" title="ChengHM , ChiangLC , JanYM , ChenGW , LiTC . The efficacy and safety of a Chinese herbal product (Xiao‐Feng‐San) for the treatment of refractory atopic dermatitis: a randomized, double‐blind, placebo‐controlled trial. International Archives of Allergy &amp; Immunology2011;155(2):141‐8. [DOI: 10.1159/000318861] ">Cheng 2010</a>). The <a href="./references#CD008642-bbs2-0015" title="SunXD . Evaluation of efficacy and affect of reoccurrence of Jianpi Shenshi granules for atopic dermatitis [Clinical effect of invigorating spleen and excreting dampness granules in treating atopic dermatitis and its influence for recurrence of the patient]. Chinese Journal of Dermatovenerology Integrated Traditional and Western Medicine2009;8(6):335‐7. ">Sun 2009</a> study stated that none of the trial participants reported adverse events. </p> <p>We pooled data from the <a href="./references#CD008642-bbs2-0002" title="ChaoQ , XiaoJG . Research of Chinese herbal medicines for infantile eczema. Qingdao University, Qingdao [Masters thesis]2003. ">Chao 2003</a> and <a href="./references#CD008642-bbs2-0004" title="ChengHM , ChiangLC , JanYM , ChenGW , LiTC . The efficacy and safety of a Chinese herbal product (Xiao‐Feng‐San) for the treatment of refractory atopic dermatitis: a randomized, double‐blind, placebo‐controlled trial. International Archives of Allergy &amp; Immunology2011;155(2):141‐8. [DOI: 10.1159/000318861] ">Cheng 2010</a> studies about minor adverse events; no significant difference was seen between the treatment and control groups (RR 0.71, 95% CI 0.06 to 8.67; 2 studies, n = 129; see <a href="./references#CD008642-fig-0013" title="">Analysis 1.7</a>). There were a total of 82 minor adverse events reported by participants in the CHM group and 47 minor adverse events reported by participants in the control group in the <a href="./references#CD008642-bbs2-0006" title="HonKL , LeungTF , NgPC , LamMCA , KamWYC , WongKY , et al. Efficacy and tolerability of a Chinese herbal medicine concoction for treatment of atopic dermatitis: a randomized, double‐blind, placebo‐controlled study. British Journal of Dermatology2007;157(2):357‐63. [MEDLINE: 17501956] HonKLE , LeungTF , NgPC , LamMCA , KamWYC , WongKY , et al. Therapeutic effect and safety of a traditional Chinese medicine for atopic dermatitis in children: a randomised, double‐blind, placebo‐controlled study. Hong Kong Medical Journal2011;17(1 Suppl 2):38‐40. ">Hon 2007</a> study. The trial investigators claimed that there was no significant difference in terms of frequency of minor adverse events in the two groups. We treated the frequency of those adverse events as 'count data' and converted to risk ratio (<a href="./references#CD008642-bbs2-0051" title="DeeksJJ , HigginsJPT , Altman DG(editors) . Chapter 9: Analysing data and undertaking meta‐analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Deeks 2011</a>). It showed a statistically significant difference in the minor adverse events between the 2 groups, and the CHM group had a higher rate in the incident of the events (RR 1.77, 95% CI 1.24 to 2.53; see <a href="./references#CD008642-fig-0014" title="">Analysis 1.8</a>). </p> </section> <section id="CD008642-sec-0111"> <h6 class="title"><i>Subgroup analysis and investigation of heterogeneity</i> </h6> <p>We found substantial heterogeneity (I² statistic = 87%, see <a href="#CD008642-fig-0004">Figure 4</a>) across the 4 studies in the outcome 'overall severity score'. We planned to perform subgroup analyses of "children (16 years old or under) with eczema versus adults with eczema" and "application of interventions based on Chinese medicine syndrome differentiation versus non‐individualisation formula" where there were at least moderate levels of heterogeneity across the included studies. However, only the <a href="./references#CD008642-bbs2-0002" title="ChaoQ , XiaoJG . Research of Chinese herbal medicines for infantile eczema. Qingdao University, Qingdao [Masters thesis]2003. ">Chao 2003</a> study recruited children aged from 1 to 38 months; the other 3 studies mixed children with adults, and these 3 studies used non‐individualised formulae. Thus, we did not conduct subgroup analyses. </p> <div class="figure" id="CD008642-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 CHM versus placebo, outcome: 1.3 Overall severity score" data-id="CD008642-fig-0004" src="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/image_n/nCD008642-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 CHM versus placebo, outcome: 1.3 Overall severity score</p> </div> </div> </div> <p>We could not explain such differences by further analysis of the sources of heterogeneity, which included the following: </p> <p> <ul id="CD008642-list-0007"> <li> <p>participant factors, e.g. age (children versus adults, because we were not able to identify the difference for the reasons stated above), diagnosis (infantile eczema in the <a href="./references#CD008642-bbs2-0002" title="ChaoQ , XiaoJG . Research of Chinese herbal medicines for infantile eczema. Qingdao University, Qingdao [Masters thesis]2003. ">Chao 2003</a> study versus atopic eczema in the <a href="./references#CD008642-bbs2-0004" title="ChengHM , ChiangLC , JanYM , ChenGW , LiTC . The efficacy and safety of a Chinese herbal product (Xiao‐Feng‐San) for the treatment of refractory atopic dermatitis: a randomized, double‐blind, placebo‐controlled trial. International Archives of Allergy &amp; Immunology2011;155(2):141‐8. [DOI: 10.1159/000318861] ">Cheng 2010</a>; <a href="./references#CD008642-bbs2-0006" title="HonKL , LeungTF , NgPC , LamMCA , KamWYC , WongKY , et al. Efficacy and tolerability of a Chinese herbal medicine concoction for treatment of atopic dermatitis: a randomized, double‐blind, placebo‐controlled study. British Journal of Dermatology2007;157(2):357‐63. [MEDLINE: 17501956] HonKLE , LeungTF , NgPC , LamMCA , KamWYC , WongKY , et al. Therapeutic effect and safety of a traditional Chinese medicine for atopic dermatitis in children: a randomised, double‐blind, placebo‐controlled study. Hong Kong Medical Journal2011;17(1 Suppl 2):38‐40. ">Hon 2007</a>; and <a href="./references#CD008642-bbs2-0015" title="SunXD . Evaluation of efficacy and affect of reoccurrence of Jianpi Shenshi granules for atopic dermatitis [Clinical effect of invigorating spleen and excreting dampness granules in treating atopic dermatitis and its influence for recurrence of the patient]. Chinese Journal of Dermatovenerology Integrated Traditional and Western Medicine2009;8(6):335‐7. ">Sun 2009</a> studies), sex (mixed gender in all four studies), race (all Asians), and comorbidity (not able to identify because of insufficient data); </p> </li> <li> <p>treatment factors, e.g. dosage (various CHM dosages applied across the four studies) and formulation (four different CHM formulae used in four studies); and </p> </li> <li> <p>study factors, e.g. concordance rates (all four studies reported high compliance rates), quality of reporting (this was overcome by assessment of risk of bias in this review), and quality control for the Chinese herbal preparations, e.g. source, purity, and preparation facilities (all four studies reported quality control for the CHM interventions). </p> </li> </ul> </p> </section> <section id="CD008642-sec-0112"> <h6 class="title"><i>Sensitivity analysis</i> </h6> <p>We planned to perform sensitivity analyses of the primary outcomes by excluding studies of low methodological quality. We found substantial heterogeneity (I² statistic = 74%; see <a href="./references#CD008642-fig-0008" title="">Analysis 1.2</a>) in the 2 studies that measured 1 of the primary outcomes, the severity of itching, by VAS. We could not perform sensitivity analysis as there were only two studies in the meta‐analysis. </p> </section> </section> </section> <section id="CD008642-sec-0113"> <h4 class="title">II. CHM versus no treatment</h4> <p>None of the included studies compared CHM with no treatment.</p> </section> <section id="CD008642-sec-0114"> <h4 class="title">III. CHM versus acupuncture</h4> <p>None of the included studies compared CHM with acupuncture treatment.</p> </section> <section id="CD008642-sec-0115"> <h4 class="title">IV. CHM versus conventional medicines (drugs)</h4> <section id="CD008642-sec-0116"> <h5 class="title">1. Primary outcomes</h5> <section id="CD008642-sec-0117"> <h6 class="title">a) Total effectiveness rate</h6> <p>A total of 20 included studies employed total effectiveness rate as the outcome measure. In addition, we included one arm of the <a href="./references#CD008642-bbs2-0002" title="ChaoQ , XiaoJG . Research of Chinese herbal medicines for infantile eczema. Qingdao University, Qingdao [Masters thesis]2003. ">Chao 2003</a> study, which was a four‐arm design where CHM was used topically (second arm) compared to steroid cream (third arm) in the current category. We pooled data from the 21 included studies using the statistical method of inverse‐variance with the random‐effects analysis model and expressed an estimate of their overall effects as RR with 95% CI. The forest plot of comparison showed that application of CHM significantly improved the condition compared to control interventions (RR 1.43, 95% CI 1.27 to 1.61; see <a href="./references#CD008642-fig-0015" title="">Analysis 2.1</a>). </p> <p>The <a href="./references#CD008642-bbs2-0001" title="CaoM , WeiYG . Clinical study of Zhuling Jianpi Huashi decoction for atopic dermatitis. Nanjing University of Chinese Medicine, Nanjing [Masters thesis]2009. ">Cao 2009</a>; <a href="./references#CD008642-bbs2-0002" title="ChaoQ , XiaoJG . Research of Chinese herbal medicines for infantile eczema. Qingdao University, Qingdao [Masters thesis]2003. ">Chao 2003</a>; <a href="./references#CD008642-bbs2-0003" title="ChenH . Clinical observation of Huanglian Qingdai cream for infantile eczema. Journal of Sichuan of Traditional Chinese Medicine2011;29(6):88‐9. ">Chen 2011</a>; <a href="./references#CD008642-bbs2-0009" title="LangN , YaoCH , BoYJ , ChiHY , TuYY , HuangYZ . Treatment of blood deficiency with wind dryness type of atopic dermatitis with combination of Shengui decoction and Shidu ointment. Chinese Journal of Dermatovenerology Integrated Traditional &amp; West Medicine2007;6(1):22‐3. ">Lang 2007</a>; <a href="./references#CD008642-bbs2-0013" title="MaYB , SunLY , WangP , ZhangGZ , CaiNN . Clinical observation of combination of Jianpi Runfu decoction and topical application of Gancao oil for atopic dermatitis with syndrome of spleen deficiency and blood dryness. Beijing Journal of Traditional Chinese Medicine2010;29(9):680‐2. ">Ma 2010</a>; <a href="./references#CD008642-bbs2-0016" title="TianF , HeT . Observation of efficacy of Fuyang granules for infantile eczema. Liaoning Journal of Traditional Chinese Medicine2005;32(8):810‐1. ">Tian 2005</a>; <a href="./references#CD008642-bbs2-0017" title="WangP , CaiL , XuJJ . Observation of efficacy of Chushi Zhiyang ointment for infantile eczema. Journal of Sichuan of Traditional Chinese Medicine2008;26(9):92‐3. ">Wang 2008</a>; <a href="./references#CD008642-bbs2-0020" title="XueSQ , TanJH . Clinical observation of Shengxue Runfu decoction with modifications for childhood atopic dermatitis. Journal of New Chinese Medicine2011;43(2):94‐5. ">Xue 2011</a>; <a href="./references#CD008642-bbs2-0021" title="YangY , SunJL , FengYL , YangYF , WangLX . Analysis of efficacy of Chinese herbs Jianpi Zhiyang granules with Pibo Xiaoyan Xuanshi ointment for atopic dermatitis. Chinese Journal of Dermatovenerology Integrated Traditional &amp; Western Medicine2007;6(3):135‐7. ">Yang 2007</a>; <a href="./references#CD008642-bbs2-0022" title="YangXS , YeJZ , LiK . Clinical efficacy of Jianpi Yangxue Qufeng method for atopic dermatitis and its affect for skin barrier function [The effects of the clinical efficacy of method of strengthening spleen and enriching blood eliminating wind in treatment of chronic atopic dermatitis]. Journal of Yunnan University of Traditional Chinese Medicine2009;32(3):5‐7. ">Yang 2009</a>; and <a href="./references#CD008642-bbs2-0024" title="ZhangQS , WeiYG . Clinical study of Jianpi Huashi formula for childhood atopic dermatitis. Nanjing University of Chinese Medicine, Nanjing [Masters thesis]2005. ">Zhang 2005</a> studies did not report short‐term or long‐term improvement. The <a href="./references#CD008642-bbs2-0025" title="ZhangXJ , SongXL . Observation of clinical efficacy of Xiao'er Huashi decoction for infantile eczema. Proceedings of the First International Dermatology Academic Symposium of TCM and Integrated TCM‐WM. Beijing: World Federation of Chinese Medicine Societies, 2009:297‐9. ">Zhang 2009</a> study reported short‐term improvement assessed with 'Recurrence rate'. The <a href="./references#CD008642-bbs2-0007" title="HuangZK , ChenP , WeiWN . Observation of efficacy of Chushi Zhiyang cream for atopic dermatitis. Modern Journal of Integrated Traditional Chinese &amp; Western Medicine2010;19(21):2647‐8. ">Huang 2010</a>; <a href="./references#CD008642-bbs2-0011" title="LiuHC . Investigation of efficacy of Chinese medicine for atopic dermatitis. Hua‐xia Medicine2005;25(3):208‐9. ">Liu 2005</a>; <a href="./references#CD008642-bbs2-0019" title="XiaoWM , LiG , LuoB , ZhuQJ . Observation of efficacy of Huailian decoction for atopic dermatitis. Journal of China Traditional Chinese Medicine Information2011;3(3):37‐9. ">Xiao 2011</a>; <a href="./references#CD008642-bbs2-0026" title="ZhangCJ . Clinical observation of Zhiyin Qingre method for 30 cases with atopic dermatitis. Guiding Journal of Traditional Chinese Medicine &amp; Pharmacy2011;17(8):22‐4. ">Zhang 2011</a>; <a href="./references#CD008642-bbs2-0027" title="ZhouYZ . Observation of clinical efficacy of Canger Kushen lotion for 88 cases with infantile eczema. Guide of China Medicine2011;9(25):115‐6. ">Zhou 2011</a>; and <a href="./references#CD008642-bbs2-0028" title="ZouGM , XieB . Clincial study of Fufang Sanhuang lotion for infantile eczema. Liaoning Journal of Traditional Chinese Medicine2011;38(2):297‐9. ">Zou 2011</a> studies also used 'Recurrence rate' to report long‐term improvement. All of them stated that the CHM groups had a lower recurrence rate than their comparators. The <a href="./references#CD008642-bbs2-0012" title="LuoFJ , WeiYG . Evaluation of efficacy of Xiaofengsan with modifications for atopic dermatitis. Nanjing University of Chinese Medicine, Nanjing [Masters thesis]2010. ">Luo 2010</a> study reported long‐term improvement, but provided no data. The <a href="./references#CD008642-bbs2-0005" title="GongXH , KuangL , LiuX . Clinical observation of Liangxue Xiaofeng formula for adult atopic dermatitis. Journal of TCM University of Hunan2010;30(3):61‐3. ">Gong 2010</a> and <a href="./references#CD008642-bbs2-0023" title="YuTG , ZhuJT , XuJL , ZhuangYR , ShenB , WuBL , et al. Clincial and laboratory study of Piyan Xiaojingyin granules II for atopic dermatitis. Journal of Traditional Chinese Medicine1999;40(3):165‐7. ">Yu 1999</a> studies reported long‐term improvement and stated that CHM groups had a higher effectiveness rate than the control groups (RR 1.52, 95% CI 1.11 to 2.08; see <a href="./references#CD008642-fig-0016" title="">Analysis 2.2</a>). </p> </section> <section id="CD008642-sec-0118"> <h6 class="title">b) Severity of itching score measured by VAS</h6> <p>Seven included studies reported continuous VAS data to measure the severity of itching score. The scale was 0 to 10 in all studies except the <a href="./references#CD008642-bbs2-0003" title="ChenH . Clinical observation of Huanglian Qingdai cream for infantile eczema. Journal of Sichuan of Traditional Chinese Medicine2011;29(6):88‐9. ">Chen 2011</a> study where the scale of VAS was 0 to 3. We expressed the data as SMD with 95% CI as the included studies used different outcome scales. The forest plot figure showed that there was a statistically significant difference between the CHM group and control group in terms of reduction of the severity of itching, and overall effects were favourable to the CHM groups (SMD ‐0.83, 95% CI ‐1.43 to ‐0.22; see <a href="./references#CD008642-fig-0017" title="">Analysis 2.3</a>). </p> <p>None of the seven included studies reported short‐term or long‐term improvement in terms of itching score (<a href="./references#CD008642-bbs2-0003" title="ChenH . Clinical observation of Huanglian Qingdai cream for infantile eczema. Journal of Sichuan of Traditional Chinese Medicine2011;29(6):88‐9. ">Chen 2011</a>; <a href="./references#CD008642-bbs2-0008" title="JinPZ , YeQH , ShenM . Observation of efficacy of Jianpi Zhiyang granules for 32 cases with atopic dermatitis. Henan Traditional Chinese Medicine2007;27(12):61‐2. ">Jin 2007</a>; <a href="./references#CD008642-bbs2-0009" title="LangN , YaoCH , BoYJ , ChiHY , TuYY , HuangYZ . Treatment of blood deficiency with wind dryness type of atopic dermatitis with combination of Shengui decoction and Shidu ointment. Chinese Journal of Dermatovenerology Integrated Traditional &amp; West Medicine2007;6(1):22‐3. ">Lang 2007</a>; <a href="./references#CD008642-bbs2-0013" title="MaYB , SunLY , WangP , ZhangGZ , CaiNN . Clinical observation of combination of Jianpi Runfu decoction and topical application of Gancao oil for atopic dermatitis with syndrome of spleen deficiency and blood dryness. Beijing Journal of Traditional Chinese Medicine2010;29(9):680‐2. ">Ma 2010</a>; <a href="./references#CD008642-bbs2-0020" title="XueSQ , TanJH . Clinical observation of Shengxue Runfu decoction with modifications for childhood atopic dermatitis. Journal of New Chinese Medicine2011;43(2):94‐5. ">Xue 2011</a>; <a href="./references#CD008642-bbs2-0021" title="YangY , SunJL , FengYL , YangYF , WangLX . Analysis of efficacy of Chinese herbs Jianpi Zhiyang granules with Pibo Xiaoyan Xuanshi ointment for atopic dermatitis. Chinese Journal of Dermatovenerology Integrated Traditional &amp; Western Medicine2007;6(3):135‐7. ">Yang 2007</a>; <a href="./references#CD008642-bbs2-0024" title="ZhangQS , WeiYG . Clinical study of Jianpi Huashi formula for childhood atopic dermatitis. Nanjing University of Chinese Medicine, Nanjing [Masters thesis]2005. ">Zhang 2005</a>). </p> </section> </section> <section id="CD008642-sec-0119"> <h5 class="title">2. Secondary outcomes</h5> <section id="CD008642-sec-0120"> <h6 class="title">a) Overall severity score measured by the scoring system (e.g. EASI, SAASAD, or SCORAD)</h6> <p>The <a href="./references#CD008642-bbs2-0011" title="LiuHC . Investigation of efficacy of Chinese medicine for atopic dermatitis. Hua‐xia Medicine2005;25(3):208‐9. ">Liu 2005</a>; <a href="./references#CD008642-bbs2-0016" title="TianF , HeT . Observation of efficacy of Fuyang granules for infantile eczema. Liaoning Journal of Traditional Chinese Medicine2005;32(8):810‐1. ">Tian 2005</a>; <a href="./references#CD008642-bbs2-0017" title="WangP , CaiL , XuJJ . Observation of efficacy of Chushi Zhiyang ointment for infantile eczema. Journal of Sichuan of Traditional Chinese Medicine2008;26(9):92‐3. ">Wang 2008</a>; <a href="./references#CD008642-bbs2-0027" title="ZhouYZ . Observation of clinical efficacy of Canger Kushen lotion for 88 cases with infantile eczema. Guide of China Medicine2011;9(25):115‐6. ">Zhou 2011</a>; and <a href="./references#CD008642-bbs2-0028" title="ZouGM , XieB . Clincial study of Fufang Sanhuang lotion for infantile eczema. Liaoning Journal of Traditional Chinese Medicine2011;38(2):297‐9. ">Zou 2011</a> studies did not report measurement of overall severity of the condition. The <a href="./references#CD008642-bbs2-0022" title="YangXS , YeJZ , LiK . Clinical efficacy of Jianpi Yangxue Qufeng method for atopic dermatitis and its affect for skin barrier function [The effects of the clinical efficacy of method of strengthening spleen and enriching blood eliminating wind in treatment of chronic atopic dermatitis]. Journal of Yunnan University of Traditional Chinese Medicine2009;32(3):5‐7. ">Yang 2009</a>; <a href="./references#CD008642-bbs2-0023" title="YuTG , ZhuJT , XuJL , ZhuangYR , ShenB , WuBL , et al. Clincial and laboratory study of Piyan Xiaojingyin granules II for atopic dermatitis. Journal of Traditional Chinese Medicine1999;40(3):165‐7. ">Yu 1999</a>; and <a href="./references#CD008642-bbs2-0025" title="ZhangXJ , SongXL . Observation of clinical efficacy of Xiao'er Huashi decoction for infantile eczema. Proceedings of the First International Dermatology Academic Symposium of TCM and Integrated TCM‐WM. Beijing: World Federation of Chinese Medicine Societies, 2009:297‐9. ">Zhang 2009</a> studies did not provide data for the scores. We pooled data collected from the remaining 15 included studies and expressed them as SMD with 95% CI as the studies used different outcome scales. The <a href="./references#CD008642-bbs2-0001" title="CaoM , WeiYG . Clinical study of Zhuling Jianpi Huashi decoction for atopic dermatitis. Nanjing University of Chinese Medicine, Nanjing [Masters thesis]2009. ">Cao 2009</a>; <a href="./references#CD008642-bbs2-0012" title="LuoFJ , WeiYG . Evaluation of efficacy of Xiaofengsan with modifications for atopic dermatitis. Nanjing University of Chinese Medicine, Nanjing [Masters thesis]2010. ">Luo 2010</a>; and <a href="./references#CD008642-bbs2-0024" title="ZhangQS , WeiYG . Clinical study of Jianpi Huashi formula for childhood atopic dermatitis. Nanjing University of Chinese Medicine, Nanjing [Masters thesis]2005. ">Zhang 2005</a> studies reported data measured at the end point as percentage of reduction of total SASSAD score and expressed the data as 'numbers ±'. We assumed unlabelled data in these three studies were 'mean and SD'. We multiplied the mean by ‐1 to ensure all scales were in the same direction in the meta‐analysis. The forest plot figure showed that application of CHM significantly reduced the severity of skin lesions measured by various scoring systems when compared to Western medications (SMD ‐0.97, 95% CI ‐1.23 to ‐0.71; see <a href="./references#CD008642-fig-0018" title="">Analysis 2.4</a>). </p> <p><a href="./references#CD008642-bbs2-0001" title="CaoM , WeiYG . Clinical study of Zhuling Jianpi Huashi decoction for atopic dermatitis. Nanjing University of Chinese Medicine, Nanjing [Masters thesis]2009. ">Cao 2009</a>; <a href="./references#CD008642-bbs2-0002" title="ChaoQ , XiaoJG . Research of Chinese herbal medicines for infantile eczema. Qingdao University, Qingdao [Masters thesis]2003. ">Chao 2003</a>; <a href="./references#CD008642-bbs2-0003" title="ChenH . Clinical observation of Huanglian Qingdai cream for infantile eczema. Journal of Sichuan of Traditional Chinese Medicine2011;29(6):88‐9. ">Chen 2011</a>; <a href="./references#CD008642-bbs2-0008" title="JinPZ , YeQH , ShenM . Observation of efficacy of Jianpi Zhiyang granules for 32 cases with atopic dermatitis. Henan Traditional Chinese Medicine2007;27(12):61‐2. ">Jin 2007</a>; <a href="./references#CD008642-bbs2-0009" title="LangN , YaoCH , BoYJ , ChiHY , TuYY , HuangYZ . Treatment of blood deficiency with wind dryness type of atopic dermatitis with combination of Shengui decoction and Shidu ointment. Chinese Journal of Dermatovenerology Integrated Traditional &amp; West Medicine2007;6(1):22‐3. ">Lang 2007</a>; <a href="./references#CD008642-bbs2-0013" title="MaYB , SunLY , WangP , ZhangGZ , CaiNN . Clinical observation of combination of Jianpi Runfu decoction and topical application of Gancao oil for atopic dermatitis with syndrome of spleen deficiency and blood dryness. Beijing Journal of Traditional Chinese Medicine2010;29(9):680‐2. ">Ma 2010</a>; <a href="./references#CD008642-bbs2-0020" title="XueSQ , TanJH . Clinical observation of Shengxue Runfu decoction with modifications for childhood atopic dermatitis. Journal of New Chinese Medicine2011;43(2):94‐5. ">Xue 2011</a>; <a href="./references#CD008642-bbs2-0021" title="YangY , SunJL , FengYL , YangYF , WangLX . Analysis of efficacy of Chinese herbs Jianpi Zhiyang granules with Pibo Xiaoyan Xuanshi ointment for atopic dermatitis. Chinese Journal of Dermatovenerology Integrated Traditional &amp; Western Medicine2007;6(3):135‐7. ">Yang 2007</a>; and <a href="./references#CD008642-bbs2-0024" title="ZhangQS , WeiYG . Clinical study of Jianpi Huashi formula for childhood atopic dermatitis. Nanjing University of Chinese Medicine, Nanjing [Masters thesis]2005. ">Zhang 2005</a> reported no short‐term or long‐term improvement. The <a href="./references#CD008642-bbs2-0005" title="GongXH , KuangL , LiuX . Clinical observation of Liangxue Xiaofeng formula for adult atopic dermatitis. Journal of TCM University of Hunan2010;30(3):61‐3. ">Gong 2010</a>; <a href="./references#CD008642-bbs2-0007" title="HuangZK , ChenP , WeiWN . Observation of efficacy of Chushi Zhiyang cream for atopic dermatitis. Modern Journal of Integrated Traditional Chinese &amp; Western Medicine2010;19(21):2647‐8. ">Huang 2010</a>; <a href="./references#CD008642-bbs2-0012" title="LuoFJ , WeiYG . Evaluation of efficacy of Xiaofengsan with modifications for atopic dermatitis. Nanjing University of Chinese Medicine, Nanjing [Masters thesis]2010. ">Luo 2010</a>; <a href="./references#CD008642-bbs2-0018" title="XiaoM , AiRD . Observation of clinical efficacy of combination of Machixian decoction and topical application of Chinese herbs for atopic dermatitis and evaluation of IgE level in serum. Chengdu University of Chinese Medicine, Chengdu [Masters thesis]2008. ">Xiao 2008</a>; <a href="./references#CD008642-bbs2-0019" title="XiaoWM , LiG , LuoB , ZhuQJ . Observation of efficacy of Huailian decoction for atopic dermatitis. Journal of China Traditional Chinese Medicine Information2011;3(3):37‐9. ">Xiao 2011</a>; and <a href="./references#CD008642-bbs2-0026" title="ZhangCJ . Clinical observation of Zhiyin Qingre method for 30 cases with atopic dermatitis. Guiding Journal of Traditional Chinese Medicine &amp; Pharmacy2011;17(8):22‐4. ">Zhang 2011</a> studies reported long‐term improvement. Only the <a href="./references#CD008642-bbs2-0018" title="XiaoM , AiRD . Observation of clinical efficacy of combination of Machixian decoction and topical application of Chinese herbs for atopic dermatitis and evaluation of IgE level in serum. Chengdu University of Chinese Medicine, Chengdu [Masters thesis]2008. ">Xiao 2008</a> study provided data to support a long‐term improvement observed in the CHM group (MD ‐8.50, 95% CI ‐13.40 to ‐3.60; see <a href="./references#CD008642-fig-0019" title="">Analysis 2.5</a>). </p> </section> <section id="CD008642-sec-0121"> <h6 class="title">b) QoL index</h6> <p>No studies in this group employed QoL questionnaires as outcome measures.</p> </section> <section id="CD008642-sec-0122"> <h6 class="title">c) Adverse events</h6> <p>The <a href="./references#CD008642-bbs2-0008" title="JinPZ , YeQH , ShenM . Observation of efficacy of Jianpi Zhiyang granules for 32 cases with atopic dermatitis. Henan Traditional Chinese Medicine2007;27(12):61‐2. ">Jin 2007</a>; <a href="./references#CD008642-bbs2-0020" title="XueSQ , TanJH . Clinical observation of Shengxue Runfu decoction with modifications for childhood atopic dermatitis. Journal of New Chinese Medicine2011;43(2):94‐5. ">Xue 2011</a>; <a href="./references#CD008642-bbs2-0025" title="ZhangXJ , SongXL . Observation of clinical efficacy of Xiao'er Huashi decoction for infantile eczema. Proceedings of the First International Dermatology Academic Symposium of TCM and Integrated TCM‐WM. Beijing: World Federation of Chinese Medicine Societies, 2009:297‐9. ">Zhang 2009</a>; and <a href="./references#CD008642-bbs2-0026" title="ZhangCJ . Clinical observation of Zhiyin Qingre method for 30 cases with atopic dermatitis. Guiding Journal of Traditional Chinese Medicine &amp; Pharmacy2011;17(8):22‐4. ">Zhang 2011</a> studies did not report adverse events. The <a href="./references#CD008642-bbs2-0001" title="CaoM , WeiYG . Clinical study of Zhuling Jianpi Huashi decoction for atopic dermatitis. Nanjing University of Chinese Medicine, Nanjing [Masters thesis]2009. ">Cao 2009</a>; <a href="./references#CD008642-bbs2-0012" title="LuoFJ , WeiYG . Evaluation of efficacy of Xiaofengsan with modifications for atopic dermatitis. Nanjing University of Chinese Medicine, Nanjing [Masters thesis]2010. ">Luo 2010</a>; <a href="./references#CD008642-bbs2-0027" title="ZhouYZ . Observation of clinical efficacy of Canger Kushen lotion for 88 cases with infantile eczema. Guide of China Medicine2011;9(25):115‐6. ">Zhou 2011</a>; and <a href="./references#CD008642-bbs2-0028" title="ZouGM , XieB . Clincial study of Fufang Sanhuang lotion for infantile eczema. Liaoning Journal of Traditional Chinese Medicine2011;38(2):297‐9. ">Zou 2011</a> studies stated that no adverse events were reported during the trial period. None of the studies reported withdrawals of participants due to any adverse event. When combined, the 15 studies indicated there were significantly less minor adverse events in the CHM than the control groups (RR 0.44, 95% CI 0.32 to 0.61; see <a href="./references#CD008642-fig-0020" title="">Analysis 2.6</a>). </p> </section> <section id="CD008642-sec-0123"> <h6 class="title"><i>Subgroup analysis and investigation of heterogeneity</i> </h6> <p>There was substantial heterogeneity (I² statistic = 65%; see <a href="./references#CD008642-fig-0015" title="">Analysis 2.1</a> and <a href="#CD008642-fig-0005">Figure 5</a>) across the 21 included studies with the outcome measured by total effectiveness rate. We planned to conduct a subgroup analysis of the studies of "children (16 years old or under) with eczema versus adults with eczema" and identified 12 studies in which the participants were 16 years old or under. The other nine studies however recruited participants with a mix of children and adults; therefore, we were unable to conduct subgroup analysis under this heading. </p> <div class="figure" id="CD008642-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 2 CHM versus drugs, outcome: 2.1 Total effectiveness rate (number of participants recovered and significantly improved) with subgroup analysis" data-id="CD008642-fig-0005" src="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/image_n/nCD008642-AFig-FIG05.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 2 CHM versus drugs, outcome: 2.1 Total effectiveness rate (number of participants recovered and significantly improved) with subgroup analysis </p> </div> </div> </div> <p>We also compared the difference in the total effectiveness rate between two groups where application of CHM was based on Chinese medicine syndrome differentiation or non‐individualised formula. There was low inconsistency (I² statistic = 22%) within the 7 subgrouped studies, which applied CHM based on Chinese medicine syndrome differentiation (individualised modifications) and showed that CHM was more effective than the Western medications (RR 1.50, 95% CI 1.30 to 1.74; see analysis 2.1.1 in <a href="./references#CD008642-fig-0015" title="">Analysis 2.1</a>). There were no subgroup differences (I² statistic = 0) when comparing the individualised treatment subgroup to the non‐individualised subgroup. Where non‐individualised formulae were used, there was a high level of heterogeneity between the studies in this subgroup (I² statistic = 71%; see analysis 2.1.2 in <a href="#CD008642-fig-0005">Figure 5</a>). </p> <p>We performed a posthoc subgroup analysis of 'CHM versus topical steroid', 'CHM versus antihistamines', and 'CHM versus other agents' as the different types of comparators could be a possible reason for heterogeneity in the studies. We found substantial heterogeneity in the subgroup of topical steroid (I² statistic = 72%). Although there were no inconsistencies in the subgroups of antihistamines or other agents, the total subgroup differences were statistically significant (P = 0.02; I² statistic = 74.4%; see <a href="./references#CD008642-fig-0021" title="">Analysis 2.7</a>). </p> <p>We were unable to further investigate the sources of the heterogeneity in this group from participant factors (e.g. age, diagnosis, sex, race, comorbidity), treatment factors (e.g. dosage, formulation), study factors (e.g. concordance rates, quality of reporting), and quality control for the Chinese herbal preparations as no data were available for appropriate comparisons. </p> </section> <section id="CD008642-sec-0124"> <h6 class="title"><i>Sensitivity analysis</i> </h6> <p>We could not perform sensitivity analyses of the primary outcomes by further excluding studies of low methodological quality as all studies in this category had similar methodological weaknesses (e.g. high risk of bias in blinding of participants and research personnel). </p> </section> <section id="CD008642-sec-0125"> <h6 class="title"><i>Assessment of reporting bias</i> </h6> <p>We generated a funnel plot (<a href="#CD008642-fig-0006">Figure 6</a>) to inspect visually for evidence of potential reporting bias including publication bias across 15 included studies, which compared effects of CHM and Western medications (<a href="./references#CD008642-bbs2-0001" title="CaoM , WeiYG . Clinical study of Zhuling Jianpi Huashi decoction for atopic dermatitis. Nanjing University of Chinese Medicine, Nanjing [Masters thesis]2009. ">Cao 2009</a>; <a href="./references#CD008642-bbs2-0002" title="ChaoQ , XiaoJG . Research of Chinese herbal medicines for infantile eczema. Qingdao University, Qingdao [Masters thesis]2003. ">Chao 2003</a>; <a href="./references#CD008642-bbs2-0003" title="ChenH . Clinical observation of Huanglian Qingdai cream for infantile eczema. Journal of Sichuan of Traditional Chinese Medicine2011;29(6):88‐9. ">Chen 2011</a>; <a href="./references#CD008642-bbs2-0005" title="GongXH , KuangL , LiuX . Clinical observation of Liangxue Xiaofeng formula for adult atopic dermatitis. Journal of TCM University of Hunan2010;30(3):61‐3. ">Gong 2010</a>; <a href="./references#CD008642-bbs2-0007" title="HuangZK , ChenP , WeiWN . Observation of efficacy of Chushi Zhiyang cream for atopic dermatitis. Modern Journal of Integrated Traditional Chinese &amp; Western Medicine2010;19(21):2647‐8. ">Huang 2010</a>; <a href="./references#CD008642-bbs2-0008" title="JinPZ , YeQH , ShenM . Observation of efficacy of Jianpi Zhiyang granules for 32 cases with atopic dermatitis. Henan Traditional Chinese Medicine2007;27(12):61‐2. ">Jin 2007</a>; <a href="./references#CD008642-bbs2-0009" title="LangN , YaoCH , BoYJ , ChiHY , TuYY , HuangYZ . Treatment of blood deficiency with wind dryness type of atopic dermatitis with combination of Shengui decoction and Shidu ointment. Chinese Journal of Dermatovenerology Integrated Traditional &amp; West Medicine2007;6(1):22‐3. ">Lang 2007</a>; <a href="./references#CD008642-bbs2-0012" title="LuoFJ , WeiYG . Evaluation of efficacy of Xiaofengsan with modifications for atopic dermatitis. Nanjing University of Chinese Medicine, Nanjing [Masters thesis]2010. ">Luo 2010</a>; <a href="./references#CD008642-bbs2-0013" title="MaYB , SunLY , WangP , ZhangGZ , CaiNN . Clinical observation of combination of Jianpi Runfu decoction and topical application of Gancao oil for atopic dermatitis with syndrome of spleen deficiency and blood dryness. Beijing Journal of Traditional Chinese Medicine2010;29(9):680‐2. ">Ma 2010</a>; <a href="./references#CD008642-bbs2-0018" title="XiaoM , AiRD . Observation of clinical efficacy of combination of Machixian decoction and topical application of Chinese herbs for atopic dermatitis and evaluation of IgE level in serum. Chengdu University of Chinese Medicine, Chengdu [Masters thesis]2008. ">Xiao 2008</a>; <a href="./references#CD008642-bbs2-0019" title="XiaoWM , LiG , LuoB , ZhuQJ . Observation of efficacy of Huailian decoction for atopic dermatitis. Journal of China Traditional Chinese Medicine Information2011;3(3):37‐9. ">Xiao 2011</a>; <a href="./references#CD008642-bbs2-0020" title="XueSQ , TanJH . Clinical observation of Shengxue Runfu decoction with modifications for childhood atopic dermatitis. Journal of New Chinese Medicine2011;43(2):94‐5. ">Xue 2011</a>; <a href="./references#CD008642-bbs2-0021" title="YangY , SunJL , FengYL , YangYF , WangLX . Analysis of efficacy of Chinese herbs Jianpi Zhiyang granules with Pibo Xiaoyan Xuanshi ointment for atopic dermatitis. Chinese Journal of Dermatovenerology Integrated Traditional &amp; Western Medicine2007;6(3):135‐7. ">Yang 2007</a>; <a href="./references#CD008642-bbs2-0024" title="ZhangQS , WeiYG . Clinical study of Jianpi Huashi formula for childhood atopic dermatitis. Nanjing University of Chinese Medicine, Nanjing [Masters thesis]2005. ">Zhang 2005</a>; <a href="./references#CD008642-bbs2-0026" title="ZhangCJ . Clinical observation of Zhiyin Qingre method for 30 cases with atopic dermatitis. Guiding Journal of Traditional Chinese Medicine &amp; Pharmacy2011;17(8):22‐4. ">Zhang 2011</a>). We further assessed for any bias captured in the funnel plot with the test proposed by <a href="./references#CD008642-bbs2-0052" title="EggerM , Davey SmithG , SchneiderM , MinderC . Bias in meta‐analysis detected by a simple, graphical test. British Medical Journal1997;315(7109):629‐34. ">Egger 1997</a>. The results of the assessment indicated that there were no statistically asymmetrical distributions among those 15 studies (Egger test P = 0.2021). </p> <div class="figure" id="CD008642-fig-0006"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 6</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: 2 CHM vs drugs, outcome: 2.4 Overall severity score" data-id="CD008642-fig-0006" src="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/image_n/nCD008642-AFig-FIG06.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: 2 CHM vs drugs, outcome: 2.4 Overall severity score</p> </div> </div> </div> </section> </section> </section> <section id="CD008642-sec-0126"> <h4 class="title">V. Combination of oral and topical CHM interventions versus same oral CHM alone</h4> <section id="CD008642-sec-0127"> <h5 class="title">1. Primary outcomes</h5> <section id="CD008642-sec-0128"> <h6 class="title">a) Total effectiveness rate</h6> <p>The <a href="./references#CD008642-bbs2-0010" title="LinY , ChenDC . Efficacy of anti‐inflammatory moisturising washing formula for atopic dermatitis and its biological evaluation. Guangzhou University of Chinese Medicine, Guangzhou [PhD thesis]2010. ">Lin 2010</a> study did not express the outcomes as 'effectiveness rate'. The <a href="./references#CD008642-bbs2-0014" title="RaoMR , WeiYG . Clinical study of Qingxin Peitu method for atopic dermatitis. Nanjing University of Chinese Medicine, Nanjing [Masters thesis]2010. ">Rao 2010</a> study reported no difference in the effects between the first arm (CHM used orally and topically) and second arm (CHM was used by oral ingestion only, but there was no topical intervention) at the end of the 12‐week treatment period (RR 1.13, 95% CI 0.78 to 1.63; see <a href="./references#CD008642-fig-0022" title="">Analysis 3.1</a>). </p> <p>The <a href="./references#CD008642-bbs2-0010" title="LinY , ChenDC . Efficacy of anti‐inflammatory moisturising washing formula for atopic dermatitis and its biological evaluation. Guangzhou University of Chinese Medicine, Guangzhou [PhD thesis]2010. ">Lin 2010</a> study did not report short‐term or long‐term improvement. The <a href="./references#CD008642-bbs2-0014" title="RaoMR , WeiYG . Clinical study of Qingxin Peitu method for atopic dermatitis. Nanjing University of Chinese Medicine, Nanjing [Masters thesis]2010. ">Rao 2010</a> study reported long‐term improvement (24 weeks after stopping the treatment), but no difference was observed between the 2 groups (RR 1.00, 95% CI 0.75 to 1.34; see <a href="./references#CD008642-fig-0023" title="">Analysis 3.2</a>). </p> </section> <section id="CD008642-sec-0129"> <h6 class="title">b) Severity of itching score measured by VAS</h6> <p>The <a href="./references#CD008642-bbs2-0010" title="LinY , ChenDC . Efficacy of anti‐inflammatory moisturising washing formula for atopic dermatitis and its biological evaluation. Guangzhou University of Chinese Medicine, Guangzhou [PhD thesis]2010. ">Lin 2010</a> study reported that there was statistically significant improvement in terms of itching relief (scale from 0 to 10) in the treatment site compared to the control site of the limb at the end of 2 weeks of treatment (MD ‐1.05, 95% CI ‐1.75 to ‐0.35; see <a href="./references#CD008642-fig-0024" title="">Analysis 3.3</a>). The <a href="./references#CD008642-bbs2-0010" title="LinY , ChenDC . Efficacy of anti‐inflammatory moisturising washing formula for atopic dermatitis and its biological evaluation. Guangzhou University of Chinese Medicine, Guangzhou [PhD thesis]2010. ">Lin 2010</a> study did not report short‐term or long‐term improvement. The <a href="./references#CD008642-bbs2-0014" title="RaoMR , WeiYG . Clinical study of Qingxin Peitu method for atopic dermatitis. Nanjing University of Chinese Medicine, Nanjing [Masters thesis]2010. ">Rao 2010</a> study did not report severity of itching score. </p> </section> </section> <section id="CD008642-sec-0130"> <h5 class="title">2. Secondary outcomes</h5> <section id="CD008642-sec-0131"> <h6 class="title">a) Overall severity score measured by the scoring system (e.g. EASI, SAASAD, or SCORAD)</h6> <p>The <a href="./references#CD008642-bbs2-0010" title="LinY , ChenDC . Efficacy of anti‐inflammatory moisturising washing formula for atopic dermatitis and its biological evaluation. Guangzhou University of Chinese Medicine, Guangzhou [PhD thesis]2010. ">Lin 2010</a> study used a self‐developed scale (scale 0 to 24) for scoring the severity of skin lesions and reported a statistically significant improvement in terms of skin lesions at the treatment site of the limb compared to the control site, at the end of the 2‐week treatment period (MD ‐1.59, 95% CI ‐2.92 to ‐0.26; see <a href="./references#CD008642-fig-0025" title="">Analysis 3.4</a>). We did not pool the score of SCORAD in the <a href="./references#CD008642-bbs2-0010" title="LinY , ChenDC . Efficacy of anti‐inflammatory moisturising washing formula for atopic dermatitis and its biological evaluation. Guangzhou University of Chinese Medicine, Guangzhou [PhD thesis]2010. ">Lin 2010</a> study as the data provided were recorded at the baseline and the end of the treatment period rather than the treatment site and control site. The <a href="./references#CD008642-bbs2-0014" title="RaoMR , WeiYG . Clinical study of Qingxin Peitu method for atopic dermatitis. Nanjing University of Chinese Medicine, Nanjing [Masters thesis]2010. ">Rao 2010</a> study stated no difference in the reduction of SCORAD between the treatment group and control group at the end of the 12‐week treatment period (MD ‐3.43, 95% CI ‐7.01 to 0.15; see <a href="./references#CD008642-fig-0026" title="">Analysis 3.5</a>). We did not pool the data from the two studies for meta‐analysis as the <a href="./references#CD008642-bbs2-0010" title="LinY , ChenDC . Efficacy of anti‐inflammatory moisturising washing formula for atopic dermatitis and its biological evaluation. Guangzhou University of Chinese Medicine, Guangzhou [PhD thesis]2010. ">Lin 2010</a> study was a within‐patient trial. </p> <p>The two studies did not report short‐term or long‐term improvement.</p> </section> <section id="CD008642-sec-0132"> <h6 class="title">b) QoL index</h6> <p>The <a href="./references#CD008642-bbs2-0010" title="LinY , ChenDC . Efficacy of anti‐inflammatory moisturising washing formula for atopic dermatitis and its biological evaluation. Guangzhou University of Chinese Medicine, Guangzhou [PhD thesis]2010. ">Lin 2010</a> study did not use a QoL index for measurement of outcomes. The <a href="./references#CD008642-bbs2-0014" title="RaoMR , WeiYG . Clinical study of Qingxin Peitu method for atopic dermatitis. Nanjing University of Chinese Medicine, Nanjing [Masters thesis]2010. ">Rao 2010</a> study used CDLQI as the secondary outcome measure and recorded the scores at the end of the 12‐week treatment period, which indicated no difference between the 2 groups (MD 0.90, 95% CI ‐2.89 to 4.69; see <a href="./references#CD008642-fig-0027" title="">Analysis 3.6</a>). </p> <p>The <a href="./references#CD008642-bbs2-0014" title="RaoMR , WeiYG . Clinical study of Qingxin Peitu method for atopic dermatitis. Nanjing University of Chinese Medicine, Nanjing [Masters thesis]2010. ">Rao 2010</a> study also used CDLQI scores for measuring long‐term improvement in 24 weeks after stopping the treatment, but provided no data. </p> </section> <section id="CD008642-sec-0133"> <h6 class="title">c) Adverse events</h6> <p>There was one participant withdrawal (a severe adverse event) from the <a href="./references#CD008642-bbs2-0010" title="LinY , ChenDC . Efficacy of anti‐inflammatory moisturising washing formula for atopic dermatitis and its biological evaluation. Guangzhou University of Chinese Medicine, Guangzhou [PhD thesis]2010. ">Lin 2010</a> study due to exacerbation of the skin condition after using the Chinese herbs for two days, and three participants complained of mild to moderate burning and pain sensations, but they still completed the two‐week treatment. The <a href="./references#CD008642-bbs2-0014" title="RaoMR , WeiYG . Clinical study of Qingxin Peitu method for atopic dermatitis. Nanjing University of Chinese Medicine, Nanjing [Masters thesis]2010. ">Rao 2010</a> study stated that there was 1 participant with increased serum alanine transaminase (ALT) each in the treatment and control group (RR 1.00, 95% CI 0.07 to 13.87; see <a href="./references#CD008642-fig-0028" title="">Analysis 3.7</a>). </p> <p>We did not perform subgroup or sensitivity analyses for this comparison.</p> </section> <section id="CD008642-sec-0134"> <h6 class="title"><i>Number needed to treat (NNT) or number needed to benefit (NNTB)</i> </h6> <p>Because of high risk of bias in most of the included studies, we decided not to express dichotomous data as NNT or continuous data as NNTB as these additional variations may have induced unnecessary misleading implications. </p> </section> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD008642-sec-0135" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD008642-sec-0135"></div> <section id="CD008642-sec-0136"> <h3 class="title" id="CD008642-sec-0136">Summary of main results</h3> <p>This review is an updated version with a new team of authors and a newly published protocol. We did not include the four studies that were included in the previous version of this review as they all investigated a Chinese herbal medicine (CHM) product, Zemaphyte, which the manufacturer withdrew from the market in 2004 (<a href="./references#CD008642-bbs2-0080" title="ZhangW , LeonardT , Bath‐HextallF , ChambersCA , LeeC , HumphreysR , et al. Chinese herbal medicine for atopic eczema. Cochrane Database of Systematic Reviews2004, Issue 4. [DOI: 10.1002/14651858.CD002291] ">Zhang 2004</a>). And we think it would skew the significance of systematically produced evidence‐based medicine if we incorporated data that is not linked to current clinical practice or research. </p> <p>This review included 28 studies, with a total of 2306 participants. Chinese herbal medicines and comparators were taken orally or applied topically by children and adults with eczema. Four studies compared CHM to placebo. Two studies compared a combination of oral and topical CHM to the same oral CHM formula alone, and 22 studies and 1 arm of the <a href="./references#CD008642-bbs2-0002" title="ChaoQ , XiaoJG . Research of Chinese herbal medicines for infantile eczema. Qingdao University, Qingdao [Masters thesis]2003. ">Chao 2003</a> study compared CHM to Western medications. </p> <p>We found evidence from one 12‐week study of moderate to severe eczema, comparing an oral CHM to placebo, of a statistically significant difference between the 2 groups with respect to QoL score (MD ‐2.50, 95% CI ‐4.77 to ‐0.23; see <a href="./references#CD008642-fig-0011" title="">Analysis 1.5</a>) (<a href="./references#CD008642-bbs2-0006" title="HonKL , LeungTF , NgPC , LamMCA , KamWYC , WongKY , et al. Efficacy and tolerability of a Chinese herbal medicine concoction for treatment of atopic dermatitis: a randomized, double‐blind, placebo‐controlled study. British Journal of Dermatology2007;157(2):357‐63. [MEDLINE: 17501956] HonKLE , LeungTF , NgPC , LamMCA , KamWYC , WongKY , et al. Therapeutic effect and safety of a traditional Chinese medicine for atopic dermatitis in children: a randomised, double‐blind, placebo‐controlled study. Hong Kong Medical Journal2011;17(1 Suppl 2):38‐40. ">Hon 2007</a>). The mean QoL score in the CHM groups was 2.5 lower than that in the placebo groups, which indicated that oral ingestion of CHM could improve QoL. Although the overall effect in the outcomes of 'total effectiveness rate', 'severity of itching score', and 'overall severity score' showed a statistically significant difference between the groups in favour of CHM, these findings were inconclusive because of the high risk of bias with regard to blinding of participants and research personnel, incomplete outcomes, or other unclear risk of bias that existed across these four studies (see <a href="./full#CD008642-tbl-0001">summary of findings Table for the main comparison</a>). Unexplained high heterogeneity (I² statistic = 87%; see <a href="#CD008642-fig-0004">Figure 4</a>) among the 4 studies in the outcome measured by 'overall severity score' further weakened the strength of the positive estimates. </p> <p>The majority of the included studies (22 studies and 1 arm of the <a href="./references#CD008642-bbs2-0002" title="ChaoQ , XiaoJG . Research of Chinese herbal medicines for infantile eczema. Qingdao University, Qingdao [Masters thesis]2003. ">Chao 2003</a> study) used conventional medicines (Western medications) as comparators, which included oral ingestion of antihistamine tablets; topical use of corticosteroid cream; and other agents, such as antifungals, antiseptics, or emollients. Twenty‐one studies expressed their primary outcome as 'total effectiveness rate', and all reported that effectiveness of CHM interventions was superior to the comparators except the <a href="./references#CD008642-bbs2-0002" title="ChaoQ , XiaoJG . Research of Chinese herbal medicines for infantile eczema. Qingdao University, Qingdao [Masters thesis]2003. ">Chao 2003</a> and <a href="./references#CD008642-bbs2-0003" title="ChenH . Clinical observation of Huanglian Qingdai cream for infantile eczema. Journal of Sichuan of Traditional Chinese Medicine2011;29(6):88‐9. ">Chen 2011</a> studies, which used corticosteroid cream as the control intervention. In addition to these two studies, our meta‐analyses showed no statistically significant difference between the CHM and conventional medicine groups observed in the studies of <a href="./references#CD008642-bbs2-0005" title="GongXH , KuangL , LiuX . Clinical observation of Liangxue Xiaofeng formula for adult atopic dermatitis. Journal of TCM University of Hunan2010;30(3):61‐3. ">Gong 2010</a>; <a href="./references#CD008642-bbs2-0007" title="HuangZK , ChenP , WeiWN . Observation of efficacy of Chushi Zhiyang cream for atopic dermatitis. Modern Journal of Integrated Traditional Chinese &amp; Western Medicine2010;19(21):2647‐8. ">Huang 2010</a>; <a href="./references#CD008642-bbs2-0009" title="LangN , YaoCH , BoYJ , ChiHY , TuYY , HuangYZ . Treatment of blood deficiency with wind dryness type of atopic dermatitis with combination of Shengui decoction and Shidu ointment. Chinese Journal of Dermatovenerology Integrated Traditional &amp; West Medicine2007;6(1):22‐3. ">Lang 2007</a>; <a href="./references#CD008642-bbs2-0016" title="TianF , HeT . Observation of efficacy of Fuyang granules for infantile eczema. Liaoning Journal of Traditional Chinese Medicine2005;32(8):810‐1. ">Tian 2005</a>; <a href="./references#CD008642-bbs2-0017" title="WangP , CaiL , XuJJ . Observation of efficacy of Chushi Zhiyang ointment for infantile eczema. Journal of Sichuan of Traditional Chinese Medicine2008;26(9):92‐3. ">Wang 2008</a>; <a href="./references#CD008642-bbs2-0019" title="XiaoWM , LiG , LuoB , ZhuQJ . Observation of efficacy of Huailian decoction for atopic dermatitis. Journal of China Traditional Chinese Medicine Information2011;3(3):37‐9. ">Xiao 2011</a>; and <a href="./references#CD008642-bbs2-0025" title="ZhangXJ , SongXL . Observation of clinical efficacy of Xiao'er Huashi decoction for infantile eczema. Proceedings of the First International Dermatology Academic Symposium of TCM and Integrated TCM‐WM. Beijing: World Federation of Chinese Medicine Societies, 2009:297‐9. ">Zhang 2009</a>, although the overall effects of the 21 included studies favoured the CHM groups (RR 1.43, 95% CI 1.27 to 1.61; see <a href="./references#CD008642-fig-0015" title="">Analysis 2.1</a>). </p> <p>The claim of positive effects with CHM intervention needs to be interpreted with caution because of substantial heterogeneity (I² statistic = 65%; see <a href="#CD008642-fig-0005">Figure 5</a>) across the studies. The result from a posthoc subgroup analysis (subgroup differences I² statistic = 74.4%) also confirmed there was unexplained heterogeneity. We also found there was high risk of bias in the domains for blinding of participants and research personnel and blinding of outcome assessment, as well as other potential sources of bias (absence of usage of published and validated scoring systems for outcome measures) in this group of studies (see <a href="./full#CD008642-tbl-0002">summary of findings Table 2</a>). All included studies in this group were associated with several major methodological weaknesses. For example, although all studies used randomisation for grouping of participants, none of them provided information of the procedure for allocation concealment (see <a href="#CD008642-fig-0003">Figure 3</a>). Inadequate randomisation could give rise to an investigator's bias for grouping of participants, which consequently affects the outcomes (<a href="./references#CD008642-bbs2-0064" title="Liu , JP . Clinical research methodology for evidence‐based Chinese medicine. Clinical Research Methodology for Evidence‐based Chinese Medicine. Beijing: People's Medical Publishing House, 2006. ">Liu 2006</a>). </p> <p>Two studies reported a statistically significant difference in outcomes of 'total effectiveness rate' or 'severity of itching score measured by VAS', respectively, and overall effects in the combination of oral and topical CHM groups were always superior to the oral CHM control groups (<a href="./references#CD008642-bbs2-0010" title="LinY , ChenDC . Efficacy of anti‐inflammatory moisturising washing formula for atopic dermatitis and its biological evaluation. Guangzhou University of Chinese Medicine, Guangzhou [PhD thesis]2010. ">Lin 2010</a>; <a href="./references#CD008642-bbs2-0014" title="RaoMR , WeiYG . Clinical study of Qingxin Peitu method for atopic dermatitis. Nanjing University of Chinese Medicine, Nanjing [Masters thesis]2010. ">Rao 2010</a>). We did not pool data from the two studies as the <a href="./references#CD008642-bbs2-0010" title="LinY , ChenDC . Efficacy of anti‐inflammatory moisturising washing formula for atopic dermatitis and its biological evaluation. Guangzhou University of Chinese Medicine, Guangzhou [PhD thesis]2010. ">Lin 2010</a> study was a within‐patient study. The <a href="./references#CD008642-bbs2-0010" title="LinY , ChenDC . Efficacy of anti‐inflammatory moisturising washing formula for atopic dermatitis and its biological evaluation. Guangzhou University of Chinese Medicine, Guangzhou [PhD thesis]2010. ">Lin 2010</a> study had a high risk of performance bias and attrition bias. The <a href="./references#CD008642-bbs2-0014" title="RaoMR , WeiYG . Clinical study of Qingxin Peitu method for atopic dermatitis. Nanjing University of Chinese Medicine, Nanjing [Masters thesis]2010. ">Rao 2010</a> study had a high risk of bias in the domain of blinding of the participants and research personnel, and both studies had small sample sizes (a total of 42 participants in 2 studies evaluated). Their claims that overall effects in CHM groups were superior to the control groups were in doubt (see <a href="./full#CD008642-tbl-0003">summary of findings Table 3</a>). </p> <p>It is worth pointing out that nearly half of the included studies did not use published and validated scoring systems for measuring the severity of the condition. Some studies used the scoring system but did not provide continuous data for the scores. The absence of these data made quantifiable data analysis impossible and downgraded the credibility of the results (<a href="./references#CD008642-bbs2-0053" title="EichenfieldLF , HanifinJM , LugerTA , StevensSR , PrideHB . Consensus conference on paediatric atopic dermatitis. Journal of the American Academy of  Dermatology2003;49(6):1088‐95. [MEDLINE: 14639390] ">Eichenfield 2003</a>). We were unable to further estimate if CHM has potential for short‐term or long‐term improvement of eczema because of limited data provided by the included studies. </p> <p>Chinese herbal medicines' possible association with hepatotoxicity (liver toxicity) was discussed when 11 cases of liver damage following oral ingestion of some raw Chinese herbal mixtures for skin conditions were reported in the UK between 1991 to 1993 (<a href="./references#CD008642-bbs2-0067" title="PerharicL , ShawD , LeonC , DeSmetPA , MurrayVS . Possible association of liver damage with the use of Chinese herbal medicine for skin disease. Veterinary &amp; Human Toxicology1995;37(6):562‐6. [MEDLINE: 8588298] ">Perharic 1995</a>). The reporters indicated that the mechanism of toxicity was not clear. The adverse effects of those CHM mixtures seemed to not be dose‐related and were probably idiosyncratic. The safety issue of oral ingestion of CHM has been a concern of healthcare professionals and the public (<a href="./references#CD008642-bbs2-0050" title="ChitturiS , FarrellGC . Herbal hepatotoxicity: an expanding but poorly defined problem. Journal of Gastroenterology &amp; Hepatology2000;15(10):1093‐9. [DOI: 11106086] ">Chitturi 2000</a>). In this review, we evaluated both beneficial effects and adverse effects of interventions from the included studies. We found only a quarter (7/28) of the included studies had monitored the liver and renal function of the participants during the period of the trial (<a href="./references#CD008642-bbs2-0004" title="ChengHM , ChiangLC , JanYM , ChenGW , LiTC . The efficacy and safety of a Chinese herbal product (Xiao‐Feng‐San) for the treatment of refractory atopic dermatitis: a randomized, double‐blind, placebo‐controlled trial. International Archives of Allergy &amp; Immunology2011;155(2):141‐8. [DOI: 10.1159/000318861] ">Cheng 2010</a>; <a href="./references#CD008642-bbs2-0006" title="HonKL , LeungTF , NgPC , LamMCA , KamWYC , WongKY , et al. Efficacy and tolerability of a Chinese herbal medicine concoction for treatment of atopic dermatitis: a randomized, double‐blind, placebo‐controlled study. British Journal of Dermatology2007;157(2):357‐63. [MEDLINE: 17501956] HonKLE , LeungTF , NgPC , LamMCA , KamWYC , WongKY , et al. Therapeutic effect and safety of a traditional Chinese medicine for atopic dermatitis in children: a randomised, double‐blind, placebo‐controlled study. Hong Kong Medical Journal2011;17(1 Suppl 2):38‐40. ">Hon 2007</a>; <a href="./references#CD008642-bbs2-0012" title="LuoFJ , WeiYG . Evaluation of efficacy of Xiaofengsan with modifications for atopic dermatitis. Nanjing University of Chinese Medicine, Nanjing [Masters thesis]2010. ">Luo 2010</a>; <a href="./references#CD008642-bbs2-0014" title="RaoMR , WeiYG . Clinical study of Qingxin Peitu method for atopic dermatitis. Nanjing University of Chinese Medicine, Nanjing [Masters thesis]2010. ">Rao 2010</a>; <a href="./references#CD008642-bbs2-0018" title="XiaoM , AiRD . Observation of clinical efficacy of combination of Machixian decoction and topical application of Chinese herbs for atopic dermatitis and evaluation of IgE level in serum. Chengdu University of Chinese Medicine, Chengdu [Masters thesis]2008. ">Xiao 2008</a>; <a href="./references#CD008642-bbs2-0019" title="XiaoWM , LiG , LuoB , ZhuQJ . Observation of efficacy of Huailian decoction for atopic dermatitis. Journal of China Traditional Chinese Medicine Information2011;3(3):37‐9. ">Xiao 2011</a>; <a href="./references#CD008642-bbs2-0028" title="ZouGM , XieB . Clincial study of Fufang Sanhuang lotion for infantile eczema. Liaoning Journal of Traditional Chinese Medicine2011;38(2):297‐9. ">Zou 2011</a>). </p> <p>With regard to adverse events including liver or kidney dysfunction, there was one withdrawal due to aggravation of the condition (a severe adverse event) after using CHM (<a href="./references#CD008642-bbs2-0010" title="LinY , ChenDC . Efficacy of anti‐inflammatory moisturising washing formula for atopic dermatitis and its biological evaluation. Guangzhou University of Chinese Medicine, Guangzhou [PhD thesis]2010. ">Lin 2010</a>), no severe adverse events were reported in 23 studies, and the remaining 4 studies did not report adverse events (<a href="./references#CD008642-bbs2-0008" title="JinPZ , YeQH , ShenM . Observation of efficacy of Jianpi Zhiyang granules for 32 cases with atopic dermatitis. Henan Traditional Chinese Medicine2007;27(12):61‐2. ">Jin 2007</a>; <a href="./references#CD008642-bbs2-0020" title="XueSQ , TanJH . Clinical observation of Shengxue Runfu decoction with modifications for childhood atopic dermatitis. Journal of New Chinese Medicine2011;43(2):94‐5. ">Xue 2011</a>; <a href="./references#CD008642-bbs2-0025" title="ZhangXJ , SongXL . Observation of clinical efficacy of Xiao'er Huashi decoction for infantile eczema. Proceedings of the First International Dermatology Academic Symposium of TCM and Integrated TCM‐WM. Beijing: World Federation of Chinese Medicine Societies, 2009:297‐9. ">Zhang 2009</a>; <a href="./references#CD008642-bbs2-0026" title="ZhangCJ . Clinical observation of Zhiyin Qingre method for 30 cases with atopic dermatitis. Guiding Journal of Traditional Chinese Medicine &amp; Pharmacy2011;17(8):22‐4. ">Zhang 2011</a>). Twenty‐four studies reported minor adverse events; 2 studies observed transient elevation of aspartate aminotransferase or alanine transaminase in the trial participants (<a href="./references#CD008642-bbs2-0004" title="ChengHM , ChiangLC , JanYM , ChenGW , LiTC . The efficacy and safety of a Chinese herbal product (Xiao‐Feng‐San) for the treatment of refractory atopic dermatitis: a randomized, double‐blind, placebo‐controlled trial. International Archives of Allergy &amp; Immunology2011;155(2):141‐8. [DOI: 10.1159/000318861] ">Cheng 2010</a>; <a href="./references#CD008642-bbs2-0014" title="RaoMR , WeiYG . Clinical study of Qingxin Peitu method for atopic dermatitis. Nanjing University of Chinese Medicine, Nanjing [Masters thesis]2010. ">Rao 2010</a>). Apart from the <a href="./references#CD008642-bbs2-0006" title="HonKL , LeungTF , NgPC , LamMCA , KamWYC , WongKY , et al. Efficacy and tolerability of a Chinese herbal medicine concoction for treatment of atopic dermatitis: a randomized, double‐blind, placebo‐controlled study. British Journal of Dermatology2007;157(2):357‐63. [MEDLINE: 17501956] HonKLE , LeungTF , NgPC , LamMCA , KamWYC , WongKY , et al. Therapeutic effect and safety of a traditional Chinese medicine for atopic dermatitis in children: a randomised, double‐blind, placebo‐controlled study. Hong Kong Medical Journal2011;17(1 Suppl 2):38‐40. ">Hon 2007</a> study, which recorded a statistically significant difference in minor adverse events with a higher incidence in the CHM group, pooled data from other included studies demonstrated significantly less minor adverse events with CHM interventions than their comparators. Nevertheless, the quality of evidence was low. </p> <p>There were eight included studies (<a href="./references#CD008642-bbs2-0004" title="ChengHM , ChiangLC , JanYM , ChenGW , LiTC . The efficacy and safety of a Chinese herbal product (Xiao‐Feng‐San) for the treatment of refractory atopic dermatitis: a randomized, double‐blind, placebo‐controlled trial. International Archives of Allergy &amp; Immunology2011;155(2):141‐8. [DOI: 10.1159/000318861] ">Cheng 2010</a>; <a href="./references#CD008642-bbs2-0005" title="GongXH , KuangL , LiuX . Clinical observation of Liangxue Xiaofeng formula for adult atopic dermatitis. Journal of TCM University of Hunan2010;30(3):61‐3. ">Gong 2010</a>; <a href="./references#CD008642-bbs2-0006" title="HonKL , LeungTF , NgPC , LamMCA , KamWYC , WongKY , et al. Efficacy and tolerability of a Chinese herbal medicine concoction for treatment of atopic dermatitis: a randomized, double‐blind, placebo‐controlled study. British Journal of Dermatology2007;157(2):357‐63. [MEDLINE: 17501956] HonKLE , LeungTF , NgPC , LamMCA , KamWYC , WongKY , et al. Therapeutic effect and safety of a traditional Chinese medicine for atopic dermatitis in children: a randomised, double‐blind, placebo‐controlled study. Hong Kong Medical Journal2011;17(1 Suppl 2):38‐40. ">Hon 2007</a>; <a href="./references#CD008642-bbs2-0013" title="MaYB , SunLY , WangP , ZhangGZ , CaiNN . Clinical observation of combination of Jianpi Runfu decoction and topical application of Gancao oil for atopic dermatitis with syndrome of spleen deficiency and blood dryness. Beijing Journal of Traditional Chinese Medicine2010;29(9):680‐2. ">Ma 2010</a>; <a href="./references#CD008642-bbs2-0015" title="SunXD . Evaluation of efficacy and affect of reoccurrence of Jianpi Shenshi granules for atopic dermatitis [Clinical effect of invigorating spleen and excreting dampness granules in treating atopic dermatitis and its influence for recurrence of the patient]. Chinese Journal of Dermatovenerology Integrated Traditional and Western Medicine2009;8(6):335‐7. ">Sun 2009</a>; <a href="./references#CD008642-bbs2-0020" title="XueSQ , TanJH . Clinical observation of Shengxue Runfu decoction with modifications for childhood atopic dermatitis. Journal of New Chinese Medicine2011;43(2):94‐5. ">Xue 2011</a>; <a href="./references#CD008642-bbs2-0021" title="YangY , SunJL , FengYL , YangYF , WangLX . Analysis of efficacy of Chinese herbs Jianpi Zhiyang granules with Pibo Xiaoyan Xuanshi ointment for atopic dermatitis. Chinese Journal of Dermatovenerology Integrated Traditional &amp; Western Medicine2007;6(3):135‐7. ">Yang 2007</a>; <a href="./references#CD008642-bbs2-0023" title="YuTG , ZhuJT , XuJL , ZhuangYR , ShenB , WuBL , et al. Clincial and laboratory study of Piyan Xiaojingyin granules II for atopic dermatitis. Journal of Traditional Chinese Medicine1999;40(3):165‐7. ">Yu 1999</a>) that were funded by governments. In addition, 75% of the included studies, all conducted in mainland China, reported identical numbers of participants randomised and analysed. These studies reported no incomplete outcome data. We were not able to find out the underlying reasons for such unusually high compliance in RCTs. </p> </section> <section id="CD008642-sec-0137"> <h3 class="title" id="CD008642-sec-0137">Overall completeness and applicability of evidence</h3> <p>We included studies with CHM interventions administered orally or applied topically, or a combination of both, for children or adults diagnosed with eczema. All 28 included studies specifically focused on management of eczema with CHM. Based on a Chinese medicine description, the selected Chinese herbs in the included studies were under categories of "exterior‐releasing", "heat‐clearing", "purgative", "wind‐damp‐dispelling", "damp‐resolving", "damp‐draining", "interior‐warming", "Qi‐regulating", "digestant", "haemostatic", "blood‐activating and stasis‐resolving", "liver‐pacifying wind‐extinguishing", "resuscitative", "tonifying", "astringent", and "externally applied and miscellaneous" (<a href="./references#CD008642-bbs2-0063" title="Li , ZJ . International Standard Chinese‐English Basic Nomenclature of Chinese Medicine. Beijing: People's Medical Publishing House, 2008. ">Li 2008</a>). The top seven most commonly used herbs were Gancao (<i>Radix glycyrrhizae</i> ) (16 studies), Cangzhu (<i>Rhizoma atractylodis</i> ) (13 studies), Danggui (<i>Radix angelicae sinensis</i> ) (11 studies), Baizhu (<i>Rhizoma atractylodis macrocephalae</i> ) (9 studies), Baixianpi (<i>Cortex dictamni</i> ) (9 studies), Fuling (<i>Poria</i> ) (9 studies), and Shengdihuang (<i>Radix rehmanniae</i>) (9 studies). We also included studies in which the CHM formulae were modified based on Chinese medicine syndrome differentiation, as well as the studies that only recruited people with eczema who had a prespecified Chinese medicine syndrome. Many of the included studies were conducted in Chinese medicine teaching hospitals or general medical teaching hospitals, which are expected to have standardised facilities and qualified personnel and represent the standard of clinical practice of the profession (<a href="./references#CD008642-bbs2-0065" title="Ministry of Education of the People's Republic of China. Interim provisions for management of general tertiary medical education clinical teaching base. http://202.205.177.9/edoas/website18/41/info5941.htm (accessed 1 May 2012). ">MEPRC 1992</a>). The results have reflected the up‐to‐date management of eczema with CHM. The findings of this review could provide a crucial reference for current evidence‐based Chinese medical practice and research. </p> </section> <section id="CD008642-sec-0138"> <h3 class="title" id="CD008642-sec-0138">Quality of the evidence</h3> <p>We used the Grading of Recommendations Assessment, Development and Evaluation (GRADE) system, recommended by the <i>Cochrane Handbook for Systematic Reviews of Interventions</i>, to assess the level of evidence on outcome measures reported by the included studies (<a href="./references#CD008642-bbs2-0072" title="SchünemannHJ , OxmanAD , VistGE , HigginsJPT , DeeksJJ , GlasziouP , et al. Chapter 12: Interpreting results and drawing conclusions. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Schünemann 2011</a>). Overall, the quality of the included studies was poor except the <a href="./references#CD008642-bbs2-0006" title="HonKL , LeungTF , NgPC , LamMCA , KamWYC , WongKY , et al. Efficacy and tolerability of a Chinese herbal medicine concoction for treatment of atopic dermatitis: a randomized, double‐blind, placebo‐controlled study. British Journal of Dermatology2007;157(2):357‐63. [MEDLINE: 17501956] HonKLE , LeungTF , NgPC , LamMCA , KamWYC , WongKY , et al. Therapeutic effect and safety of a traditional Chinese medicine for atopic dermatitis in children: a randomised, double‐blind, placebo‐controlled study. Hong Kong Medical Journal2011;17(1 Suppl 2):38‐40. ">Hon 2007</a> study where the level of quality of the evidence was 'moderate' in the outcome measured by QoL. The majority of the included studies showed unclear risk of bias for allocation concealment and high risk of bias due to lack of blinding; thus, we had to downgrade the strength of evidence of those studies into 'low level' because of serious limitations in their design and implementation (absence of allocation concealment and blinding). The 2306 participants within the 28 included studies were diverse, with their ages ranging from newborn babies to 65 years, and most of the studies had mixed children with adults. There were heterogeneous Chinese herbs or formulae with regard to the ingredients, dosage, and administration in the included studies. This contributed to a high level of inconsistency of the outcomes across the studies although such underlying sources of heterogeneity have not been confirmed by statistical analyses because of insufficiency of data. </p> </section> <section id="CD008642-sec-0139"> <h3 class="title" id="CD008642-sec-0139">Potential biases in the review process</h3> <p>The randomised controlled trial is a gold standard to test efficacy of an intervention for a defined condition within a population (<a href="./references#CD008642-bbs2-0061" title="KaneM . Research Made Easy in Complementary &amp; Alternative Medicine. Edinburgh: Churchill Livingstone, 2004. ">Kane 2004</a>). It is debatable however whether results from RCTs can really reflect the intrinsic effect obtained from an individualised treatment, which is one of the essential features of Chinese medicine practice. For this reason, we scrupulously aimed to include studies using individualised treatments or studies only recruiting people with eczema who had a specific type of Chinese medicine syndrome as far as there was an appropriate control group, i.e. with balanced numbers of randomised participants, in the study. We further performed subgroup analysis in those included studies with individualised treatment. We tried our best to search for any studies that matched the inclusion criteria, but it could still be possible that we overlooked some papers, in particular those published in Chinese. This is because we had limited access to the printed Chinese medical journals that were not covered by the Chinese databases we had searched. We were unable to rule out the possibility of potential language bias in this review as Chinese medicine is also popularly used in other Asian countries, such as Japan, Vietnam, and Korea. We were not able to search databases developed by these countries. </p> <p>The funnel plot in <a href="#CD008642-fig-0006">Figure 6</a> and Egger test did not show statistically asymmetrical distributions among those 15 studies that compared the effects of CHM and Western medications. However, we could not exclude reporting bias including publication bias in those 15 studies because of the relatively low power of the Egger test (<a href="./references#CD008642-bbs2-0073" title="SterneJAC , EggerM , MoherD (editors) . Chapter 10: Addressing reporting biases. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Sterne 2011</a>). </p> </section> <section id="CD008642-sec-0140"> <h3 class="title" id="CD008642-sec-0140">Agreements and disagreements with other studies or reviews</h3> <p>The first Cochrane systematic review of CHM for eczema was published in 2004 (<a href="./references#CD008642-bbs2-0080" title="ZhangW , LeonardT , Bath‐HextallF , ChambersCA , LeeC , HumphreysR , et al. Chinese herbal medicine for atopic eczema. Cochrane Database of Systematic Reviews2004, Issue 4. [DOI: 10.1002/14651858.CD002291] ">Zhang 2004</a>); it included only 4 studies with oral ingestion of a CHM product, which is no longer available on the market. We did not include these studies in this updated review. Poor trial quality and "small study effect" were found across the included studies in both the version published in 2004 and this review. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD008642-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/urn:x-wiley:14651858:media:CD008642:CD008642-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/image_t/tCD008642-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study selection flow diagram" data-id="CD008642-fig-0001" src="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/image_n/nCD008642-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study selection flow diagram</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/full#CD008642-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/image_n/nCD008642-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008642-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/urn:x-wiley:14651858:media:CD008642:CD008642-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/image_t/tCD008642-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' graph: review authors' judgements about each 'Risk of bias' item presented as percentages across all included studies" data-id="CD008642-fig-0002" src="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/image_n/nCD008642-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each 'Risk of bias' item presented as percentages across all included studies </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/full#CD008642-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/image_n/nCD008642-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008642-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/urn:x-wiley:14651858:media:CD008642:CD008642-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/image_t/tCD008642-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' summary: review authors' judgements about each 'Risk of bias' item for each included study" data-id="CD008642-fig-0003" src="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/image_n/nCD008642-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each 'Risk of bias' item for each included study </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/full#CD008642-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/image_n/nCD008642-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008642-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/urn:x-wiley:14651858:media:CD008642:CD008642-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/image_t/tCD008642-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 CHM versus placebo, outcome: 1.3 Overall severity score" data-id="CD008642-fig-0004" src="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/image_n/nCD008642-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 CHM versus placebo, outcome: 1.3 Overall severity score</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/full#CD008642-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/image_n/nCD008642-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008642-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/urn:x-wiley:14651858:media:CD008642:CD008642-AFig-FIG05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/image_t/tCD008642-AFig-FIG05.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 2 CHM versus drugs, outcome: 2.1 Total effectiveness rate (number of participants recovered and significantly improved) with subgroup analysis" data-id="CD008642-fig-0005" src="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/image_n/nCD008642-AFig-FIG05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Forest plot of comparison: 2 CHM versus drugs, outcome: 2.1 Total effectiveness rate (number of participants recovered and significantly improved) with subgroup analysis </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/full#CD008642-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/image_n/nCD008642-AFig-FIG05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008642-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/urn:x-wiley:14651858:media:CD008642:CD008642-AFig-FIG06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/image_t/tCD008642-AFig-FIG06.png" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 2 CHM vs drugs, outcome: 2.4 Overall severity score" data-id="CD008642-fig-0006" src="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/image_n/nCD008642-AFig-FIG06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 6</div> <div class="figure-caption"> <p>Funnel plot of comparison: 2 CHM vs drugs, outcome: 2.4 Overall severity score</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/full#CD008642-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/image_n/nCD008642-AFig-FIG06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008642-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/urn:x-wiley:14651858:media:CD008642:CD008642-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/image_t/tCD008642-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 CHM versus placebo, Outcome 1 Total effectiveness rate (number of participants recovered and significantly improved)." data-id="CD008642-fig-0007" src="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/image_n/nCD008642-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 CHM versus placebo, Outcome 1 Total effectiveness rate (number of participants recovered and significantly improved). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/references#CD008642-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/image_n/nCD008642-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008642-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/urn:x-wiley:14651858:media:CD008642:CD008642-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/image_t/tCD008642-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 CHM versus placebo, Outcome 2 Itching VAS." data-id="CD008642-fig-0008" src="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/image_n/nCD008642-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 CHM versus placebo, Outcome 2 Itching VAS.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/references#CD008642-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/image_n/nCD008642-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008642-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/urn:x-wiley:14651858:media:CD008642:CD008642-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/image_t/tCD008642-CMP-001-03.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 CHM versus placebo, Outcome 3 Overall severity score." data-id="CD008642-fig-0009" src="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/image_n/nCD008642-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 CHM versus placebo, Outcome 3 Overall severity score.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/references#CD008642-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/image_n/nCD008642-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008642-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/urn:x-wiley:14651858:media:CD008642:CD008642-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/image_t/tCD008642-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 CHM versus placebo, Outcome 4 Overall severity score (short‐term improvement)." data-id="CD008642-fig-0010" src="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/image_n/nCD008642-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 CHM versus placebo, Outcome 4 Overall severity score (short‐term improvement).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/references#CD008642-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/image_n/nCD008642-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008642-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/urn:x-wiley:14651858:media:CD008642:CD008642-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/image_t/tCD008642-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 CHM versus placebo, Outcome 5 QoL." data-id="CD008642-fig-0011" src="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/image_n/nCD008642-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 CHM versus placebo, Outcome 5 QoL.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/references#CD008642-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/image_n/nCD008642-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008642-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/urn:x-wiley:14651858:media:CD008642:CD008642-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/image_t/tCD008642-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 CHM versus placebo, Outcome 6 QoL (short‐term improvement)." data-id="CD008642-fig-0012" src="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/image_n/nCD008642-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 CHM versus placebo, Outcome 6 QoL (short‐term improvement).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/references#CD008642-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/image_n/nCD008642-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008642-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/urn:x-wiley:14651858:media:CD008642:CD008642-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/image_t/tCD008642-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 CHM versus placebo, Outcome 7 Adverse events." data-id="CD008642-fig-0013" src="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/image_n/nCD008642-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 CHM versus placebo, Outcome 7 Adverse events.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/references#CD008642-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/image_n/nCD008642-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008642-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/urn:x-wiley:14651858:media:CD008642:CD008642-CMP-001-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/image_t/tCD008642-CMP-001-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 CHM versus placebo, Outcome 8 Adverse events in one study." data-id="CD008642-fig-0014" src="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/image_n/nCD008642-CMP-001-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1 CHM versus placebo, Outcome 8 Adverse events in one study.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/references#CD008642-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/image_n/nCD008642-CMP-001-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008642-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/urn:x-wiley:14651858:media:CD008642:CD008642-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/image_t/tCD008642-CMP-002-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 CHM versus drugs, Outcome 1 Total effectiveness rate (number of participants recovered and significantly improved) with subgroup analysis." data-id="CD008642-fig-0015" src="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/image_n/nCD008642-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 CHM versus drugs, Outcome 1 Total effectiveness rate (number of participants recovered and significantly improved) with subgroup analysis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/references#CD008642-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/image_n/nCD008642-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008642-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/urn:x-wiley:14651858:media:CD008642:CD008642-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/image_t/tCD008642-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 CHM versus drugs, Outcome 2 Total effectiveness rate (long‐term improvement)." data-id="CD008642-fig-0016" src="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/image_n/nCD008642-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 CHM versus drugs, Outcome 2 Total effectiveness rate (long‐term improvement).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/references#CD008642-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/image_n/nCD008642-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008642-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/urn:x-wiley:14651858:media:CD008642:CD008642-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/image_t/tCD008642-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 CHM versus drugs, Outcome 3 Itching VAS." data-id="CD008642-fig-0017" src="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/image_n/nCD008642-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 CHM versus drugs, Outcome 3 Itching VAS.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/references#CD008642-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/image_n/nCD008642-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008642-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/urn:x-wiley:14651858:media:CD008642:CD008642-CMP-002-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/image_t/tCD008642-CMP-002-04.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 CHM versus drugs, Outcome 4 Overall severity score." data-id="CD008642-fig-0018" src="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/image_n/nCD008642-CMP-002-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2 CHM versus drugs, Outcome 4 Overall severity score.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/references#CD008642-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/image_n/nCD008642-CMP-002-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008642-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/urn:x-wiley:14651858:media:CD008642:CD008642-CMP-002-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/image_t/tCD008642-CMP-002-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 CHM versus drugs, Outcome 5 Overall severity score (long‐term improvement)." data-id="CD008642-fig-0019" src="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/image_n/nCD008642-CMP-002-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2 CHM versus drugs, Outcome 5 Overall severity score (long‐term improvement).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/references#CD008642-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/image_n/nCD008642-CMP-002-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008642-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/urn:x-wiley:14651858:media:CD008642:CD008642-CMP-002-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/image_t/tCD008642-CMP-002-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 CHM versus drugs, Outcome 6 Adverse events." data-id="CD008642-fig-0020" src="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/image_n/nCD008642-CMP-002-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.6</div> <div class="figure-caption"> <p>Comparison 2 CHM versus drugs, Outcome 6 Adverse events.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/references#CD008642-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/image_n/nCD008642-CMP-002-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008642-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/urn:x-wiley:14651858:media:CD008642:CD008642-CMP-002-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/image_t/tCD008642-CMP-002-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 CHM versus drugs, Outcome 7 Total effectiveness rate with posthoc subgroup analysis." data-id="CD008642-fig-0021" src="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/image_n/nCD008642-CMP-002-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.7</div> <div class="figure-caption"> <p>Comparison 2 CHM versus drugs, Outcome 7 Total effectiveness rate with posthoc subgroup analysis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/references#CD008642-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/image_n/nCD008642-CMP-002-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008642-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/urn:x-wiley:14651858:media:CD008642:CD008642-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/image_t/tCD008642-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Combination of oral and topical CHM versus same oral CHM, Outcome 1 Total effectiveness rate (number of participants recovered and significantly improved)." data-id="CD008642-fig-0022" src="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/image_n/nCD008642-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Combination of oral and topical CHM versus same oral CHM, Outcome 1 Total effectiveness rate (number of participants recovered and significantly improved). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/references#CD008642-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/image_n/nCD008642-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008642-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/urn:x-wiley:14651858:media:CD008642:CD008642-CMP-003-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/image_t/tCD008642-CMP-003-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Combination of oral and topical CHM versus same oral CHM, Outcome 2 Total effectiveness rate (long‐term improvement)." data-id="CD008642-fig-0023" src="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/image_n/nCD008642-CMP-003-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 Combination of oral and topical CHM versus same oral CHM, Outcome 2 Total effectiveness rate (long‐term improvement). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/references#CD008642-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/image_n/nCD008642-CMP-003-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008642-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/urn:x-wiley:14651858:media:CD008642:CD008642-CMP-003-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/image_t/tCD008642-CMP-003-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Combination of oral and topical CHM versus same oral CHM, Outcome 3 Itching VAS." data-id="CD008642-fig-0024" src="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/image_n/nCD008642-CMP-003-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3 Combination of oral and topical CHM versus same oral CHM, Outcome 3 Itching VAS. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/references#CD008642-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/image_n/nCD008642-CMP-003-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008642-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/urn:x-wiley:14651858:media:CD008642:CD008642-CMP-003-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/image_t/tCD008642-CMP-003-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Combination of oral and topical CHM versus same oral CHM, Outcome 4 Skin lesion score." data-id="CD008642-fig-0025" src="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/image_n/nCD008642-CMP-003-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3 Combination of oral and topical CHM versus same oral CHM, Outcome 4 Skin lesion score. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/references#CD008642-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/image_n/nCD008642-CMP-003-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008642-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/urn:x-wiley:14651858:media:CD008642:CD008642-CMP-003-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/image_t/tCD008642-CMP-003-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Combination of oral and topical CHM versus same oral CHM, Outcome 5 Overall severity score." data-id="CD008642-fig-0026" src="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/image_n/nCD008642-CMP-003-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.5</div> <div class="figure-caption"> <p>Comparison 3 Combination of oral and topical CHM versus same oral CHM, Outcome 5 Overall severity score. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/references#CD008642-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/image_n/nCD008642-CMP-003-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008642-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/urn:x-wiley:14651858:media:CD008642:CD008642-CMP-003-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/image_t/tCD008642-CMP-003-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Combination of oral and topical CHM versus same oral CHM, Outcome 6 QoL." data-id="CD008642-fig-0027" src="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/image_n/nCD008642-CMP-003-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.6</div> <div class="figure-caption"> <p>Comparison 3 Combination of oral and topical CHM versus same oral CHM, Outcome 6 QoL.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/references#CD008642-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/image_n/nCD008642-CMP-003-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008642-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/urn:x-wiley:14651858:media:CD008642:CD008642-CMP-003-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/image_t/tCD008642-CMP-003-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Combination of oral and topical CHM versus same oral CHM, Outcome 7 Adverse events." data-id="CD008642-fig-0028" src="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/image_n/nCD008642-CMP-003-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.7</div> <div class="figure-caption"> <p>Comparison 3 Combination of oral and topical CHM versus same oral CHM, Outcome 7 Adverse events. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/references#CD008642-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/media/CDSR/CD008642/image_n/nCD008642-CMP-003-07.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD008642-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">CHM compared to placebo</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>CHM compared to placebo for atopic eczema</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> Participants with atopic eczema<br/> <b>Settings:</b> Hospital outpatients<br/> <b>Intervention:</b> CHM<br/> <b>Comparison:</b> Placebo </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risk* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Number of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Placebo</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> CHM</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Total effectiveness rate</b> (<a href="./references#CD008642-fig-0007" title="">Analysis 1.1</a>)<br/> Clinician's rating<br/> Follow up: 2 to 4 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Low¹</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 2.09</b> <br/> (1.32 to 3.32) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>85<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low²,³</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>2 additional studies did not report this outcome. A higher total effectiveness rate indicates improvement of the condition </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>1 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>2 per 100</b> <br/> (1 to 3) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>High¹</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>40 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>84 per 100</b> <br/> (53 to 100) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Itching VAS</b> (<a href="./references#CD008642-fig-0008" title="">Analysis 1.2</a>)<br/> Participant's rating. Scale from 1 to 10<br/> Follow up: 4 to 12 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean itching VAS ranged across control groups from<br/> <b>0.2 to 7.8 scores</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean itching in VAS in the intervention groups was <b>1.53 standard deviations lower</b> (2.64 to 0.41 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>94<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low³,⁴</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lower score indicates improvement of the condition. 2 additional studies did not report this outcome </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Overall severity score</b> (<a href="./references#CD008642-fig-0009" title="">Analysis 1.3</a>) <br/> Clinician's rating. Scale from 1 to 80<br/> Follow up: 2 to 16 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean overall severity score ranged across control groups from<br/> <b>5.7 to 46.9 scores</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean overall severity score in the intervention groups was <b>0.88 standard deviations lower</b> (1.67 to 0.09 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>239<br/> (4 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low²,³,⁴</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lower score indicates improvement of the condition</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>QoL</b> (<a href="./references#CD008642-fig-0011" title="">Analysis 1.5</a>)<br/> Participant's rating. Scale from 0 to 30<br/> Follow up: 4 to 16 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean QoL in the control groups was<br/> <b>10.1 scores</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean QoL in the intervention groups was <b>2.5 lower</b> (4.77 to 0.23 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>85<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate³</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lower score indicates better quality of life. 3 additional studies did not report this outcome </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Adverse events</b> (<a href="./references#CD008642-fig-0013" title="">Analysis 1.7</a>)<br/> Participant's report<br/> Follow up: 2 to 12 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Low¹</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 0.71</b> <br/> (0.06 to 8.67) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>129<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low²,³</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>1 additional study reported numbers of adverse events that were greater than the total participants. Data were treated as adverse event 'count data' rather than participant level data, which could not be pooled with these 2 studies </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>1 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>1 per 100</b> <br/> (0 to 9) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>High¹</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>6 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>4 per 100</b> <br/> (0 to 52) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in the footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI)<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate<br/> <b>Very low quality:</b> We are very uncertain about the estimate </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p>¹The low and high assumed risk values are the two extreme numbers of the events taken from the control groups in the included studies.<br/> ²Unclear risk of bias in allocation concealment and high risk of bias in blinding of participants and personnel.<br/> ³Total number of events was less than 300.<br/> ⁴Unexplained heterogeneity. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">CHM compared to placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/full#CD008642-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD008642-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">CHM compared to drugs</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>CHM compared to drugs for atopic eczema</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> Participants with atopic eczema<br/> <b>Settings:</b> Hospital outpatients<br/> <b>Intervention:</b> CHM<br/> <b>Comparison:</b> Drugs </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risk* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Number of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Drugs</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> CHM</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Total effectiveness rate</b> (<a href="./references#CD008642-fig-0015" title="">Analysis 2.1</a>)<br/> Clinician's rating<br/> Follow up: 2 to 52 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Low¹</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 1.43</b> <br/> (1.27 to 1.61) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>1868<br/> (21 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low²,³,⁴,⁵</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>A higher total effectiveness rate indicates improvement of the condition</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>20 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>29 per 100</b> <br/> (25 to 32) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>High¹</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>90 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>100 per 100</b> <br/> (100 to 100) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Total effectiveness rate with subgroup analysis ‐ individualised treatment</b> <br/> Clinician's rating<br/> Follow up: 4 to 8 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Low¹</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 1.50</b> <br/> (1.30 to 1.74) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>567<br/> (7 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low²,³,⁴</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>20 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>30 per 100</b> <br/> (26 to 35) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>High¹</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>70 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>100 per 100</b> <br/> (91 to 100) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Total effectiveness rate with subgroup analysis ‐ non‐individualised treatment</b> <br/> Clinician's rating<br/> Follow up: 2 to 52 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Low¹</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 1.37</b> <br/> (1.17 to 1.60) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>1301<br/> (14 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low²,³,⁴,⁵</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>20 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>27 per 100</b> <br/> (23 to 32) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>High¹</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>90 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>100 per 100</b> <br/> (100 to 100) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Itching VAS</b> (<a href="./references#CD008642-fig-0017" title="">Analysis 2.3</a>)<br/> Participant's rating. Scale from 0 to 10<br/> Follow up: 2 to 12 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean itching VAS ranged across control groups from<br/> <b>0.3 to 5.75 scores</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean itching VAS in the intervention groups was <b>0.83 standard deviations lower</b> (1.43 to 0.22 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>465<br/> (7 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low²,³,⁵</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lower score indicates improvement of the condition. 16 additional studies did not report this outcome </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Overall severity score</b> (<a href="./references#CD008642-fig-0018" title="">Analysis 2.4</a>)<br/> Clinician's rating. Scale from 0 to 103<br/> Follow up: 2 to 12 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean overall severity score ranged across control groups from<br/> <b>0.3 to 70.82 scores</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean overall severity score in the intervention groups was <b>0.97 standard deviations lower</b> (1.23 to 0.71 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1062<br/> (15 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low²,³,⁵</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lower score indicates improvement of the condition. 8 additional studies did not report this outcome </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Adverse events</b> (<a href="./references#CD008642-fig-0020" title="">Analysis 2.6</a>)<br/> Participant's reports<br/> Follow up: 2 to 52 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Low¹</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 0.44</b> <br/> (0.32 to 0.61) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>1396<br/> (15 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low²,³,⁴</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>4 additional studies did not report this outcome</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>1 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>0 per 100</b> <br/> (0 to 1) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>High¹</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>60 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>26 per 100</b> <br/> (19 to 37) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in the footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI)<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate<br/> <b>Very low quality:</b> We are very uncertain about the estimate </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p>¹The low and high assumed risk values are the two extreme numbers of the events taken from the control groups in the included studies.<br/> ²Unclear risk of bias in allocation concealment and high risk of bias in blinding participants and personnel.<br/> ³High risk of bias in blinding of outcome assessment.<br/> ⁴High risk of bias in other potential sources of bias.<br/> ⁵Unexplained heterogeneity. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">CHM compared to drugs</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/full#CD008642-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD008642-tbl-0003"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Combination of oral and topical CHM compared to same oral CHM</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Combination of oral and topical CHM compared to same oral CHM for atopic eczema</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> Participants with atopic eczema<br/> <b>Settings:</b> Hospital outpatients<br/> <b>Intervention:</b> Combination of oral and topical CHM<br/> <b>Comparison:</b> Same oral CHM </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risk* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Number of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>CHM (oral)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> CHM (combination of oral and topical)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Total effectiveness rate</b> (<a href="./references#CD008642-fig-0022" title="">Analysis 3.1</a>)<br/> Clinician's rating<br/> Follow up: 4 to 24 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.13</b> <br/> (0.78 to 1.63) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>20<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low¹,</b>² </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1 additional study did not report this outcome. A higher total effectiveness rate indicates improvement of the condition </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>80 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>90 per 100</b> <br/> (62 to 100) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Overall severity score</b> (<a href="./references#CD008642-fig-0026" title="">Analysis 3.5</a>)<br/> Clinician's rating. Scale from 0 to 103<br/> Follow up: 4 to 24 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean overall severity score in the control groups was<br/> <b>21.02 scores</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean overall severity score in the intervention groups was <b>3.43 lower</b> (7.01 lower to 0.15 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low¹,</b>² </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lower score indicates improvement of the condition. 1 additional study was a within‐patient design; data were analysed separately </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>QoL</b> (<a href="./references#CD008642-fig-0027" title="">Analysis 3.6</a>)<br/> Participant's rating. Scale from 0 to 30<br/> Follow up: 4 to 24 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean QoL in the control groups was<br/> <b>5.8 scores</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean QoL in the intervention groups was <b>0.9 higher</b> (2.89 lower to 4.69 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low¹,</b>² </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lower score indicates better quality of life. 1 additional study did not report this outcome </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Adverse events</b> (<a href="./references#CD008642-fig-0028" title="">Analysis 3.7</a>)<br/> Participant's report<br/> Follow up: 4 to 12 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1</b> <br/> (0.07 to 13.87) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>20<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low¹,</b>² </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1 additional study was a within‐patient study, and data on adverse events were analysed separately in this review </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>10 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>10 per 100</b> <br/> (1 to 100) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Itching VAS</b> (<a href="./references#CD008642-fig-0024" title="">Analysis 3.3</a>)<br/> Participant's rating. Scale from 0 to 10<br/> Follow up: 1 to 2 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean itching VAS in the control groups was<br/> <b>5.76 scores</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean itching VAS in the intervention groups was <b>1.05 lower</b> (1.75 to 0.35 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low¹,²,³</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lower score indicates improvement of the condition. This was a within‐patient study</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Skin lesion score</b> (<a href="./references#CD008642-fig-0025" title="">Analysis 3.4</a>)<br/> Clinician's rating. Scale from 0 to 24<br/> Follow up: 1 to 2 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean skin lesion score in the control groups was<br/> <b>9.05 scores</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean skin lesion score in the intervention groups was <b>1.59 lower</b> (2.92 to 0.26 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low¹,</b> ²<b>,³</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lower score indicates improvement of the condition. This was a within‐patient study</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI)<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate<br/> <b>Very low quality:</b> We are very uncertain about the estimate </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p>¹Unclear risk of bias in allocation concealment and high risk of bias in blinding of participants and personnel.<br/> ²Total number of events was less than 300.<br/> ³High risk of bias in incomplete outcome data. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Combination of oral and topical CHM compared to same oral CHM</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/full#CD008642-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD008642-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">CHM versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Total effectiveness rate (number of participants recovered and significantly improved) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>85</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.09 [1.32, 3.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Itching VAS <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>94</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.53 [‐2.64, ‐0.41]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Overall severity score <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>239</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.88 [‐1.67, ‐0.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Overall severity score (short‐term improvement) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 QoL <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 QoL (short‐term improvement) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>129</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.71 [0.06, 8.67]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Adverse events in one study <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">CHM versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/references#CD008642-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD008642-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">CHM versus drugs</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Total effectiveness rate (number of participants recovered and significantly improved) with subgroup analysis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1868</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.43 [1.27, 1.61]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Individualised treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>567</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.50 [1.30, 1.74]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Non‐individualised treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1301</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.37 [1.17, 1.60]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Total effectiveness rate (long‐term improvement) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>276</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.52 [1.11, 2.08]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Itching VAS <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>465</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.83 [‐1.43, ‐0.22]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Overall severity score <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1062</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.97 [‐1.23, ‐0.71]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Overall severity score (long‐term improvement) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1396</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.44 [0.32, 0.61]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Total effectiveness rate with posthoc subgroup analysis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1868</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.43 [1.27, 1.61]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 CHM versus topical steroid</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>671</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.18 [0.99, 1.40]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 CHM versus antihistamines</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>906</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.58 [1.37, 1.82]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.3 CHM versus other agents</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>291</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.58 [1.31, 1.90]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">CHM versus drugs</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/references#CD008642-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD008642-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Combination of oral and topical CHM versus same oral CHM</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Total effectiveness rate (number of participants recovered and significantly improved) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Total effectiveness rate (long‐term improvement) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Itching VAS <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Skin lesion score <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Overall severity score <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 QoL <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Combination of oral and topical CHM versus same oral CHM</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD008642.pub2/references#CD008642-tbl-0006">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD008642.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD008642-note-0006">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD008642-note-0007">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD008642-note-0005">Français</a> </li> <li class="section-language"> <a class="" href="hr#CD008642-note-0004">Hrvatski</a> </li> <li class="section-language"> <a class="" href="ja#CD008642-note-0003">日本語</a> </li> <li class="section-language"> <a class="" href="ko#CD008642-note-0001">한국어</a> </li> <li class="section-language"> <a class="" href="ms#CD008642-note-0002">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD008642-note-0014">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008642\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD008642\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008642\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD008642\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008642\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD008642\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008642\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD008642\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008642\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD008642\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008642\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD008642\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008642\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD008642\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008642\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD008642\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008642\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD008642\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=Qh5938oe&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD008642.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD008642.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD008642.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD008642.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD008642.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740726716912"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD008642.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740726716916"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD008642.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918e9a7509649368',t:'MTc0MDcyNjcxNy4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 